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ABSTRACT 
Active immunisation against GnRH inhibits reproductive function by inducing a hypo-
gonadotropic condition associated with gonadal atrophy. Despite economic, ethical 
and environmental advantages of GnRH immunisation in cattle over conventional 
castration methods, the techn?logy has not yet been comn:'ercially adopted. Primarily 
because of the requirement for numerous booster vaccinations because of the 
reversibility of physiological effects, the commercial efficacy of immunocastration is 
currently poor. However, neonatal GnRH immunisation in sheep can result in a 
permanent suppression of reproduction (Brown et al., 1994; 1995; Clarke et al., 
1998). These findings and a study in pigs (Molenaar et al., 1993) indicate that, the 
hypothalamic/pituitary gland unit (HPU) may be particularly susceptible to GnRH 
antibodies during a specific window of development in the pre-pubertal animal, but no 
long-term studies in cattle have been conducted. Therefore the primary objective of 
this project was to determine the effect of neonatal immunisation against GnRH in 
cattle. Beef cross bull (n=9; Chapter 3) and heifer calves (n=9; Chapter 4) were 
vaccinated against a newly developed (Pfizer®) GnRH construct vaccine at -2, 6 and 
13 weeks of age. Nine calves of each sex served as negative controls, receiving 
saline injections only. The GnRH vaccine had proved effective (Dr. A.R. Peters, 
personnel communication 2000) in inducing immune responses and reducing 
variation between animals in unpublished industrial studies, corripared to earlier 
vaccines, and hence was reasoned to be capable of raising GnRH antibodies despite 
the relative immaturity of the neonatal immune system. Following vaccination, 
circulating GnRH antibodies and reproductive hormones, such as FSH (Chapters 3 
and 4), testosterone (Chapter 3), progesterone (to assess onset of puberty) and 
oestradiol (Chapter 4) were measured and additional intensive serial bleeds were 
carried out to assess LH parameters up to and beyond puberty (puberty defined by 
testes circumference in bulls). Gonadal (antral follicles and testes growth) and 
accessory gland development was quantified throughout the trial using ultrasound 
scanning. Sexual behaviour (Chapter 3) was studied from 38 weeks of age, while an 
• assessment of sperm quality (Chapter 3), and anabolic response to vaccination was 
also performed post-mortem (Chapters 3 and 4). 
GnRH immunisation in neonatal calves did not permanently impair reproduction. A 
temporary suppression in reproductive function was evident through the disruption of 
pituitary gland function, as indicated by a reduction of LH pulse amplitude and mean 
plasma LH concentrations (Chapters 3 and 4). In addition, a reduction in medium-
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sized follicle numbers, testes growth, plasma testosterone concentration, vesicular 
gland length and juvenile aggression occurred. Some beneficial anabolic effects were 
observed e.g., carcass composition grades. Changes all occurred subsequent to 
increased GnRH antibody titres in immunised cattle. Despite some evidence of 
prolonged effects on LH amplitude and circulating testosterone after anti-GnRH titres 
had dissipated, all inhibited parameters, except carcass. quality, returned to levels 
comparable to control animals by 72 weeks of age. No treatment effects on FSH 
concentrations, large follicle numbers, reproductive tracts (post mortem) or peri- and 
post-pubertal behaviours were observed following treatment. Sperm morphological 
abnormalities tended to be more prevalent in GnRH immunised bulls. 
A significant increase in GnRH antibody titres occurred at -23 weeks of age (Chapter 
4), this may have been a rebound in antibody titre, possibly caused by an anti-
idiotype immune response (antibody response to GnRH antibodies), or due to 
significant maturational changes in immune function at this time causing a delayed 
response to vaccination. Alternatively a novel "auto-immune" response may have 
been detected, which if confirmed/repeatable might be incorporated into an 
immunisation protocol to act as a "self-booster". However, no previous reports of 
such an event have been published and further investigation is urgently required. 
A more prolonged or permanent suppression of reproductive function may be 
possible following an earlier, greater and more sustained elevation of antibody titres 
during the neonatal period. Further development of GnRH vaccines and/or protocols 
(prime-boost, cytokine modulation vaccines, concomitant passive and active 
immunisation and pregnant cow GnRH vaccination), and studies of performance and 
GnRH antibody mechanism(s) of action in cattle are required. Chapters 3 and 4 
provide a comprehensive study on pubertal development and neonatal GnRH 
vaccination, thus contributing significantly to knowledge in these fields. Currently, the 
vaccine used in this trial may be used to delay puberty in older calves or transiently 
suppress reproductive function to aid management. 
The economical viability of animal production systems such as beef and lamb are 
closely related to rates of reproduction. The Fec B gene in ewes increases ovulation 
rate and litter size, possibly through the development of precocious follicles, which 
can switch their primary dependence from FSH to LH. As a result, more follicles are 
selected to continue growth to an ovulatory size. The precise mechanisms by which 
these processes occur have recently been shown to involve oocyte follicle 
XIV 
interactions (see section 1.1.5). Follicle development is modulated by GHIIGF and 
inhibin, however attempts to increase follicular development and ovulation through 
active inhibin immunisation alone have been variable and hence not commercially 
attractive. To develop successful protocols to induce twin ovulations in cows· and 
ewes, without superovulation, a clearer, more details understanding of 
fOllicullogenesis is required ... The objective of the current study was to better 
understand these mechanisms through investigating interactions of GHIIGF and 
inhibin in the ovary, follicle development, steroidogenesis, and receptor populations 
using an anoestrous sheep model. 
Spring born Mule x Charolais ewe lambs were actively immunised (n=8) against 
porcine inhibin a-C 1-26 peptide conjugated to KLH in NUFCA (primary and 3 
boosters (NUFA», while 8 served as negative controls. Seven days following the final 
booster, the ewes were subdivided to give four groups: (1) controls + saline (n=4); (2) 
controls + rbGH (4ml s.c; 1mg. mr1; n=4); (3) inhibin immunised + saline (n=4); and 
(4) immunised + rbGH (n=4). Recombinant bovine growth hormone (rbGH) was given 
(Lm.) for 6 days. On day 4 GnRH (Receptal®; 1 ml) was injected s.c, to all animals to 
initiate the beginning of a new follicular wave. Blood samples were collected 
fortnightly to measure inhibin antibody titres, IGF-I, FSH and steroids. On the seventh 
day ensuing slaughter serum antibodies and ovaries were harvested. Left ovaries 
were intended for ISH (mRNA for P450arom) and/or immunohistochemical analysis. 
Follicles from right ovaries were dissected out, counted, measured and cultured in 
M199 at 37°C for 2 hours. Culture media was then assayed for oestradiol. Follicle 
shells were stored at -180°C for LH receptor binding studies. 
This work reports on the influence of different treatments on follicle populations. All 
immunised animals produced antibodies, which bound to 1251-inhibin. Using ANOVA 
to compare treatments it was observed that, Inhibin immunisation significantly 
(P<O.05) increased the number of follicles >3.5mm in diameter, but did not affect the 
smaller <3.5mm population. In contrast, rbGH administration led to a significant 
(P<O.05) elevation of follicles <3.5mm, without increasing the >3.5mm follicle 
numbers:" These findings are in agreement with previous research. The molecular 
studies of left ovaries are not presented herein as due to time constraints the work 
was not completed and is currently on going. 
In conclusion, additional results of this study are required to meet the objectives of 
the experiment. Further research is required on dominant follicle selection if 
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superovulatory programmes in both livestock and humans are to be more precisely 
controlled and readily accepted. 
An increased twinning rate in beef suckler cows is acknowledged as an optimal 
means of improving production efficiency (Diskin et a/., 1987), and preliminary 
observations (Campbell, Webb and Gong, unpublished) suggests that following 
oestrous cycle synchronisation, a passive inhibin immunisation protocol gives a more 
predictable twin ovulation response than active inhibin vaccination. Therefore, using 
inhibin antiserum raised in ewes (Chapter5), the final thesis objective was to 
investigate the efficacy of a bolus and booster antiserum administration protocol in 
heifers and the effects of passive inhibin immunisation on hormone parameters (FSH 
and progesterone), folliculogenesis (in vivo) ovulation rate and conception. 
Beef cross heifers (n=18; used earlier in Chapter 4 study) were randomly allocated to 
receive inhibin antiserum or NSS (controls). Following the Chapter 4 study, and 4 
months summer break at pasture, heifers were considered to be exhibiting typical 
cyclic reproductive function based on hormone measurements and scanning of 
ovaries. Oestrous cycles' were synchronised using 2 injections (Lm.) of PG 11 days 
apart and antiserum 'bolus' (108ml) was injected into the jugular vein 4 days after 2nd 
PG treatment. Subsequently, at 24h intervals for 5 days 14ml booster infusions were 
administered. Five days after ovulation, as confirmed by twice daily scanning, a 3rd 
PG was given and 72 and 96h later, heifers were A.1. Blood samples were collected 
every 8 hours from 2nd PG to 2nd A.1. 
Dominant follicle number and ovulation rate was unaffected by treatment due to 
inadequate inhibin antibodies in antiserum compared with the earlier trial (Campbell, 
Webb and Gong, unpublished), however, recruited follicle numbers were enhanced in 
inhibin immunised heifers. In addition, further evidence that inhibin antibodies act at 
the ovarian level to enhance recruitment, or reduce atresia was provided, as FSH 
concentrations were similar between groups. Higher inhibin antibody titre may be 
necessary to over-ride the strong dominant follicle selection mechanism in heifers. In 
... addition, the results of this and a previous trial demonstrate that a threshold inhibin 
antibody titre range is required to obtain a reproducible increase in ovulation rate on 
Which future passive inhibin immunisation studies may be based. Finally, this 
approach of a bolus followed by subsequent small antiserum injections has 
Successfully been shown to give a steady and consistent concentration of circulating 
inhibin antibody titres. 
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Chapter 1: Review of Literature 
CHAPTER ONE 
REVIEW OF LITERATURE 
1.1 ENDOCRINOLOGICAL CONTROL OF REPRODUCTION 
Spermatogenesis and folliculogenesis are controlled by complex relationships 
between the hypothalamic-pituitary-gonadal (HPG) feedback axis (Figures 1.3 and 
1.9), together with intra-gonadal steroids, growth and extra-gonadal factors (see 
Sharpe, 1990; Campbell, Scaramuzzi and Webb, 1995; Campbell et a/., 1999a). 
1.1.1 GnRH and ~ y p o t h a l a m u s s
Gonadotrophin releasing hormone (GnRH) is a low molecular weight (1183) 
decapeptide released from the basal hypothalamus (Fraser, 1980), and is highly 
conserved among mammals (Schally, Arimura and Kastin, 1973). GnRH was first 
isolated and characterised from sheep (8urgus and Guilleman, 1970) and pig 
hypothalami (Schally et a/., 1971), and was shown to have the same structure in 
cattle (Currie et a/., 1971). GnRH was synthesised by Matsuo et aI, (1971) and shown 
to possess the same biological activity as hypothalamic extracts. The GnRH peptide 
is acknowledged as the primary controlling hormone of reproductive activity in both 
sexes, as it affects gonadotrophins, synthesis and release, and steroids and gonadal 
proteins either directly or indirectly. GnRH synthesis and secretion is regulated by 
numerous neurotransmitters from higher brain centres (see Smith and Jennes, 2001; 
Goodman et a/., 2002), as well as by ovarian (Williams et a/., 2000; Tsai and Legan, 
2002; Looper et a/., 2003) and testicular steroids (Tilbrook et a/., 1991; Hileman and 
Jackson, 1999). Gonadal steroids act both centrally to control GnRH secretion and 
also directly at the pituitary level to modulate gonadotroph responsiveness to GnRH 
(Evans et a/., 1991a; Williams et al., 2000; Looper et a/., 2003; see Evans et a/., 
2002; McNeilly et a/., 2003). 
GnRH has been detected in several areas, both within the hypothalamus and in other 
regions of the brain, with high concentrations in the mid-brain, appreciable amounts 
in the cerebellum, brainstem and cerebral cortex (Wilber et al., 1976). In addition, 
GnRH producing cells and GnRH receptors were identified in the medial amygdala 
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Figure 1.1 Schematic diagram of the hypothalamic/pituitary gland portal system. Key: 
dark dots represent GnRH and white dots gonadotrophins. 
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plexus 
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pituitary 
Cells that produce 
anterior pituitary hormones 
including gonadotroph cells 
and accessory olfactory bulb (Lehman et al., 1986), the gonads (Hsueh and Jones, 
1981), placenta (Khodr and Siler-Khodr, 1980; Iwashita, Evans and Catt, 1986) and 
lactating mammary glands (Seeburg et al., 1987). Hypothalamic function is influenced 
by hormonal and neural signals from extra-hypothalamic tissues. Furthermore, the 
mid-brain has the ability to increase or decrease gonadotrophin output depending on 
- . 
the site of stimulation (Sharpe and Fraser, 1978). 
1.1.1.1 GnRH synthesis 
GnRH synthesis occurs in the cell bodies of hypothalamic neurons (Thompson Jr., 
2000), which are found in relatively high concentrations such as the arcuate nucleus 
(McCann, 1983), the medial pre-optic area (Lehman et aI., 1986) and 
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suprachiasmatic nuclei. These tissues are therefore considered to be the major sites 
of GnRH synthesis (Silverman, 1987). GnRH is synthesized as a large precursor 
molecule, made up of 92 amino acids in the human (MW 10,000; Seeburg and 
Adelman, 1984). The GnRH precursor encodes a signal sequence (23 amino acids), 
the GnRH peptide sequence (Pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2), a 
cleavage sequence (Gly-Lys-Arg) and a long (56 amino acid) C-terminal peptide 
called GnRH associated protein (GAP; Seeburg and Adelman, 1984; Adelman et a/., 
1986; Seeburg et a/., 1987). Following its synthesis, GnRH is transported via the 
respective long and short axons, to the terminal buttons, which synapse on the 
vessels within the median eminence (Kainer, 1993; Thompson Jr. 2000). It is during 
axonal transport that the pro-hormone is cleaved (Seeburg and Adelman, 1984). 
1.1.1.2 GnRH release 
Excited GnRH neurons secrete the peptide from granules into the extra-cellular 
space, where GnRH diffuses into the capillaries and travels via the hypophysial portal 
system to the sinusoidal capillary plexus within the adenohypophysis. Here GnRH 
exits the capillaries and binds to receptors on the anterior pituitary gland cells known 
as gonadotrophs. Pioneering studies involving hypophyseal portal blood sampling 
from ewes conclusively showed that GnRH release is pulsatile (Clarke and Cummins 
1982; Levine et a/., 1982), i.e., relatively large amounts of GnRH are released over a 
short period of time, followed ~ y y a period of low secretion and subsequently another 
pulse of GnRH. 
1.1.1.3 GnRH receptors 
The response of pituitary gonadotrophs to GnRH correlates directly with the 
concentrations of GnRH receptors on the cell surface (Norwitz et· a/., 2002). On 
binding to GnRH, G-protein coupled receptors on gonadotrophs microaggregate and 
are internalised (Hazum and Conn, 1988; D'Occhio, Aspden and Trigg, 2001; 
McArdle et al., 2002). The second messenger signal transduction pathway is 
activated (Figure 1.2) inducing the release of stored LH and FSH and de novo 
synthesis of both gonadotrophins (Huckle and Conn, 1988; Hawes et a/., 1992). The 
GnRH receptor population increases with exposure to GnRH (see Clayton and Catt, 
1981; Popkin and Fraser, 1985). Endogenous GnRH is essential for the maintenance 
and expression of pituitary gland receptors (Fraser et al., 1982; Popkin and Fraser, 
1985; Brown et al., 1994). In sheep, GnRH receptor mRNA appears to be increased 
by rising follicular phase oestradiol (Brooks and McNeilly, 1994). However, further 
3 
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investigations are required to confirm the relationship between GnRH receptor 
expression and oestrogen receptors on gonadotrophs (see McNeilly et al., 2003). 
Figure 1.2 Pathways of GnRH action. (Pis = phosphoinositides; IPS = inositol 
phosphates; DAG = diacylglycerol) (adapted from Huckle and Conn, 1988). 
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1.1.1.4 GnRH priming 
After an initial exposure of the pituitary gland to GnRH, an additional exposure results 
in a much larger release of LH. Several researchers have explained the phenomenon 
whereby small pulses of GnRH prime the pituitary gland to respond 'with increased 
efficiency to subsequent larger pulses by stimulating GnRH receptor formation 
(Foster, 1978; Padmamabhan, Kesner and Convey, 1981; Clayton, 1982; Catt et al., 
1985). GnRH stimulates gonadotroph expression of its receptor and promotes 
gonadotrophin synthesis (Fraser et al., 1974). For example, a reduction in 
gonadotrophin a and J3-subunit mRNA, pituitary LH and FSH content, and GnRH 
receptors was recently reported in three to four year old ewes, which had diminished 
GnRH secretion following neonatal immunisation against GnRH (Clarke et al., 1998). 
Gonadotrophs, like many hormone-responsive cell types, can become desensitised 
to GnRH or GnRH analogues, following long-term administration (see McArdle et al., 
2002). Desensitisation can result in virtually the complete cessation of episodic 
gonadotrophin release, with a concomitant decrease in sex steroid production 
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(chemical castration; Evans and Rawlings, 1994; Gong et a/., 1995; D'Occhio, 
Aspden and Whyte, 1996; Chandolia, Evans and Rawlings, 1997; Jimenez-Severiano 
et al., 1998; 2003; see O'Occhio and Aspden, 1999). 
1.1.2 Gonadotrophins and the Anterior Pituitary Gland 
FSH and LH are synthesized in the basophil cells of the anterior pituitary gland. 
" .-
Gonadotrophin structure was described first by Reichert (1962) and Reichert and 
Jiang (1965). Both are glycoprotein hormones (MW 28,000) consisting of two 
glycosylated polypeptide (a. and P) chains. The a. chains (92 amino acid) are identical 
in both molecules, but the P chains differ. The FSH and LH P chains consist of 111 
and 121 amino acids respectively. It is the characteristics of the p chain, which 
confers the hormones functional properties. The two sub-units are bound non-
covalently and they become inert when dissociated. Vaitukaitis et a/. (1976) 
demonstrated that re-association of the units could be achieved and biological activity 
restored by incubating equimolar concentrations of the isolated complementary 
subunits. Later it was proposed that the two sub-units are synthesised separately 
within the pituitary gland (Landefeld and Kepa, 1979; Godine, Chin and Habener, 
1980). In all species examined to date, both LH and FSH are present in the same 
gonadotrophs, however it is not clear whether all gonadotrophs release both FSH 
and LH (see McNeilly et a/., 2003). After synthesis, LH predominantly enters storage 
granules and is released in response to GnRH stimulation. In contrast, FSH release 
is dependent on the synthesis and hence gene expression of FSH ~ - s u b u n i t . .
Alternate intracellular packaging and secretory pathways explain how gonadotrophs 
release LH and FSH differentially, and why basal LH levels, are not inhibited by 
chronic GnRH agonist (Gong et a/., 1996a; Jimmenez-Severiano et.,a/., 2003) and 
GnRH immunisation (Finnerty et a/., 1996), while these treatments inhibit LH pulse 
frequency and amplitude (McNeilly, personal communication 2003). It is still not 
known how gonadotrophs respond to multiple positive and negative signals to 
achieve the differential pattern of gonadotrophin secretion that is essential to 
reproductive function (see McNeilly et a/., 2003). 
1.1.2.1 6 Gonadotrophin release 
By sampling hypophseal portal blood in conscious ~ h e e p , , Clarke and Cummins 
(1982) confirmed the IIneurohumoral theory" of Harris (1955) by showing that GnRH 
secretion is pulsatile and each pulse of GnRH induces a pulsatile secretory episode 
of LH. Proving Harris's theory had been difficult due to the short half-life (4-7 minutes) 
of GnRH in the peripheral circulation. Clarke and Cummins (1982) discovered that 
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each pulse of LH preceded a GnRH pulse. However, GnRH pulses were not 
necessarily followed by an LH episode (see Clarke, 2002). 
Interestingly, FSH seems to be differentially regulated by GnRH. For example, after 
hypothalamic disconnection from the pituitary gland in sheep (Clarke, Cummins and 
de Kretser, 1983), GnRH immunisation (active; Clarke, Fraser and McNeilly, 1978; 
" 
McNeilly, Jonassen and Fraser, 1986; passive; Fraser and McNeilly, 1983), or down 
regulation of GnRH receptors with GnRH agonists (ram; Lincoln and Fraser, 1987; 
heifer; Gong et al., 1996a) FSH secretion continued for days, but at a decreased rate 
as FSH synthesis does depend on GnRH input (Mercer et al., 1989; Gong et al., 
1995; 1996a), whereas LH secretion had stopped within 48-72h (Findlay and Clarke, 
1987). 
Measurements of metabolic clearance of circulating FSH in sheep (Akbar et al., 1974; 
Findley and Cumming, 1976) support the notion that the changes in FSH secretion 
that occur throughout the cycle, are due to changes in secretion of FSH by the 
pituitary gland and not removal of hormone from blood. Clarke et al. (1986) 
concluded that, unlike LH, FSH secretion in sheep is not pulsatile. However, small-
dose GnRH injection studies in beef cows (Walters et a/., 1982) and other FSH 
studies in heifers (Ireland and Roche, 1982a) and cows (Schallenberger and 
Peterson, 1982; Walters, Schams and Schallenberger, 1984) indicate that in this 
species FSH release may be pulsatile. However, the pulsatility of FSH in blood 
samples may be obscured in some studies due to the relatively long half-life of FSH 
of about 300 minutes in cattle (Laster, Glimp and Gregory, 1972) and 100 minutes in 
sheep (Akbar et a/., 1974; Fry et a/., 1987). By comparison shorter half-lives for LH in 
cattle (Katangole, Naftolin and Short, 1971; Steinberger, 1981) and sheep 
(Geschwind and Dewey, 1968), of between 26 and 35 minutes have been reported. 
A recent study in sheep indicated that 930/0 of FSH pulses were associated with 
GnRH/LH pulses (Padmanabhan et a/., 1997). The remaining portion of FSH is 
released independently of GnRH pulses (McNeilly, 1988; Farnworth, 1995; 
Padmanj3bhan, Karsch and Lee, 2002). Recent reviews haveaddressed in detail the 
arguments for and against the existence of a separate hypothalamic FSH releasing 
factor (see Padmanabhan and McNeilly, 2001; Padmanabhan and Sharma, 2001). 
The bulk of the evidence indicates that such a factor does not exist (Padmanabhan 
and McNeilly, 2001; McNeilly et a/., 2003). 
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1.1.3 Gonadotrophin Control of Gametogenesis I: Spermatogenesis 
The development of the reproductive system and the gonadotrophin influence on pre-
pubertal development are discussed in section 1.4. 
The testes can be divided functionally into the interstitium, containing testosterone 
producing Leydig cells bathed in interstitial fluid, and the seminiferous tubules, were 
Sertoli cells aid spermatogenesis. Several hormones of the HPG axis regulate 
spermatogenesis (Figure 1.3). 
Figure 1.3 Schematic illustration of hormonal regulation of reproduction in the male 
(adapted from Intervet® Compendium of Reproduction, 1993). 
1.1.3.1 
Negative 
feedback 
Testosterone 
HYPOTHALAM.JS 
LH FSH 
Anterior 
Pituitary 
Inhibin 
Spermatogenesis 
Functions of Leydig cells and LH on spermatogenesis 
LH binds to its receptors on the cell membrane of Leydig cells, causing a rise in 
intrace"ular cyclic adenosine monophosphate (cAMP), which promotes 
steroidogenesis. The development of assays for LH and testosterone enabled 
Katangole, Naftolin and Short, (1971) to publish that testosterone pulse release 
follows within 90 minutes of each LH pulse, and despite just two bulls and infrequent 
sampling, Thibier, (1976) later confirmed the results. From the Leydig cells in the 
interstitium, testosterone diffuses into the Sertoli cells in the seminiferous tubules 
where the steroid stimulates further Sertoli cell FSH and testosterone receptor 
expression (Verhoeven and Cailleau, 1988). Therefore, testosterone is critical for the 
initiation and maintenance of spermatogenesis (Kerr, Maddocks and Sharpe, 1992; 
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Maddocks, Kern and Setchell, 1995). While the development of spermatids from 
spermatogonia appears to be androgen independent, the maturation of spermatids to 
spermatozoa (spermiogenesis) depends on androgens acting on Sertoli cells in which 
the developing sperm are embedded. Intra-testicular testosterone concentrations 
must be concentrated 100 to 300 fold, compared to peripheral concentrations, for 
spermatogenesis (Sharpe, Oonachie and Cooper, 1 9 8 ~ ; ; Maddocks and Sharpe, 
1989; Maddocks, Kern and Setchell, 1995). As testosterone is freely diffusible, the 
relatively high intra-testicular concentrations are achieved by binding to albumin or 
androgen binding proteins which aid transport and retention of the androgen in the 
seminiferous tubule (Maddocks and Setchell, 1988) and by movement of testosterone 
from venous to arterial blood vessels within the pampiniform plexus. 
1.1.3.2 Endoc[ine negative feedback in male ruminants 
A myriad of publications support the negative feedback effect of both androgens and 
oestrogens on gonadotrophin secretion. For example, castration in rams (O'Occhio, 
Schanbacher and Kinder, 1982) and peri-pubertal (8-9 month old) (Schanbacher, 
1982; Schanbacher, O'Occhio and Gettys, 1983; Gettys et a/., 1984) and post-
pubertal bulls (Carragher et a/., 1997; Inwalle and Schillo, 2002) resulted in reduced 
peripheral testosterone and increased gonadotroph size and mean LH 
concentrations. LH pulse frequency increased from zero to three pulses over a 12-
hour sampling period to one pulse per hour, within one week. This increase in LH 
pulse release was prevented by the administration of testosterone propionate 
(Inwalle and Schillo, 2002). Administration of exogenous testosterone has also been 
shown to suppress LH in pre-pubertal (Crim and Geschwind, 1972), pubertal 
(Schanbacher, 1980) and mature rams (Pelletier, 1970; Bolt, 1971; Garnier, Terqui 
and Pelletier, 1977; Schanbacher and Ford, 1977; Bremner et a/., 1980; O'Occhio, 
Schanbacher and Kinder, 1982). Furthermore, as testosterone implanted wethers 
had reduced LH response to a GnRH challenge, O'Occhio, Schanbacher and Kinder, 
(1982) concluded that testosterone negative feedback could possibly occur at both 
the hypothalamic and pituitary level in the ram (Figure 1.3). As a result of the 
suppression of both LH parameters and the presence of steroid receptors in the 
pituitary gland (Schanbacher, O'Occhio and Gettys, 1983; Schanbacher, 1984) and 
hypothalamus (Pelletier, Carrez-Camous and Thiery, 1981; Glass, Amann and Nett, 
1984), it was concluded that negative feedback effects of testicular steroids occur at 
both sites. However, more recent evidence in rams (Tilbrook et a/., 1991) suggests 
that the principal negative feedback effect is at the hypothalamic level, with only 
minimal effects on the anterior pituitary gland. 
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1.1.3.3 FSH and Sertoli cells 
FSH stimulates Sertoli cells (Bicsak et al., 1986) to synthesise and secrete inhibin 
(McCullogh, 1932; Steinberger and Steinberger, 1976). In addition, Sertoli cells 
proliferation and function is influenced by FSH, testosterone and several growth 
factors including IGF-I (Orth, Higginbotham and Salisbury, 1984). Furthermore, the 
negative feed back role of testicular oestrogens during pubertal development (see 
Sharpe, 1994) was clearly shown by Land, Baird and Carr, (1981), when oestradiol 
and oestrone immunised ram lambs exhibited elevated FSH concentrations and 
associated testicular growth relative to control animals. The increased numbers of 
Sertoli cells with advancing age towards puberty and key stages of spermatogenesis 
are illustrated in Figure 1.4. 
Figure 1.4 Increase in Sertoli cell number in young Holstein bulls as puberty 
approaches (adapted from Curtis and Amann, 1981). 
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1.1.3.4 Inhibin and negative feedback 
McCullogh, (1932) first used the term inhibin to describe a testicular factor, which 
inhibited anterior pituitary gland FSH release. Later, testicular extracts (Setchell and 
Jacks, 1974; Franchimont et al., 1975) and bovine ovarian follicular fluid (De Jong 
and Sharpe, 1976) were found to contain high levels of a substance, which 
suppresses FSH secretion. Later still, that substance, inhibin, was purified from 
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bovine (Robertson et a/., 1985; Fukuda et a/., 1986), ovine (Leversha et a/., 1987) 
and porcine (Ling et al., 1985; Miyamoto et al., 1985) follicular fluid. 
Inhibin, like other members of the transforming growth factor J3 (TGF-J3) superfamily, 
is a disulphide-linked dimer of homologous subunits that contain a characteristic set 
of seven cysteine residues, which form a cysteine knot within each subunit 
(Robertson, Hertan and Farnworth, 2000). Inhibin consists of a. and J3 subunits 
(Glencross, 1992). As there are two forms of the J3-subunit, J3A and J3B, inhibin may 
exist as either inhibin A, a. subunit combined with the J3A-subunit, or inhibin B, a. 
subunit combined with the PB subunit (Figure 1.5). Knight et al. (1989) showed that 
much of the immuno-reactivity detected in the first RIAs was free a. sub-unit. 
Confirmation of the biological significance of inhibin was clarified with the 
development of 2-site assays specific for both inhibin forms (Groome et a/., 1996). 
Different post-translational processing gives rise to several different variants of inhibin 
A and B (see Knight and Glister, 2001). 
Figure 1.5 Basic molecular structures of the different isoforms of inhibin and activin. 
Each subunit is derived from a separate precursor molecule. Follistatin is structurally 
dissimilar to inhibins and activins and functions as a high affinity activin-binding 
protein (after Knight and Glister, 2001). 
Inhibin A Inhibin B 
pro 
a-subunit precursor 
pro pro B 
~ A - s u b u n i t t precursor ~ B - s u b u n i t t precursor 
Activin A Activin AB Activin B 
flAIB 
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Simple castration studies indicated the involvement of inhibin in FSH regulation 
(Amman and Walker, 1983; MacDonald, Deaver and Schanbacher, 1991), and in 
support of the earlier findings, active immunisation of intact pre-pubertal bulls against 
the inhibin a-subunit resulted in a 2-3 fold increase in peripheral FSH (Schanbacher, 
1991; Martin et al., 1991). The higher increase in peripheral FSH after inhibin 
immunisation compared to castration was explained fcHowing rodent trials, and 
results from neutralisation of pituitary inhibin (Roberts et al., 1989), which may locally 
regulate FSH release (Silezikjian et al., 1996). Some research in bulls stated that 
following a rise in FSH testes size increased, spermatid numbers were elevated 
(Schanbacher, 1991; Martin et al., 1991), and sperm output enhanced (Same et al., 
1999). In contrast Schanbacher (1991) found no effect on pituitary gland weight, and 
no testicular hypertrophy. Interestingly, peripheral testosterone concentrations and 
live weight were increased (Same et al., 1999), and LH reduced (Martin et al., 1991) 
with long-term inhibin immunisation. 
In addition to "long-loop" FSH regulation, elegant experiments in rodents indicate that 
inhibin is a prime candidate for autocrine/paracrine regulation of spermatogenesis. 
For example, intra-testicular injections of bovine follicular fluid reduce spermatogonia 
populations in the treated, but not the contralateral, rat testis (van Diessel-Emiliani et 
al., 1989). However, other components of follicular fluid, such as follistatin, may have 
been responsible at least in part, for the observed results. More recently, Hakovirta et 
al. (1993) stated that inhibin reduced DNA synthesis in spermatogonia. Evidence to 
date indicates that inhibin inhibits spermatogenesis, however, the exact intra-
testicular roles of inhibins have yet to be elucidated. 
1.1.4 Gonadotrophin Control of Gametogenesis II: Folliculogenesis 
1.1.4.1 Follicular growth initiation and pre-antral folliculogenesis 
The factor(s) responsible for triggering the onset of follicular growth remain elusive. 
Dufour, Cahill and Mauleon, (1979) demonstrated by hypophysectomy that ovine 
follicles are able to develop from the primordial to the late antral (-2mm diameter) 
stage in the complete absence of gonadotrophins. Furthermore, mRNA encoding the 
FSH receptor was observed in ovine granulosa cells o ~ ~ pre-antral follicles only after 
they had already committed themselves to growth (Tisaall et al., 1995; see Fortune, 
2003). However, it is suggested that gonadotrophins have a modulatory role, as FSH 
stimulates DNA synthesis (Roy and Greenwald, 1989) and steroidogenesis in 
neonatal rodents. Furthermore, hypophysectomy resulted in a decline in the number 
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of follicles growing at all stages of development (Wang and Greenwald, 1993). 
Indeed FSH receptors are present in early pre-antral follicles (Wandji et al., 1992), at 
a time when follicles respond to FSH administration with elevated cAMP and 
granulosa cell proliferation (Ralph, 1996; see Webb et al., 1999a). During antrum 
formation, when follicles measure 0.8-2mm and 1-3mm in sheep and cattle 
respectively, follicles may be referred to as ( g o n a d o ~ . r o p h i n n responsive) (see 
Scaramuzzi et al., 1993; Draincourt, 2001). These gonadotrophins promote antrum 
formation, increase follicular growth and protect follicles from early atresia (Wang and 
Greenwald, 1993). 
1.1.4.2 Gonadotrophin dependent follicle recruitment 
From the group of slow growing (gonadotrophin responsive) follicles rising peripheral 
FSH concentrations (Ginther, Kot and Wiltbank, 1995; Ginther et al., 1996) recruit a 
group of 5-10 medium-sized follicles (Adams et al., 1993b:c; Adams, Evans and 
Rawlings, 1994; Sunderland et al., 1994). The "recruitment window" lasts for 1 day in 
the ewe and 2 days in the cow (see Draincourt, 2001). The process is also described 
as follicular wave emergence (Ginther et al., 1996), and it is at this stage that the 
antral cavity becomes fully formed. For recruitment to proceed, FSH must reach a 
minimum threshold, which is believed to vary between animals (Picton and McNeilly, 
1991) and follicles (Fry and Draincourt, 1996; see Campbell, 1999). 
It would appear that approximately 4mm and 9mm diameters are key stages in 
bovine follicular development. Between 4-9mm diameter FSH is required for follicle 
growth. A reduction or withdrawal of FSH below normal concentrations by means of 
hypophysectomy (Dufour, Cahill and Mauleon, 1979; Draincourt et al., 1987; Wang 
and Greenwald, 1993), chronic GnRH agonist treatment (buserelin;' Picton and 
McNeilly, 1991; Gong et al., 1996a), or GnRH immunisation (Crowe et al., 2001 a;b) is 
associated with no growth of follicles larger than 4mm. This is supported by the re-
initiation of growth of follicles 4-8mm following exogenous FSH administration in 
immuno- (Crowe et al., 2001a;b) and chemical (Picton and McNeilly, 1991) castrates. 
This is further supported by observations that, circulating FSH concentrations in the 
cow display a wave pattern, each FSH peak closely preceding a wave of follicle 
development (Ginther, Kot and Wiltbank, 1995; Ginther et al., 1996). 
FSH stimulation has numerous effects on ovarian follicles by binding to its receptor 
on the granulosa cells: 
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1. Induces aromatase activity (Saumande, 1990), enabling them to produce 
oestradiol. In situ hybridisation experiments in cattle have shown that p450scc 
mRNAexpression is first detected at a follicle diameter of 4mm, with increasing 
P450arom mRNA in healthy follicles (Xu et al., 1995a;b). More recently the key role 
that FSH plays in the induction of follicular growth and differentiation has been 
demonstrated (Gaverick etal., 2002). A slightly p r o l o n g ~ d d FSH infusion, in GnRH 
agonist induced hypogonadotrophic heifers, stimulated medium-sized follicle 
growth and induced precocious expression of mRNAs for P450scc and P450arom in 
granulosa cells from small follicles and up regulated the expression of these 
enzymes from granulosa cells from recruited follicles. 
2. Stimulates the production of inhibin, follistatin and activin (Knight, 1996), but 
increases the ratio of activin to follistatin and activin A to inhibin A i.e., increases 
'activin tone' (Glister, Groome and Knight, 2003) 
3. Suppresses IGFBP-2 production (Armstrong et al., 1998; Webb et al., 2003a). 
4. Stimulates protease (PAPP-A), which degrades IGFBP-4 (see Draincourt, 2001; 
Webb et al., 2003a). 
Hence, follicle recruitment represents the "starting gun" in a race, during which 
follicles must proliferate and differentiate under the influence of FSH, to render them 
best able to respond to selection. Dominance may be seen as the end of the race, 
although the true "finish line" is ovulation (see Draincourt, 2001). 
1.1.4.3 Dominant follicle selection and LH 
Ginther et al. (1996) defined dominant follicle selection in mono-ovulatory species 
such as cattle, as the beginning of a difference, or "deviation", in growth rates 
between the two largest developing follicles in a wave. Another popular definition, as 
stated by Webb et al. (1999a), is that selection is a process whereby only some of the 
recruited follicles are selected to continue growth further with the eventual 
establishment of a dominant follicle(s). The exact selection mechanism is not fully 
elucidated however, it is known that selection occurs 36-72 hours after recruitment 
(Bao et al., 1997a; b), and when, during the follicular phase, FSH concentrations are 
... falling and.LH pulse frequency is increasing (Campbell et al., 1999b; see Baird 1983; 
Scaramuzzi et al., 1993; Armstrong and Webb, 1997; Draincourt, 2001). 
Prior to selection, LH principally binds to theca interna cells (Webb and England, 
1982). In addition numerous researchers, utilising in vivo studies, have demonstrated 
a requirement for pulsatile LH in follicles >8mm. For example, when GnRH agonist is 
Used to suppress LH pulses, but FSH concentrations are maintained, follicle 
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development does not proceed beyond 9mm (Gong et al., 1995; 1996a). More 
recently, Crowe et al. (2001 a;b) reported similar findings after GnRH immunisation 
and exogenous FSH treatment. However, FSH alone can stimulate follicle selection 
(Gong et al., 1995; 1996a). Furthermore, a single high dose LH infusion has been 
observed to be as effective at inducing selection as pulsatile LH infusions (Campbell, 
unpublished observations). Indeed, it is the fall in FSH co,]centrations, coupled with 
the availability of LH high frequency pulses, which necessitates the "switch" in 
gonadotrophin dependence from FSH to LH in the dominant follicle (see Campbell et 
al., 1999b). 
Follicle selection is associated with a number of changes in the presumptive (7 to 
9mm) dominant follicle (Mihm et al., 2000). In medium-size follicles, up to -7mm in 
cattle, and 2-3mm in sheep, LH receptors (LH-R) are only expressed on the theca 
interna cells and oestradiol and androstenedione levels in follicular fluid are low, 
relative to testosterone. In selected follicles (ovine: >3mm, bovine: >8mm) oestradiol 
production increases rapidly, while testosterone concentrations fall (Carson et al., 
1981). Importantly, as LH stimulation increased, LH-R numbers on theca cells also 
increase. This newfound "oestrogenic status" coincides with the appearance of LH-R 
on the granulosa cells, and only occurs in the ovulatory follicle(s) (Carson et al., 
1979; Webb and England, 1982; Ireland and Roche, 1983). These morphological 
observations are supported by gene expression data, which show that, mRNA 
expression of LH-R (Xu et al., 1995b) and 3J3HSD (Bao et al., 1997a;b) in bovine 
granulosa cells can only be detected when follicles are ~ ~ 9mm. 
1.1.4.4 Endocrine negative feedback in females 
The selected follicle(s) produces the majority of the oestradiol (Straigmiller and 
England, 1982; Henderson et al., 1984) and inhibin (Schwall et al., 1990; Knight and 
Glister, 2003) that is found in the circulation. Robust evidence exists for the negative 
feedback action of both oestradiol and inhibin (Webb and Morris, 1988; Baird et al., 
1991; Campbell, Scaramuzzi and Webb, 1995). This has been demonstrated by 
treating animals with exogenous oestradiol and inhibin, which suppresses follicular 
development in both sheep and cattle via reduced gonadotrophin secretion (Johnson 
and Smith, 1985; O'Shea et al., 1994; Bo et al., 1995; Campbell et al., 1995; see 
Webb et al., 1992a:b). Conversely, inhibin immunised a'nimals exhibit elevated FSH 
levels, which were increased further by concomitant immunisation against oestradiol 
in both sheep (Mann et al., 1989) and cattle (Kaneko et al., 1995). Furthermore, 
inhibin-binding sites, with high affinity and specificity, have been identified on ovine 
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pituitary cells, consistent with the presence of a putative inhibin receptor and inhibin 
action on the pituitary gland (Hertan et al., 1999). 
Around the time of follicle selection, and as a result of negative feedback actions of 
these hormones on the anterior pituitary gland, FSH release is reduced (Kaneko et 
al., 1991; Gibbons, Wiltbank and Ginther, 1997; M i h ~ . . et al., 1997) to levels 
insufficient for the survival of the subordinate follicles (Straigmiller et al., 1982; Webb 
and Morris, 1988; Beard et al., 1989; Baird et al., 1991; Campbell, Scaramuzzi and 
Webb, 1995). Hence, the dominant follicle(s) must differentiate in a way, which will 
allow it to sustain growth in an environment of lower circulating concentrations of FSH 
(Fortune, 1994). The expression of LH-R on the granulosa cells is believed to give 
the dominant follicle(s) an advantage, enabling development to continue by utilising 
LH, while other follicles- in the cohort undergo atresia, starved of FSH on which they 
depend (Draincourt, 1991; Campbell et al., 2000; see Figure 1.10). Despite switching 
dependency from FSH to LH, the dominant follicle(s) still requires a low concentration 
of FSH in order to survive (Fortune, 1994; Gong et al., 1995; 1996a). The way the 
dominant follicle achieves this is described in section 1.1.5-1.1.5.2.1. After 
dominance is established growth typically continues for about 3-5 days until the 
dominant follicle reaches a size of -15-20mm in cattle and - 6-7mm in sheep; see 
Draincourt, 2001). 
1.1.4.5 Follicular waves 
Follicular waves are the recurrent succession of recruitment, selection and 
dominance (see Figure 1.6). Follicular waves are preceded by a peak of FSH 
(Rawlings et aI, 2003) in cattle commence prior to puberty (Hopper et al., 1993; 
Adams, Evans and Rawlings, 1994), within 2 weeks postpartum, with each wave 
lasting 7-9 days (Evans, Adams and Rawlings, 1994a:b). Follicle waves continue 
throughout the animals life, stopping during the last 3 and 4 weeks of pregnancy in 
the cow (Ginther et al., 1996) and ewe (Draincourt et al., 2000), respectively. Waves 
resume about 10 days after calving, and finally cease when the primordial pool is 
_ exhausted within the ovaries. The function of repeated waves of follicle growth is to 
provide a continuous source of follicles for OVUlation should fertilisation or pregnancy 
fail. The length of each wave, and hence the number per oestrous cycle may be 
influenced by LH release. For example, increased LH pulse frequency results in the 
maintenance and development of the dominant follicle (Sirios and Fortune, 1990). 
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Figure 1.6 Schematic representation of the requirement for gonadotrophins at 
different stages of ovarian development in cattle (after Webb et al., 2003a). 
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Approximately 800/0 of cattle have 3 waves of follicular development during each 
oestrous cycle (Savio et al., 1988; see Webb et al., 1999a). The first wave starts at 
the time of the second FSH rise, which typically begins on day 2 of the oestrous 
cycle. Subsequent waves begin around days 9 and 16 post-oestrus (Sirios and 
Fortune, 1988). The dominant follicle of the third wave is usually the one that 
ovulates. Sheep typically have 3 or 4 waves (Ginther, Kot and Wiltbank, 1995; see 
Evans et aI, 1999). In cattle, as the animal ages, the diameter of the dominant follicle 
increases (8.5 to 12mm), making dominance °more pronounced, as the difference 
between dominant follicle(s) and subordinates increases. After the fourth month of 
pregnancy in the cow the dominant follicle decreases to about 9mm in diameter (see 
Draincourt, 2001). 
1.1.5 Intra-Ovarian Regulators of FOlliculogenesis 
Studies on the hypothalamic-pituitary gland-ovarian (HPO) feedback system have 
been unable to explain, in full, the follicle selection mechanism and dominance. For 
example, similar sized follicles exposed to the same gonadotrophic drive respond 
differently, supporting the concept of intra-ovarian regulation (Campbell, Scaramuzzi 
and Webb, 1995; Monget and Monniaux, 1995; Webb et al., 1999a; Armstrong and 
Webb, 1997). This section introduces and summarises some intra-ovarian regulators 
of fOlliclulogenesis. These factors are discussed in more detail in Chapters 5 and 6. 
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The development of serum-free culture systems, which maintain follicular phenotypes 
of bovine (Guitierrez et a/., 1997b) and ovine (Campbell, Scaramuzzi and Webb, 
1996) granulosa and thecal cells have enabled the analyses of factors involved in the 
local regulation of folliculogenesis. Numerous growth factors have been studied 
including, insulin-like growth factors (IGFs), members of. the TGFrJ superfamily, 
fibroblast growth factors (FGFs), epidermal growth factors (EGFs), cytokines and 
angiogenic factors. For reviews see Armstrong and Webb, 1997; Webb et a/., 1999a; 
2003; Knight and Glister, 2001; 2003). 
As discussed the rise in FSH recruits follicles to continue growth and stimulates the 
acquisition of a number of key properties (aromatase enzymes and LH receptors on 
granulosa cells), which -are essential for further development. Multiple ovulation can 
be achieved by extending the "window" of time when FSH is above the threshold or 
by increasing the number of small follicles which can be recruited by the FSH rise 
(see Scaramuzzi et a/., 1993; Baird and Campbell, 1998). 
Draincourt (2001) suggested that in species with a "loose control" of ovulation rate 
(some sheep) selection is controlled by endocrine mechanisms (reduction of FSH 
support for follicles) only. However, in species with a more defined selection process, 
(cattle), products derived from the largest follicle may directly inhibit development of 
other cohort follicles. Indeed, steroid and inhibin depleted follicular fluid can inhibit 
follicular development in sheep (Campbell et a/., 1991b; O'Shea et a/., 1994) and 
cattle (Law et a/., 1992; Wood et a/., 1993). Partially purified follicular fluid fractions 
containing negligible amounts of inhibin, have been observed to inhibit the 
proliferation and aromatase activity of cultured ovine, porcine and bovine granulosa 
cells (Baxter et a/., 1995; Picton and Hunter, 1995; Rouillier et a/., 1998; see 
Armstrong and Webb, 1997; see Webb et a/., 1999a). Furthermore, administration of 
inhibin free follicular fluid by Turzillo and Fortune, (1990) after ovulation, postponed 
subsequent follicular wave by 2 days. The discovery by Ralph, Wilmut and Telfer, 
(1995) of a bovine oocyte secreted factor along with other evidence (see Webb et a/., 
1999a; Eppig, 2001) indicates that the oocyte may influence follicular development. 
Dong et a/., (1996) demonstrated that, in mice deficient in growth differentiating 
factor-9 (GDF-9), follicles only developed one layer of granulosa cells and the theca 
failed to differentiate, although development at this stage appeared normal (see 
Webb et a/., 1999a). 
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More recently, the importance of local factors in follicle development has been 
revealed in prolific sheep breeds. For example, in the Booroola Merino a single gene 
mutation named the FecB gene has been identified in the intracellular kinase domain 
of the bone morphogenetic protein receptor-1 J3 (BMP-1 (3, also known as ALK-6; 
Wilson et al., 2001; Souza et al., 2001; Mulsant et al., 2001; Fabre et al., 2003). The 
gene is expressed in oocytes, and granulosa cells of primordial and pre-antral 
follicles, and in granulosa and theca cells of all antral follicles as well as CLs (Souza 
et al., 2002). All the ligands for the BMPR-1 (3 are yet to be discovered (Galloway et 
al., 2002). Furthermore, research to date is inconclusive (see Fabre et aI., 2003) as to 
whether the mutation acts by up or down regulation of the BMPR-1 (3, however it is 
thought that, decreased signalling by BMPR-1P, leads to physiological changes in 
foetal development, pituitary and ovarian function, including precocious follicular 
-
development, which results in increased ovulation rate and litter size (Smith et al., 
1993; Boulton et al., 1995; McNatty et al., 1995; 2001; Montgomery et al., 2001; 
Fabre et al., 2003). Further evidence comes from Romney sheep in which gene 
carriers of the single point mutation named FecxH (Hanna) results in oocytes, which 
do not produce BMP15 (also known as GDF-9(3), while the Inverdale mutation 
renders the BMP15 inactive. As BMP15 is essential for granulosa proliferation during 
pre-antral development, homozygous carriers exhibit arrested oocyte development 
(Galloway et al., 2002). However, heterozygous carriers FecxH (Hanna) and Fecx1 
(Inverdale) exhibit increased antral follicle populations (McNatty et al., 1995) as 
granulosa cells develop a greater responsiveness to FSH (Souza et aI., 2002) and 
acquire LH receptors at a smaller diameter, with each "oestrogenic follicle" containing 
fewer granulosa cells (Shackell et al., 1993). It has been hypothesised that the 
oocyte has a significant influence on the number of follicles that proceed to ovulation 
(McNatty et al., 2001; Eppig, 2001). The latest research suggests that BMP signalling 
has a key role in folliculogenesis (Otsuka et al., 2001a;b). Fabre et al. (2003) stated 
that, reduced BMP signalling could positively affect the number of ovulatory follicles. 
For reviews of recent developments in prolific breeds of sheep see Montgomery et al. 
(2001), McNatty et al. (2001; 2003), Mulsant et al. (2001), Shimasaki et al. (2003) 
and Souza·et al. (2003). 
1.1.5.1 The Insulin-like growth factor (IGF) system. 
Experiments in IGF-I gene knockout mice (Baker et al., 1996) have observed reduced 
ovarian weight and anovulation, demonstrating an absolute requirement for the 
protein. However, species-specific patterns of granulosa IGF-I mRNA expression 
have been reported and controversy exists over the expression of mRNA for IGF-I in 
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ovine granulosa and thecal tissue (see Armstrong and Webb, 1997). In cows, IGF-II 
expression is restricted to the thecal tissue of antral follicles (Armstrong et a/., 2000) 
and it is generally agreed that IGF-II is the major intra-ovarian IGF (see Webb et a/., 
2003b). However, IGF-I may act in an endocrine manner and shows a positive 
correlation with follicle growth after recombinant bovine growth hormone (rbGH) 
treatment (see Webb et a/., 1999a). Echternkamp et a/. (1994) and Austin et a/. 
(2001) observed that IGF binding protein-2 (IGFBP-2), and possibly IGFBP-4 and -5 
concentrations are higher in the follicular fluid of follicles prior to selection and in large 
atretic follicles. Thus, leading them to suggest that, IGFBPs have a regulatory role in 
bovine follicle development in cattle. Yet these binding proteins are significantly 
reduced in the follicular fluid of large or dominant follicles (Nicholas et a/., 2002). 
Expression of IGFBP-2 and -4 mRNA has been demonstrated in both granulosa and 
thecal tissue of healthy bovine antral follicles up to 9mm in diameter (Armstrong et 
a/., 1998). Furthermore, IGFBP-2 mRNA expression was undetectable in granulosa 
tissue from large dominant follicles. Based on recent findings it has been suggested 
that FSH may indirectly act to inhibit IGFBP-2 expression (see Webb et a/., 2003a;b). 
These findings indicate that low IGFBP-2 concentrations and an increase in LH 
receptors on granulosa cells may be critical to the dominant follicle selection 
mechanism. A reduction in follicular fluid IGFBP-4 concentrations, coupled with an 
increase in oestradiol concentrations, has also been reported in the dominant follicle 
in cattle (Mihm et a/., 2000). Overall, these results indicate that intra-follicular IGF 
bioavailability is a key factor controlling selection and maintenance of the dominant 
follicle in cattle (Webb et a/., 2003a;b). Furthermore, during follicle development, 
post-translational modification of IGFBPs may occur, which affects the affinity of the 
binding proteins for IGFs. For example, IGF-dependent regulation of IGFBP-4 has 
been demonstrated in bovine follicular fluid (Mazerbourg et a/., 2000). Furthermore, 
IGFBP-4 proteolytic activity was reported to be maximal in the dominant follicle 
(Rivera et a/., 2001). The IGFBP-4 degrading protease has recently been identified 
as pregnancy-associated plasma protein A (PAPP-A; Monget et a/., 2002; see Webb 
et a/., 2003a;b; Armstrong, Gong and Webb, 2003). 
1.1.5.2 TGF-p superfamily 
TGF-p superfamily members are expressed by oocytes, .granulosa cells and theca 
cells in a developmental-stage related manner and function as intra-ovarian 
regulatory molecules involved in follicle recruitment and atresia, granulosa and theca 
cell proliferation, steroidogenesis, oocyte maturation, ovulation and luteinisation. The 
TGF-p superfamily comprises over 30 structurally related, but functionally diverse, 
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proteins which include TGF-p isoforms (TGF-P1,2,3), anti-mullerian hormone, inhibins, 
activins, some 20 bone morphogenetic proteins (BMP-1 to BMP-20) and at least nine 
growth! differentiation factors (GDF-1 to GDF-9) which are closely related to the BMP 
sub-group (Massague and Wotton, 2000). The TGF-p superfamily is discussed in 
more detail in other sections of this thesis. For a recent review of the TGF-p 
superfamily ligands, receptors and ancillary binding proteins see Knight and Glister, 
(2003). The remainder of this section summaries the local actions of inhibins and 
activins in the ovary. 
1.1.5.2.1 Local actions of inhibins and activins 
On the basis of mRNA expression and immunohistochemical evidence, it has been 
proposed that the relative balance between follicular activin and inhibin production 
shifts throughout follicle development. Generally, small follicles primarily produce 
activins ('high activin tone') and selected large antral follicles show 'high inhibin tone' 
i.e., increased inhibin A production (Schwall et al., 1990; Yamoto et al., 1992; 
Roberts et al., 1993). There is a paucity of information on the intra-follicular contents 
of different assembled dimeric inhibin /activin isoforms, particularly in pre-antral and 
small antral follicles (see Knight and Glister, 2003). 
Ginther et al. (2002) recently showed that following dominant follicle ablation, which 
provided the stimulus for selection of a new dominant follicle, the future dominant 
follicle showed a transient elevation in follicular fluid activin and oestradiol 
concentrations. These responses occurred after the transient FSH rise, subsequent 
to ablation of the dominant follicle. The lack of between-follicle differences for 
progesterone, androstenedione and inhibins (A and B) indicates that, an FSH 
induced rise in activin A by granulosa cells may be an early marker' of follicular 
dominance (Knight and Glister, 2003). Studies using cultured bovine granulosa cells 
have shown that both FSH and IGF-I promote secretion of activin A and oestradiol in 
medium-sized follicles (-5mm; Glister et al., 2001). Furthermore, the stimulatory 
actions of FSH and IGF-I on oestradiol secretion may be mediated by endogenous 
.. activin A (Glister et al., 2001). Moreover, the role of activin in enhancing granulosa 
cell proliferation has also been demonstrated in rodents following studies in follicle 
cell culture experiments (Li, Philips and Mather, 1995; Miro and Hillier, 1996; Zhao et 
al., 2001) and inhibin a-subunit (Matzuk et al., 1996) and activin type liB receptor 
(Matzuk et al., 1996) gene knockout mice. Enhanced antral follicle development 
following inhibin immunisation in both sheep (Tannetta et al., 1998) and cattle 
(Knight, Tannetta and Glencross, unpublished observations; as cited in Knight and 
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Glister, 2003) has been shown to increase intra-follicular activin A concentrations. 
Thus, providing further evidence, albeit indirect, supporting a local role of activin in 
amplifying or regulating FSH action. Furthermore, experiments on bovine granulosa 
cells have shown that activin can enhance P450AROM activity and oestradiol 
production, while inhibiting progesterone secretion (Hutchinson et al., 1987). These 
observations suggest a role for activin in delaying the 9nset of atresia and/or 
luteinisation, possibly by up regulating FSH receptors (Hasegawa et al., 1988). 
Follistatin binds activin, neutralising it and therefore opposes these effects of activin. 
Indeed, transgenic mice, which over express follistatin exhibit arrested follicular 
development (Guo et al., 1998). 
Despite this growing evidence (see also Chapters 5 and 6) for an intra-follicular 
action of inhibin, evidence for role of inhibin in granulosa cell development is 
inconsistent. For example, infusion of inhibin into the ovarian artery of ewes with an 
auto transplanted ovary reduced ovarian output of oestradiol (Campbell and 
Scaramuzzi, 1996). In agreement, Jimenez-Krassel et al. (2001) reported that inhibin 
suppressed oestradiol secretion by bovine granulosa cells isolated from dominant 
follicles, whereas inhibin antibodies raised oestradiol secretion. In contrast, Campbell 
and Baird, (2001) found that inhibin A enhanced FSH induced oestradiol secretion in 
vitro. Moreover, the addition of inhibin antiserum reduced FSH induced oestradiol 
production. The ability of inhibin A, to enhance LH induced androgen production from 
isolated bovine thecal cells in vitro has been demonstrated in several species (see 
Chapters 5 and 6). Furthermore, these findings may reflect an important intra-
follicular positive feedback mechanism for ensuring that the granulosa cells of 
selected follicles are provided with adequate substrate for oestradiol production. In 
cattle, oestradiol also promotes LH induced oestradiol production by "theca cells 
(Wrathall and Knight, 1995). These actions of inhibins are opposed by activin (see 
Knight and Glister, 2003). 
Oocytes express both type I and type II activin receptors (Cameron et al., 1994). 
Furthermore, studies in both primates and rodents have revealed that activin can 
accelerate meiotic maturation of oocytes (see Knight and Glister, 2003). In cattle, the 
ability of the oocyte to form blastocysts following fertilisation was enhanced by activin 
(Silva and Knight, 1998). In contrast, there is evidence that inhibin, or free a-subunit, 
may have a negative influence on oocyte maturation (0 et al., 1989) and 
developmental competence (Silva et al., 1999; see Knight and Glister, 2003). 
Following activin receptor stimulation, cytoplasmic signalling intermediaries, known 
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as receptor (R)-Smads associate with further co-Smad (Smad 4). The activated R-
Smad-co-Smad complex then trans locates to the nucleus to promote altered gene 
expression. Additional regulation is provided by inhibitory Smads (Smad 6 and 7). 
Therefore, the action of ligands on activin receptors may be further regulated at the 
cellular level. For a recent review see Knight and Glister, (2003) . 
. , 
As discussed, GHIIGF and inhibins have significant effects at the ovarian level, 
however, the literature lacks reports on the interaction between these two families, 
and thus the occurrence of such interactions is studied in Chapter 5. 
1.2 REPRODUCTIVE DEVELOPMENT AND PUBERTY IN RUMINANTS 
Due to differences in the definitions used by researchers for the stages of 
development, the age at-which endocrine parameters change during development 
varies between publications. For example, Rodriguez and Wise (1989) defined the 
period during which LH concentrations rise as pre-pubertal, whereas others define 
this as the juvenile period and class. the pre-pubertal period as the time during which 
LH levels are inhibited due to hypersensitivity to androgen negative feedback (Kinder 
et al., 1995). To describe reproductive development, in this thesis, four periods of 
pubertal maturation (see Figure 1.7) and one termed post-pubertal and sexual 
maturation will be used. 
1.2 1 Endocrinology of the young ruminant 
1.2.1.1 Pre-natal and infantile development 
Comprehensive foetal studies in both sheep (Mesiano et al., 1991; Matwijiw and 
Faiman, 1991; Caldani et al., 1995) and cattle (Leshin et al., 1988) agree that, half 
way through gestation GnRH neural systems are similar to those of adult animals 
(Caldani et al., 1995). Indeed, by day 60 of gestation bull foetuses, exhibit rising LH 
concentrations until the end of the second trimester (Rodriguez and Wise, 1989). The 
gonads respond to LH stimulation with increased steroid output, which is essential for 
reproductive tract development, testicular descent (concluded by Day 140 in bulls) 
·and sexual differentiation of GnRH neural networks (Danzer, McMullen and Rance, 
2001). Testosterone has a major influence on neural organisation of the GnRH pulse 
generator and sexual dimorphism is apparent as gonadotrophin levels are higher in 
female fetuses compared to males, suggesting that the testes, but not ovaries exert 
negative feedback by mid-gestation. Moreover, castration of the male, but not the 
female, foetus at Day 110 resulted in increased LH and FSH output in rams (Matwijiw 
and Faiman, 1991). The effects of castration on LH decline by Day 130 of gestation, 
.. . 
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to values similar to intact males and females, suggest that the suppressive effects of 
testicular hormones on GnRH (Rodriguez and Wise, 1989) and gonadotrophic output 
are superseded in late gestation by other factors (Matwijiw and Faiman, 1991; 
Mesiano et a/., 1991), possibly placental steroids. 
Concentrations of androgens and oestrogens are low in the infant relative to the adult 
(McCarthy, Convey and Hafs, 1979). An observation that led Amann and Walker, 
(1983) to conclude that low levels of GnRH, LH and FSH at birth are due to 
hypersensitivity of the hypothalamus to gonadal steroid negative feedback. Later, 
Amann et aI, (1986) stated that LH pulses are infrequent at 6 weeks of age, before 
being established at 8 weeks of age, as GnRH pulse frequency increased from 2-12 
weeks of age (Rodriguez and Wise, 1989). However, castration at birth or shortly 
after (ram; Schanbacher,- 1980; bull; McCarthy and Swanson, 1976; Bass et al., 
1977; Wise, Rodriguez and Kelly, 1987) results in a delayed increase in LH release. 
These data suggest that gonadal steroid negative feedback may not totally account 
for the changes in LH secretion observed during early development in the male. 
Indeed, function of the GnRH pulse generator might await maturation of some 
component of the CNS. Study comparisons indicate that, post-castration response 
e.g., LH rise is not seen until 7 and 12 weeks of age, and is not maximal until 13 and 
20 weeks of age, in the bull (Wise, Rodriguez and Kelly, 1987) and ram 
(Schanbacher, 1980), respectively. This indicates a species difference in the 
maturation of the GnRH pulse generator and in the response to gonadal steroid 
negative feedback. The apparent earlier maturation in the bovine contributed to the 
decision to vaccinate calves against GnRH at 2-3 weeks of age (Chapters 3 and 4) 
rather than at 3-4 weeks (Brown et aI., 1994; 1995; see section 1.5.3.2 and ,3.2.2). 
The increased GnRH pulse frequency from 2-12 weeks increases gonadotroph 
expression of the GnRH-R by 400% between 6-8 weeks of age (Rodriguez and Wise, 
1989). It also causes increased mRNA synthesis of LH(3-subunit and increases the 
available LH stores four fold (Amann et al., 1986; Rodriguez and Wise, 1989). 
Together this increase in pituitary gland GnRH-R and LH stores leads to an increase 
in LH pulse frequency and amplitude, which peak during the juven"ile period, between 
12-20 weeks of age (Amann and Walker, 1983; Amann et a ~ . , , 1986). 
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Figure 1.7 Illustrates the common categories used to describe stages of reproductive 
development in cattle. Throughout this thesis peri-pubertal (adolescence) will refer to 
2! 7 months of age to attainment of puberty. Note however, that some authors define 
peri-pubertal as 2!5 months of age to puberty. 
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During the juvenile period, there is a four-fold increase in GnRH release (Amann, 
1983). Evans and O'Doherty (2001) hypotheSised that central control mechanisms 
governing GnRH release mature at this age, however, the regulatory systems are still 
immature, resulting in a relatively uninhibited increase in GnRH release. Alternatively, 
it may be that the responsiveness of the pituitary gland to low level steroid inhibition 
decreases. Either way, LH pulse frequency, pulse amplitude and basal LH 
concentrations increase dramatically (Amann and Walker, 1983). This increased LH 
output is essential in initiating normal testicular growth and development in bulls 
(McAndrews et a/., 1994; Chandolia, Evans and Rawlings, 1997; Chandolia et a/., 
1997b). 
1,.2.1.3 Peri-pubertal development (7 months to puberty) 
The increase In LH during the juvenile period stimulates gonadal development, which 
results in the increased production of androgens (Amann, 1983). By 12-24 weeks of 
age, the high levels of steroids produce a negative feedback effect on the 
hypothalamus (McAndrews et a/., 1994). This reduces the LH output and marks the 
beginning of the peri-pubertal (adolescent) period (Amann and Walker, 1983; 
McAndrews et a/., 1994; Chandolia, Evans and Rawlings, 1997). The gonadostat and 
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steroid independent hypotheses on pubertal development are addressed in sections 
1.3.3.1 and 1.3.3.2, respectively. 
1.2.2 Puberty 
Puberty in the bull has several definitions, but is generally acknowledged as the time 
at which an ejaculate contains 59 million sperm, with a min,imum motility of 100/0 
(Lunstra, Ford and Echternkamp, 1978; Chandolia et a/., 1997b; Aravindakshan et 
a/., 2000). Puberty occurs at a scrotal circumference of approximately 28cm (Wolf, 
Almquist and Hale, 1965; Godfrey, Lunstra and Schanbacher, 1992; Chandolia et a/., 
1997b; Chandolia, Evans and Rawlings, 1997; Aravindakshan et a/., 2000) and 
between 35-42 weeks of age (Almquist, 1982; Amann, 1983; Evans, Currie and 
Rawlings, 1993; Evans et a/., 1995). By puberty the bull can produce enough sperm 
to successfully impregnate -a female (Amann and Schanbacher, 1983). This definition 
takes no account of sexual behaviour and serving capacity, which reach full intensity 
considerably later than puberty (Price and Wallach, 1991 a;b;c;d). Thus puberty 
should not be confused with sexual maturity, which takes far longer to attain. 
1.4.3 Post-pubertal Bulls and Sexual Maturity 
Semen from bulls, which have recently attained puberty, is of poor quality and 
unsuitable for freezing (Chicoteau et a/., 1990). As a bull matures the number and 
quality of spermatozoa per ejaculate increases greatly beyond those values required 
for attainment of pubertal status (Lunstra, Ford and Echternkamp, 1978). Bulls used 
in A.1. programmes attain maximum breeding efficiency by two years of age, followed 
by a gradual decline with each advancing year (Tanabe and Salisbury, 1946; Collins 
et a/., 1962). With increased age, spermatogenesis is reduced, incomplete sperm 
maturation occurs more frequently and inter-tubular connective tissue becomes more 
prevalent (Grier and Marion, 1970). However, fertility has been reported in a bull 
aged 19 years of age (Bishop, 1970). 
1.2.4 Maturation of the Reproductive Tract in the Bull 
T ~ e e growth and development of the reproductive tract is a gradual process, which is 
secondary to body growth. Several environmental factors (e.g., nutrition, social cues, 
photoperiod) and genetics influence pubertal development. The reproductive tract of 
the adult bull is presented diagrammatically in Figure 1.8. 
1.2.4.1 Testicular growth and development 
As early as Day 42 of gestation Leydig cells in the bovine embryo are functional and 
release testosterone to establish male sex ducts (Josso et a/., 1979), but they 
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regress, before re-emerging prior to puberty (Hooker, 1970). Following adequate LH 
stimulation, which occurs at around 12-16 weeks after birth (Schams et al., 1981; 
Evans, Currie and Rawlings, 1993; Rawlings and Evans, 1995), Leydig cells become 
functional. Subsequently numerous maturational changes take place, which include; 
pre-Sertoli cells differentiating to form Sertoli cells, the lumen in the seminiferous 
tubules forms and spermatogonia differentiate to primary spermatocytes. As a result, 
there is a marked acceleration in the growth of all testicular components (Van 
Demark, 1956; Grier and Marion, 1970) at 16-21 weeks of age (Abdel-Raouf, 1960; 
Macmillan and Hafs, 1969). In horses, Leydig cell development appears first in the 
left, then the right testis, resulting in greater left testis weight 800/0 of the time, relative 
to the right (Nishikawa and Horie, 1955; Johnson, 1991). Bratton et aI, (1959) 
reported similar, but less pronounced findings in the bull. However, others (Almquist 
and Amann, 1961; Macmillan and Hafs, 1969) found only small differences in testis 
weight of any given bull and no differences between the left and right testis. 
Ultrasound scanning recently confirmed that both testes are of similar size in the bull 
(Chandolia et al., 1997b). 
Figure 1.8 A schematic illustration of the bull reproductive tract in the sagittal plane 
(after Senger, 1997). 
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By around 38-40 weeks testicular growth slows (Abdel-Raouf, 1960; Macmillan and 
Hafs, 1969). Final testis weight is closely correlated to live weight, and fertility (Van 
Demark, 1956). Positive correlations have been reported between Sertoli cell 
number, total tubular length (Hochereau-de Reviers and Courot, 1978) and daily 
sperm production (Berndtson, Igoboelli and Parker, 1987) and scrotal circumference 
and sperm production (Willet and Ohms, 1957; Foote, 1978; Johnson, 1991). 
1.2.4.2 Accessory glands 
After spermatogenesis, sperm are released from the Sertoli cells (spermiation) and 
pass from the testis into the epididymis. On the 11 (bull) or 13 (tup) day journey, as 
sperm move through the epididymis they acquire motility and continue to mature 
(Holtz and Smidt, 1976). Relaxin from the prostate gland may further improve motility 
(Ganong, 1996). Interestingly, testosterone slows the passage of sperm through the 
epididymis (Sunjarit and Pholpramool, 1985), whereas frequent ejaculation increases 
it by up to 200/0 (Johnson, 1991). Sperm are stored in the caudal epididymis until 
ejaculation. At ejaculation the sperm exit the epididymis and travel along the vas 
deferens. During this passage the accessory glands add their contributions to the 
ejaculate. 
Following establishment of the penis, the prostate develops from the urethral 
epithelium between Day 50-53 of gestation in the bull. Vesicular glands (seminal 
vesicles) and Cowper's (Bulbourethral) glands develop at about 60 days from 
evaginations at the base of each vas deferens, and from the urethral duct, 
respectively (see Figure 1.11). The establishment, growth and function of accessory 
glands are influenced by testosterone. For example, protrusion of the penis during 
mounting and separation of the penis and sheath typically occurs, in all breeds, 
between 8-9 and 9-10 months, respectively (Ashdown, 1960; 1962; Wolf, Almquist 
and Hale, 1965). However, sheath penis detachment occurs earlier in bulls with 
higher mean testosterone concentrations in the circulation (Lunstra, Ford and 
Echternkamp, 1978). The size of the prostate and vesicular gland is particularly 
a ~ d r o g e n n dependent (Rocha et al., 1994; Chandolia et al., 1997a;b) throughout the 
life of the bulr, yet despite this fact and the advent of scanning enabling relatively 
easy assessment of vesicular gland growth, monitoring following GnRH immunisation 
in the live bull has not been performed to our knowledge prior to Chapter 3, herein. 
1.2.5 Behavioural Changes Associated with Puberty 
The expression of sexual and aggressive behaviours (see Table 2.1) precedes the 
full development and maturation of the testes in ruminants (Brown et al., 1994). Male 
.. . 
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calves become dominant over heifers at about 24-26 weeks of age, around the time 
of the rise in testosterone concentrations (McCarthy, Convey and Hafs, 1979). Bulls 
and heifers should be separated by about 28 weeks of age (see Bonneau and 
Enright, 1995), since by 39 weeks, 93% of Hereford bulls were found to consistently 
mount oestrus females (Price and Wallach, 1991a). The exact role of testosterone on 
behaviour is not fully elucidated" however, the influence of. gonadal steroids on 
behaviour on bull behaviour is well known (Blockley, Ade and Galloway, 1978; Jago 
et al., 1995; 1996; 1997). For example, both oestradiol and testosterone 
administration to steers and masculinised heifers (freemartins) increased aggressive 
characteristics (Greene, Mogil and Foote, 1978; Dykeman, Katz and Foote, 1982; 
Huxsoll, Price and Adams, 1998). In contrast, reducing circulating testosterone 
concentrations below a threshold concentration in rams or bulls (Blockley, Ade and 
Galloway, 1978) by surgical castration or GnRH immunisation (Robertson, Wilson 
and Fraser, 1979; Finnerty et al., 1996; Jago et al., 1995; 1996; 1997; Huxsoll, Price 
and Adams, 1998) has been reported to reduce the expression of these behaviours. 
The observations of Blockley, Ade and Galloway, (1978) led them to conclude that 
testosterone was required for sexual behaviour. In contrast, a recent study (Inwalle 
and Schillo, 2002) found that castration of sexually experienced bulls fails to 
suppress mounting behaviour. This report agrees with findings in other species such 
as the dog (Beach, 1970) and man (Rousseau et al., 1998), in which sexual 
experience delays the eventual loss of male sexual behaviour (copulation to the point 
of ejaculation) for months or even years (Meisel and Sachs, 1994). Based on this 
evidence, Inwalle and Schillo (2002) suggested three explanations. Firstly, the control 
of sexual behaviour may be androgen independent in the sexually experienced adult. 
Secondly, castrates may have increased sensitivity to low levels of. adrenal 
androgens, which would explain the delay in loss of libido. Finally, neural systems 
involved in regulating sexual behaviour may be organised prior to birth, or in the 
neonatal period, and exposure to testosterone during this critical period may be 
essential for the normal expression of reproductive behaviours in the adult animal. 
Evidence in other species supports the latter explanation. In addition, Godfrey, 
LUnstra and S ~ c h a n b a c h e r r (1992) concluded that steroidal p r o g r a ~ m i n g g of sexual 
behaviour occurs before one month of age in bulls. This was part of the reasoning 
behind the neonatal immunisation studies in Chapters 3 and 4 herein, as elevated 
GnRH antibody titres during month one of life may suppress gonadal steroid levels in 
addition to possibly permanently impairing the ability of GnRH neurons to release 
GnRH. 
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1.3 REPRODUCTIVE DEVELOPMENT, PUBERTY AND OESTROUS CYCLES 
1.3.1 Endocrirl0logy of the heifer calf 
The pre-pubertal period in the heifer is characterised by an absence of cyclical 
activity and ovulation. Gradually, under stimulation of rising episodic LH and follicle 
stimulation hormone (FSH), developing follicles secrete i n c r e a s e ~ ~ levels of oestradiol 
(Ginther et al., 2000). High amplitude, high frequency pulses of oestradiol stimulated 
mainly by LH, induce the pre-ovulatory gonadotrophin surge (see Peters, 1985). It is 
this combination of events that occur at puberty and are the culmination of a series of 
maturational changes within the hypothalamo-hypophyseal-gonadal axis leading to 
the overall induction and subsequent regulation of the oestrous cycle (see Figure 
1.9). 
Changes in episodic LH frequency have been studied, the lowest of which is 
apparent at one month of age (Schams et al., 1981; Nakada et al., 2002). There is 
then a gradual increase in LH pulse frequency from 4 months of age (Schams et al., 
1981; Day at a/., 1984), and LH amplitude and FSH from 1.5 to 6 months (Evans, 
Corrie and Rawlings, 1992; Evans, McNeilly and Webb, 1994; Honaramooz et aI., 
1999) with peak LH output occuring at about 50 days prior to puberty (Schams et al., 
1981; Day at al., 1984; Day et al., 1987; Evans, McNeilly and Webb, 1994). 
Surprisingly, McLeod et al. (1984) produced conflicting evidence, as they were 
unable to detect an increase in episodic LH release from birth to puberty in beef 
heifers. Other studies in cattle observed that as LH pulse frequency and amplitude 
increased as did mean circulating LH concentrations (Kinder, Day and Kittok, 1987; 
Day et aI, 1984; Dodson et al., 1988; Schams et al., 1981). Similar findings have also 
been reported for ewe lambs (Rawlings and Churchill, 1990) and gilts (LutZ et al., 
1984). 
Many stUdies have demonstrated that both pituitary gland and ovarian activity occurs 
throughout the pre-pubertal period (see Draincourt, 2001). For example, changes in 
the number of follicles have been examined in heifers slaughtered at intervals from 
birth to 12 months of age (Desjardin and Hafs; 1969). No antral follicles were visible 
macroscopically at birth, but their numbers appeared to increase to a maximum at 4-6 
months, decrease at 8 months and remain constant thereafter .. 
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Figure 1.9 The hypothalamic-pituitary-ovarian-uterine axis. The oestrous cycle is 
regulated by inter-relationships between the hypothalamic (GnRH) pituitary gland 
(FSH and LH), follicular (oestradiol and inhibin), luteal (progesterone and oxytocin) 
and uterine (prostaglandin F2a (PGF2a» hormones. GnRH drives the sequence of 
endocrine events that regulates the oestrous cycle. The subsequent release of 
gonadotrophins stimulates follicular development, ovulation and .corpus luteum (Cl) 
formation. Oestradiol, inhibin and progesterone have a negative feedback effect at 
the hypothalamic and anterior pituitary gland levels. Following ovulation, the 
remnants of the ovulated follicle, forms the Cl, which secretes progesterone, which 
prevents ovulation and is required for pregnancy. In the absence of pregnancy, or 
maternal recognition of pregnancy, oxytocin from the Cl causes luteolysis by 
releasing PGF2a from the uterus and a new oestrous cycle ensues. External factors 
such as photoperiod and nutrition affect the oestrous cycle and ovulation at the 
hypothalamic level. Nutrition and metabolic factors also act at the ovarian level 
directly (after Scaramuzzi et al., 1993). 
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Hopper et al. (1993) and Adams, Evans and Rawlings, (1994) observed that in pre-
pubertal heifers,. follicular development occurs in waves similar to that in post-
pubertal heifers. However, the growing phase of follicles was shorter than that in 
post-pubertal animals. Progresterone levels are low in prepubertal heifers (Adams et 
al., 1992), which are thought to prolong follicular growth. The a u t ~ o r s s suggested that 
this might be because the immature hypothalamic-pituitary gland unit (HPU) in pre-
pubertal animals cannot produce the concentrations of LH found in mature animals, 
despite low progesterone concentrations. Indeed, a recent study (Nakada et al., 
2002) demonstrated an increase in LH response to GnRH challenge with age. 
Large follicles of calves, age 12 weeks exhibit a ten-fold reduction in their ability to 
produce oestradiol, relative to cows, due to reduced aromatase activity of granulosa 
cells (Draincourt, Reynaud and Smitz, 2001). Quantitative differences in calf and cow 
follicular fluid proteins have also been reported, with more proteins in cow follicular 
fluid than in calves. In addition, calf follicular fluid is missing the 34KDa a. inhibin 
subunit, although activin is relatively high in calf follicular fluid. However, further 
investigation is required to determine whether some of these differences can 
influence follicle and/or oocyte maturation (Draincourt, Reynaud and Smitz, 2001). 
Bergfeld et al. (1994) evaluated pre-pubertal "ovarian development during the later 
pre-pubertal period and reported that ~ o m i n a n t t ovarian follicles were large as first 
ovulation approached, compared with earlier in the prepubertal period. This increase 
in follicle size was correlated with increased oestradiol-17(3 secretion. These changes 
may result from the decreased responsiveness of the HPU to oestradiol negative 
feedback, allowing increased LH and FSH secretion, subsequently resulting in follicle 
maturation. Furthermore, the largest increase in follicle size occurs during the last 30 
days before puberty, which also corresponds to an increase in LH pulse frequency, 
although at this time FSH concentrations remain relatively stable (Evans, Adams and 
Rawlings), increasing only slightly if at all (Melvin et al., 1999; Rawlings et al., 2003). 
Bergfeld et al. (1994) concluded that increased LH pulse frequency may stimulate the 
deve.lopment of dominant ovarian follicles in heifers promoting their continued growth 
- . 
and prolonged maintenance, which is in agreement with Foster and Ryan (1981), 
Adams et al. (1992) and Stock and Fortune (1993). This is the gonadostat or steroid 
dependent theory of puberty. 
The hypothalamus is known to be the final component of the reproductive endocrine 
system to mature (Schams et al., 1981; Foster et al., 1986; Kinder, Day and Kittok, 
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1987). Hypothalamic maturation allows for the onset of function of the pituitary gland, 
ovaries and uterus in the adult. Changes occur in the hypothalamus that result in an 
increase in frequency of pulses of GnRH into the hypothalamic-portal vessels during 
peri-puberty (Rodriguez and Wise, 1989). Therefore, as concluded by Kinder et a/. 
(1995) that prior to puberty GnRH is released, the pituitary gland can respond to 
GnRH by releasing LH and FSH and the ovary can respond to LH and FSH before 
puberty. This is shown by repeated administration of GnRH increasing LH pulse 
frequency, inducing follicular maturation and causing a preovulatory gonadotrophin 
surge in immature animals (Schams et a/., 1981; Foster, Ryan and Popkoff, 1984; 
McLeod et a/., 1985; Skaggs, Able and Stevenson, 1986). The uterus probably has 
the ability to respond to gonadal steroids, oestradiol and progesterone before 
puberty. However, limited release of GnRH from the hypothalamus results in 
maintenance of the prepube-rtal state until physical maturation of the animal is 
appropriate (Kinder et a/., 1995). 
1.3.2 Maturation of the Reproductive Tract 
Puberty is the result of a gradual process of sexual maturation, which is initiated prior 
to birth and continues throughout the pre-p.ubertal period of development. It is 
essentially a period of transition after which follicular development advances followed 
by ovulation and initiation of the first oestrous cycle. The reproductive tract of the cow 
is illustrated in Figure 1.10. Reproductive tract development is a gradual process and 
oestrus is not shown until 8-13 months of age (Evans, Adams and Rawlings, 
1994a;b). Following monthly slaughter of Holstein heifers, ovarian weights were 
shown to increase to 4 months, plateau until 8 months, then increase further as 
heifers started to cycle and developed corpora lutea (Desjardins and Hafs, 1969). 
Maturation of the ovaries was found to occur between 6-12 months of age, although 
using ultrasound scanning, peak antral follicle number was observed recently at 4 
months (Rawlings et a/., 2003). The uterus increases in weight from birth and though 
functional by puberty, continues to mature until at least 3 years of age (Willie, 1944). 
The ·results p r e s ~ n t e d d in Chapter 4 make a significant contribution to knowledge of 
follicular development, acquisition of puberty and associated hormone patterns in 
heifers. 
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Figure 1.10 A midsagittal view of the reproductive tract in the cow (modified from 
Ellenberger and Baum, 1943; after Senger, 1997). Note the proximity of the tract to 
the rectum. 
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1.3.3 Onset of Puberty 
As described above, during the prepubertal period, gonadotrophin secretion is 
reduced. Although at present, endocrine mechanisms that result in onset of puberty 
still remain to be clearly defined (MacDonald and Page, 1986; Evans, Adams and 
Rawlings, 1994a;b), there are two theories on how this inhibition is exerted. The first 
is the classical "gonadostat" hypothesis, which is steroid dependent and the other is 
independent of sex steroids and attributed to "intrinsic" central nervous system 
inhibitory influences. 
1.3.3.1 Gonadostat hypothesis- steroid dependent 
This theory states that a decrease in sensitivity of the hypothalamus and pituitary 
gland centres, controlling gonadotrophin secretion, in response to oestradiol negative 
feedback is necessary for the onset of puberty (Ramirez and McCann, 1963). Indeed, 
decreased sensitivity to steroid n ~ g a t i v e e feedback in the rat, allows increased 
pituitary gonadotrophin secretion, which subsequently results in a more pronounced 
follicular dominance and ovulation. Evidence to support this theory has been reported 
in lambs (Foster and Ryan, 1979), heifers (Schillo, Dierschke and Hauser, 1982; Day 
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et al., 1984} and gilts (Bernadinelli et al., 1984), where exogenous oestradiol 
suppressed LH to non-detectable concentrations in ovariectomised (OVX) animals 
until beyond the onset of puberty in age-matched intact controls. Using OVX 
oestradiol supplemented heifers Day et al. (1987) went on to conclude, that in the 
pre-pubertal heifer LH secretion is responsive to oestradiol negative feedback, which 
decreases during the pre-pubertal period, because of a decline i ~ ~ the concentration 
of binding sites and/or oestradiol receptors in the HPU. This may be the mechanism 
responsible for the pre-pubertal decline in negative feedback of oestradiol on LH 
secretion. 
1.3.3.2 Steroid independent hypothesis 
Alternatively, since pre-pubertal rats shown no major decrease in sensitivity to 
oestradiol feedback after the first pre-ovulatory LH surge, Andrews, Advis and Ojeda, 
(1981) suggested that sensitivity to oestradiol negative feedback was a 
consequence, rather than a controlling mechanism, of pubertal onset. Indeed, certain 
aspects of the gonadostat theory may not be applicable to all species (Day et al., 
1984). Dodson et al. (1988) suggested that the heifer may be similar to the rat, but 
collection of data immediately prior to first ovulation is problematic because there is 
no indication of when ovulation will occur. Research to date indicates that, the 
preovulatory gonadotrophin surge, the increase in oestradiol that precedes the surge 
and the increase in progesterone after ovulation, are not responsible for initiating this 
change in sensitivity to ovarian steroids. All of these situations have been artificially 
induced in the pre-pubertal heifer, but none were followed by puberty (Gonzalez-
padilla et al., 1975; Barnes et al., 1980; McLeod et al., 1985; Skaggs, Able and 
Stevenson, 1986). Dodson et al. (1988) therefore postulated that the central 
mechanisms controlling the release of gonadotrophins are not responsive to ovarian 
steroids until just prior to puberty. Therefore puberty awaits the final development of 
some central component involved in gonadotrophin secretion. 
1.3.4 The Post-pubertal Cow 
1.3.4.1 General oestrous cycle characteristics 
Oestrous cycles occur about every 21 days in the non-pregnant cow with 84% of 
these cycles falling into a range of 18-24 days (Hafez and Sugie, 1963; Asdell, 1964; 
Robinson and Shelton, 1991). Each oestrous cycle may be divided into two phases; 
the follicular phase (regression of the CL, ovulation and the formation of the next CL) 
and the longer luteal phase (life of the CL). The external manifestation of the 
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oestrous cycle can be recognised by behavioural characteristics, the follicular phase 
by a short period of intense sexual activity or "oestrus", the luteal phase being a 
longer period of behavioural anoestrus. 
The day on which behavioural oestrus is manifested is conventionally called Day a of 
the oestrous cycle. Oestrus is of short duration, approximately 18 hours (Trimberger, 
1948). However, more recent investigation shows that the period of sexual receptivity 
can be considerably shorter than 18 hours (Hurnik, King and Robertson, 1975; 
Walton, Veenhuizen and King, 1987; Rodtian et al., 1996). Walker, Nebel and 
McGiliiard, (1996) used a sensor transmitter patch to monitor the period of oestrus 
and subsequently reported that oestrus usually lasted 9.5 hours, which is in close 
agreement with the results of Walton et al. (1987). Behavioural signs of oestrus 
include, restlessness (Liu and Spahr, 1993; Maatje, Loeffler and Engle, 1997), chin 
resting, increased licking, sniffing and mounting (Hurnik and King, 1987). However, 
standing to be mounted by others is the strongest sign that a cow is in oestrus 
(Williamson et al., 1972; Foote, 1975). Several factors including parity, season, 
temperature, stage of lactation, breed, nutrition and stress can all influence the 
duration of oestrus (Trimberger, 1948; Gangwar, Branton and Evans, 1965; Wishort, 
1972; Moberg, 1987; Lamothe et al., 1995; Rodtian et al., 1996). 
Figure 1.11 Schematic changes in blood plasma hormone concentrations during 
the oestrous cycle (after Senger, 1997). 
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The end of oestrus is followed within 10-15 hours by ovulation (Schams et al., 1977), 
approximately 28-31 hours after standing oestrus (Hunter and Wilmut, 1984). 
Ovulation is spontaneous, but can be hastened by mating (Marion et al., 1950). 
Interestingly, the right ovary tends to ovulate more frequently, (-600/0 of ovulations) 
than the left (Asdell, 1964). Only one ovum (egg) is released in 960/0 of ovulations 
(Wiltbank et al., 2000) in cattle. 
1.3.4.2 Control of the ovarian cycle 
The essential regulatory systems involved in the oestrous cycle are the endocrine 
system and the brain. Stimuli from the environment (smell, sight, food etc) are 
registered by the senses and transmitted to the central nervous system (CNS) via 
sensory neurones. The brain then responds accordingly by modulating gonadal 
function via the HPG axis. Numerous neuromodulators of GnRH neurones regulate 
GnRH output these include, neuropeptide Y, J3-endorphin, galanin, y-amino butyric 
acid (GABA), neurotensin, glutamate, 5-hydroxy-tryptamine, vasoactive intestinal 
polypeptide and noradrenaline. Molecular and neuroanatomical evidence suggests 
that oestradiol influences the activity of these 'regulators' within the hypothalamus to 
drive reproductive cyclicity. For a recent review see Smith and Jennes, (2001) and 
Goodman et al. (2002). As discussed all events of the ovarian cycle are controlled by 
a complex interaction of both local and systemic feedback mechanisms involving 
hormones secreted by the hypothalamus, anterior pituitary gland, ovaries and uterus 
(section 1.1). Importantly, the key regulating peptide of reproductive function is 
GnRH, thus abnormalities in synthesis, storage, release or action of GnRH could 
potentially result in either partial or complete failure of gonadal function, and on the 
basis of this knowledge methods which deliberately inhibit GnRH function and thus, 
reproduction have been and continue (Chapters 3 and 4) to be studied. 
1.4 MATURATION OF THE IMMUNE SYSTEM 
The ability to respond to vaccination with antibodies is acquired in early gestation 
(Eskola and Kayhty, 1998; Offit and Hackett, 2003). However, active immunisation of 
newborns is hampered by an immature immune system and by passively derived 
maternal immunity (Morein, Abusugra and Blomqvist, 2002). 
1.4.1 Defects of the neonatal immune response 
Pioneering evidence of an immature neonatal immune system was provided when, 
newborn mice injected with allogenic hematopoietic cells failed to reject allografts 
(Billingham, Brent and Medawar, 1956), and the concept of neonatal immune 
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tolerance was born. A dose-effect relationship between neonatal responsiveness and 
amount of antigen used in vaccines, provided evidence for Ridge, Fuchs and 
Matzinger, (1996) to argue that the limited numbers rather than immaturity of 
lymphocytes might be the cause of neonatal susceptibility to tolerance. Indeed, an 
under developed neonatal spleen and reduced bone marrow reserve is considered 
responsible for low numbers of. APCs (B cells, dendritic .. cells (DCs) and 
macrophages) relative to adults (Kovarik and Siegrist, 1997). This is however, 
unlikely the sole cause of the limited and altered neonatal responses to vaccination 
as there are numerous reports of various defects of the neonatal immune system, 
which stem from the immaturity of a variety of neonatal immune cells (Petty and Hunt, 
1998; Suen et al., 1998; Pertmer et al., 2001; see Bot and Bona, 2002) and therefore, 
it seems likely that both quantitative and qualitative factors are responsible. 
1.4.1.1 Immature immune cells 
Neonates have reduced capacity to express surface molecules (CD86 and CD40) 
(Marshall-Clarke et al., 2000), which are required by APCs, most importantly DCs 
(Petty and Hunt, 1998), to signal to T cells via corresponding ligands (CD86L and 
CD40L). This signalling allows APC-T cell communication (co-stimulation), which is, 
in most cases, required for specific B cell (antibody) response. Furthermore, the lack 
of up-regUlation of CD40 and CD40L by neonatal B cells causes impaired expression 
of IL-12. As a result the response of B cells and their ability to switch to different B 
cell classes (e.g., IgG, IgA and IgE) and subclasses (e.g., IgG1 and IgG2a) is, along 
with natural killer (NK) and T cell function, compromised (Durandy et al., 1995). 
Moreover, the up-regulation of the Major Histocompatability-Class II (MHC-II) 
antigens on the surface of APCs is also reduced in newborns. MHC-II antigens are 
required to present the vaccine antigens (after the vaccine antigens have been 
enzymatically processed in the APC) to the T lymphocytes to induce the specific T 
cell response (Morein, Abusugra and Blomqvist, 2002). The reduced T cell function 
and reduced type 1 Helper T cell (Th1) cell stimulation in neonates results in sub-
optimal release of 'pro-inflammatory cytokines' such a; IFN-y and granulocyte-
macrophage col9ny-stimulating factor, which induce macrophage, n e ~ t r o p h i l l and Th1 
activation (Offit and Hackett, 2003). This leads to type 2 Helper T cell (Th2) biased 
immune responses (Adkins et al., 1993; Suen et al., 1998; Marshall-Clarke et al., 
2000). A bias towards Th 1 immunity in infant mice was reported following co-
injection of IL-12 or IFN-y-producing plasmids, an observation that elegantly 
pinpointed these cytokines as limiting factors during the neonatal period (Pertmer et 
aI., 2001). Opinions in similar neonate and adult T cell comparative human studies 
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are however, not in complete agreement, and, as exemplified above, accessory cell 
naivety and numbers (Martinez et al., 1997), particularly DCs, B cells (Marshall-
Clarke et al., 2000) and macrophages (Suen et al., 1998) are also responsible for 
typically reduced humoral immune responses. 
1.4.1.2 Immune imbalance-T helper 2 bias 
Placental progesterone, prostaglandin E and cytokines (IL-4 and IL-10; Rukavina and 
Podack, 2000) suppress Th1 inflammatory responses in the mother and foetus, and 
have evolved to evade immunological rejection of the foetus (Morein, Abusugra and 
Blomqvist, 2002; Offit and Hackett, 2003). Th2 cells release IL-4, which supports a 
preferential production of complement-independent IgG1 antibodies, whereas Th1 
immune responses are characterised by production of complement-dependent IgG2a 
antibody (Mosmann et al., 1995; 1997; Pertmer et al., 2001) and cellular immune 
responses. The Th1-Th2 balance of the immune response may influence the 
mechanism of action through which, a vaccine to GnRH might work. 
1.4.2 Maternally derived antibodies 
Passive immunity, acquired entirely through ingestion of colostrum in calves, lambs, 
piglets and foals, provides protection against disease in early life. However, passive 
immunity can block the development of serum antibodies when vaccine immunogens 
are administered to calves with maternally derived antibodies (Husband and 
Lascelles, 1975; Chappius, 1998). In colostrum fed calves maternally derived 
antibodies peak 24h after birth, and although their half-lives range from 19-23 days 
(Brar et al., 1978; Mechor et al., 2001; Kirkpatrick et al. 2001; Fulton et al., 2000), a 
comprehensive study of numerous viral antibody titres, including bovine herpes virus-
1 (BHV-1), showed huge variation between individuals in maternally-derived 
antibodies, and individual differences in the age at which maternal antibodies 
become undetectable (69-299 days; Kendrick and Franti, 1974; Fulton et al., 2004). 
Moreover, between species variation in time taken for titres to reach 1-30/0 of their 
initial value: 40 days for lambs, 60 days for pigs, 100 days for calves and 115 days 
for horses (Tizzard, 1977) has been reported, suggesting that some species may be 
less responsive to neonatal vaccination than others. The time required for cholostral 
antibodies to drop below detectable concentrations is dependent on amount of 
antibody ingested and absorbed (Fulton et al., 2004), offspring status i.e., singleton 
or twin (Keeling and Crighton, 1984), immunoglobulin content, the growth rate of the 
infant, hence dilution in the circulation and the rate of clearance from the body 
(Chappuis et al., 1998). In a possibly out-dated study of UK calf rearing, McGuire et 
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al. (1976) estimated that up to 400/0 of calves might have poor passive transfer of 
maternal antibodies and might therefore respond to primary vaccination (Fulton et al., 
2004). Obviously, the detrimental effects of passively acquired immunity on active 
immunisation boosters are reduced compared to the primary vaccination earlier in 
life, indeed a recent review of human infant studies (Glezen, 2003) concluded that 
maternally dervived antibodies have no effect on booster vaccinations. However, 
there is some evidence to suggest that even when maternally derived antibodies are 
undetectable, some blocking of immune responses may remain for a time (Morein, 
Abusugra and Blomqvist, 2002). 
The relative importance of immunocompetence compared to blocking effects of 
maternally derived antibodies appears to vary with both species and individuals. For 
example, in contrast to the dog and cat (Chappius, 1998), immunological immaturity 
has a greater effect in diminishing the response to primary immunisation against viral 
vaccines in humans, than do maternal derived antibodies (see Glezen, 2003), and 
failure of low viral antibody titre calves to respond to modified live viral (ML V; 
Kirkpatrick et aI., 2001), or inactivated viral vaccines (Fulton et al., 2004), suggests 
that this may also be the case in cattle. Furthermore, Fulton et al. (2004) after 
extensive studies recently concluded that, only the transferred of viral antibodies of 
exceptionally high titre are likely to interfere whh antibody response to vaccination in 
calves. However, most vaccination regimes, regardless of species, should consider 
the duration of maternal antibodies before the vaccinations of the infants commence. 
This has not been the case in the past (Morein, Abusugra and Blomqvist, 2002). 
1.4.3 Acquisition of immune maturation 
At birth the ability to respond is greatest for protein antigens (Glezen, 2003), as used 
in the studies herein. The ability to exhibit a response to vaccination similar to those 
seen in adults appears to, be acquired with increased age and body weight, and not 
surprisingly varies between species and vaccines (Morein, Abusugra and Blomqvist, 
2002). In cattle, for example, Adams et aI, (1996), failed to induce a detectable 
i m ~ u n e e response (>100/0 at 1: 1 000) in 47% of 1.5 month old calves immunised 
against a GnRK-KLH conjugate in FCA. The proportion of responders increased to 
800/0 at 4 months and 100% at 7 months of age. Pollock et al. (1991) observed a 2-3 
fold increase in immune response to KLH in calves 5 months of age, relative to that 
noted in calves age 3 weeks. Previous studies showed similar responses (Hauser, 
Koob and Roth, 1986; Roden et al., 1992). The only exception; showed that a 
moderate immune response (20% at 1: 1,000) to a single GnRH immunisation at ·1 
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month could not be improved upon when primary immunisation was given at 4 or 6 
months (Huxsoll, Price and Adams, 1998). This finding is in conflict with the bulk of 
the literature and earlier reports using the same conjugate and adjuvant by the same 
research group (Adams et al., 1996). Furthermore, (Huxsoll, Price and Adams, 1998) 
reported that, GnRH antibody titres were elevated for up to 11 months, after a single 
primary injection. However, sampling was very infrequent and again this is contrary to 
other reports (Robertson, Wilson and Fraser, 1979; Robertson et aL, 1981; 1982; 
1984; Jeffcoate, Lucas and Crighton, 1982; Jago et aL, 1995; 1997; Finnerty, Enright 
and Roche, 1998), as antibody titres in bulls dissipate more rapidly than in rams 
(Jeffcoate, Lucas and Crighton, 1982). It must be considered that, due to differences 
between assays, GnRH antibody titre comparisons between studies are unlikely to be 
accurate. However, titres between studies in heifers and bulls in Chapters 3 and 4 for 
example, were assayed together and are therefore comparable. Other variables such 
as genotype (Evans et aL, 1991a;b; Evans, McNeiily and Webb, 1994), health status, 
nutrition (Galyean, Perino and Duff, 1999) and breed also affect immune response. 
1.4.4 Recent developments in neonate vaccination 
Th2 biased immune responses have prevailed despite the use of a variety of vaccine 
approaches including, inactivated and live attenuated viral vaccines, live recombinant 
canary pox viral vaccines (Barrios et al., 1996; Siergrist et al., 1998), and peptides or 
proteins using conventional adjuvants such as FCA (Singh, Hahn and Sercarz, 1996) 
or alum (Barrios et al., 1996). As a result, recent attempts to promote more balanced 
and effective immune responses have included, administration of recombinant 
cytokines, which caused fever-like side effects (Vogel and Hem, 2003) and DNA 
vaccination 'genetic adjuvants'. In the latter, a plasmid encoding a gene(s) for an 
antigenic portion of a virus is administered, resulting in the in situ expression of the 
antigen and antigen-specific immunity. Genetic adjuvants promote Th1 cytokine 
production and stimulate the structure of the neonatal spleen, where Band T cells 
and MHC-II cells develop (Pertmer et al., 2001). DNA vaccination against herpes 
simplex gB antigen (Manickan, Yu and Rouse, 1997) induced a humoral immune 
response in neonatal mice despite the presence of maternal antibodies and the Th 
- . 
profile elicited by neonatal DNA immunisation comprises an important Th1 
component (Bot et al., 1997), resembling the adult response and generally 
contrasting with the neonatal immunity triggered by conventional antigens. In contrast 
to standard antigen vaccines, DNA vaccination viral genes are expressed in the host 
and viral proteins are synthesised before entering the host cells MHC-I pathway (only 
protens originating inside a cell are processed in this manner). MHC-I molecules then 
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carry the foreign protein to the cell surface, where they evoke cell-mediated immunity. 
As the protein encoded by DNA vaccine is produced endogenously and expressed in 
the context of self MHC-I, there is an increased risk of 'recognition of self', leading to 
tolerance, or autoimmunity (Mor, 1998). 
It is becoming increasingly evident .that newborn animals are immune competent 
albeit with a biased Th2 profile. Indeed, equine Herpes Simplex 2 viral antigen 
vaccination in 10 days old foals resulted in a potent immune response and protection 
against the virus (Morein, Abusugra and Blomqvist, 2002). Furthermore, I m p r o v a d ~ ~
claims to be 1000/0 effective after primary vaccination at 3-4 weeks (McCauley et al., 
2003). Recently, the view of a low competence of newborns to respond to active 
immunisation has gradually changed to realise that the competence might be low, but 
it is there, and can be used if the conditions of the newborn are considered 
(Chappius, 1998; Morein, Abusugra and Blomqvist, 2002). 
1.5IMMUNOCASTRATION 
The rearing of intact animals for meat is associated with numerous problems, which 
are discussed in more detail in subsequent chapters. Therefore, they will only be 
briefly mentioned in this literature review. Sexual and aggressive behaviours in bulls 
(Robertson, Wilson and Fraser, 1979; Jago et aI., 1995; 1996; 1997; Finnerty et aI., 
1996; Huxsoll, Price and Adams, 1998), boar taint and fighting lesions in pigs (Favlo 
et aI., 1986; Awoniyi et aI., 1988a;b; Claus and Weiler, 1994; Dunshea et aI., 2001;' 
Hohl et aI., 2002; Metz et aI., 2002; Zeng et aI., 2002; Claus, 2003; McCauley et aI., 
2003; Thun et aI., 2003) and unwanted pregnancies in extensively farmed heifers 
(Hoskinson et aI., 1990) result in management and meat quality problems, and 
increased production costs. Several strategies have been employed to overcome 
these problems. In males these include, 'bloodless castration', whereby a Burdizzo 
(instrument) is used to crush the spermatic cord, which carried blood to the testes 
(Zobell, Goonewardene and Zeigler, 1993),' rubber-ring castration (Blowey, 1993), 
short scrotum castration and intra-testicular lactic acid injections (Fordyce et aI., 
1989). In females the efficacy of fallopian tube ligation (D'Occhio, 1993) and intra-
uterine device implants (Turin et al., 1997; Fordyce et al., 2001) have been 
investigated. All proved to be ineffective, inefficient and/or unethical (see Mepham 
and Forbes, 1995). As a result, many producers have continued to resort to surgical 
castration, despite the associated risks to animal health and life, and the compromise 
to animal welfare (Meleon et aI., 1994; see D'Occhio, 1993; Bonneau and Enright, 
1995; Fisher et al., 1996; Thompson Jr, 2000). 
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1.5.1 Active GnRH Immunisation 
The more recent approaches to have included immunisation against GnRH 
analogues (e.g.octapeptides), synthetic GnRH, GnRH fusion proteins and GnRH 
constructs (e.g., variations in amino acid sequence, such as tandem repeats; Meleon 
et a/., 1994; Sosa et a/., 2000). The use of these GnRH alternatives, have resulted in 
more prolonged, less varied and greater responses. However, i ~ ~ is difficult to make 
comparisons between experiments since the new generation of GnRH vaccines have 
replaced the highly potent Freund's complete and non-complete adjuvant with 'less 
aggressive' alternatives, which do not interfere with tuberculosis testing in cattle 
(Goubau et a/., 1989). Variations between trials in hapten, conjugate, adjuvant, 
vaccination schedule (number of boosters etc), dose of vaccine, administration, 
nutrition, health status, stress, climate, breed and gender, result in obvious limitations 
to between trial comparisons.-
1.5.1.1 Antigen presentation I carrier conjugation 
The small molecular weight (1183MW; Fraser, 1980) of GnRH does not induce 
immunogenicity. To raise antibodies against GnRH the immune system must be 
fooled into recognising GnRH as foreign (Thompson Jr., 2000; Ferro et a/., 2002a;b). 
Until recently, for the reliable production of GnRH antibodies, the peptide had to first 
be conjugated to a carrier immunogenic protein molecule (Fraser, 1980; Tables 1.1 
and 1.2). However, chemical conjugation can be problematic as, the requirement for 
a repeatable homogenous chemical preparation from batch to batch (Roche and 
Crowe, 2004) is virtually impossible to obtain. More recently, a 'second generation' of 
vaccines has emerged whereby GnRH may be made immunogenic using a 
recombinant fusion protein into which specific hormone epitopes are incorporated 
into the sequence of the immunogenic protein (ovalbumin-GnRH; Sosa et a/., 2000; 
Roche and Crowe, 2004). 
1.1.5.2 Vaccine formulation I adjuvants 
The immune response to a given antigen is enhanced by the inclusion of an adjuvant, 
(adjuvare, to help or aid) i.e., a substance that non-specifically stimulates an immune 
response (Alexander and Brewer, 1995). Numerous adjuvants have been used in 
vaccines, but all work through three basic mechanisms: 1) e f f e ~ t s s on antigen delivery 
and presentation, 2) induction of immunomodulatory cytokines, and 3) effects on 
APCs (Weaver and Unanue, 1990; Vogel and Hem, 2003). As the immune system is 
antigen-driven, the simplest adjuvants simply slow the release of the antigen. 
Resulting in a prolonged immune response. To slow the rate of antigen clearance, 
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the antigen may be mixed with an insoluble antigen to form a "depot". Such adjuvants 
include, insoluble aluminium salts (e.g., crystalline aluminium oxyhydroxide 
(ALOOH». Following the injection of such a compound a macrophage-rich 
granuloma is formed in the tissues. The antigen within the granuloma is slowly 
released into the body and so provides a prolonged antigenic stimulus (Tizard, 1982). 
Evidence of secondary depots forming at draining lymph nodes. has been reported 
(Warren and Chedid, 1988). An alternative method of forming a 'depot' is to 
incorporate the antigen in a water-in-oil emulsion. The oil stimulates a local 
inflammatory response and granuloma formation, while the antigen is slowly leached 
from the aqueous phase of the emulsion. An adjuvant into which, killed mycobacteria 
are incorporated in a water-in-oil emulsion, is known as Freund's complete adjuvant 
(FCA). The active fraction of the mycobacteria, which enhances this activity, is known 
as muramyl dipeptide (n-acetYI-muamYI-L-ananYI-D-isoglutamine). FCA and FA are 
known to denature antigen, allowing recognition of internal antigen determinants 
(Kenney et al., 1989). Other compounds with adjuvant activity include, bacterial 
endotoxins, anaerobic coryneforms, polyribonucleotides, sodium alginate, lanolin, 
vitamin A, (Tizard, 1982) saponin and purified saponin (Quil A; a complex mixture of 
triterpine glycosides; Alexander and Brewer, 1995). 
The induction of modulatory cytokines by use of cytokines as adjuvants can induce 
unwanted side effects (Vogel and Hem, 2003). Therefore future focus on co-
administration of a 'non-specific immunomodulation vaccine' such as a para pox virus 
vaccine with a GnRH construct might be advantageous in cattle. The application of 
poxviruses, are known to induce non-poxvirus specific immune reactions, which 
protect against non-poxvirus specific diseases. Poxvirus based vaccines possess 
immunomodulating capacity (formerly called "beneficial side effects") which stimulate 
production and release of numerous cytokines, chemokines, interleukins and immune 
cells. Alternatively, CpG oligonucleotide adjuvants are promising and new 
approaches, which 'redirect' immune responses that have a natural Th2 bias. Short 
sequences of bacterial DNA containing un methylated cytosine and guanine 
dinucleotides, so called CpG motifs, trigger B cell activation and induce cytokine 
secretion, thus promoting Th1 response (Vogel and Hem, 2003). 
1.5.1.3 Vaccine protocols 
For both commercial application and animal welfare reasons, the number of 
vaccinations required should be kept to a minimum, preferably one (Stevens, 1993). 
Although this has been achieved in anti-disease vaccines, vaccines against "self' 
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antigens often require more administrations to cause a response of sufficient 
magnitude to induce the desired physiological effect. Furthermore, at each session, 
more than 2 injection sites are also agreed as generally unacceptable (Robertson, 
Wilson and Fraser, 1979). Despite claims of an effective "one shot" vaccine for GnRH 
in heifers and bulls (see Meloen, 1995), these results have not to our knowledge 
been confirmed. In contrast to the·· majority of publications, Adams et al. (1996) 
reported elevated titres and attenuation of testicular growth for up to one year 
following a single GnRH immunisation in prepubertal bulls. 
Data suggests that the number of vaccinations may be reduced, by using a mixture of 
slow and fast releasing particles, to deliver a primary and booster vaccination at the 
same time. Fast dissolving particle provide the primary antigenic dose, while slow 
dissolving particles release their contents when a booster immunisation is required 
(see Stevens, 1993; Meloen, 1995). 
1.5.2 Passive Immunisation Against GnRH 
Passive immunisation is not a practical alternative to conventional castration in cattle 
due to the transient nature of the elevation in antibody titre, high volumes of 
antiserum required and associated costs. However, passive GnRH immunisation has 
proved to be a useful tool in scientific research in numerous species such as, the rat 
(Bercu et al., 1977; Lincoln and Fraser, 1979; Bercu and Jackson, 1980), sheep 
(Keeling and Crighton, 1984; Millar, Fraser and Brooks, 1998; Parathasarathy et al., 
2002) and tammar wallaby (Macropus eugenii; Short, Flint and Renfree, 1985). In 
view of the difficulties encountered by researchers in inducing significant immune 
responses in a proportion of neonatal and young animals (Bell et al., 1997; Fulton et 
al., 2004), my opinion is that passive immunisation against GnRH may have an 
important role in determining when, if at all, the hypothalamic-pituitary gland unit is 
maximally susceptible to GnRH antibodies. 
1.5.3 Physiological Effects of GnRH Immunisation 
1.5.3.1 Pr.epubertal and adult animals 
Immunisation of young and adult domestic animals against GnRH, regardless of 
gender, causes the cessation of reproductive function by preventing gonadotrophin 
production and release (Tables 1.1 and 1.2; Jeffcoate, Lucas and Crighton, 1982; 
Robertson, Wilson and Fraser, 1979; Robertson et al., 1981; 1982; Schanbacher, 
1982b; Wettermann and Castree, 1988; Adams and Adams, 1990; 1992; Hoskinson 
et al., 1990; Carson, McCaughey and Steen, 1994, Brown et al., 1994, 1995; 
'" . 
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Table 1.1 Summary of previous GnRH vaccination studies in bulls 
Author(s) Carrier proteinl Dose I Hapten conjugating Adjuvant injection year 
agent site 
Robertson et Tetanus toxoid or 
al., 1979; Synthetic Thyroglobulin FCA (primary) & FA 2 x 2ml s.c. GnRH (2.0mg) carbodiimide (boosters) 1981 (600mg) 
Robertson et Synthetic HAS (10mg) 2 x 2ml chest al., 1982; Carbodiimide FCA& FA & brisket 
1984 GnRH (600mg) area 
Jeffcoate et Synthetic BSA 8 x 0.6ml al., 1982 GnRH (0.1 mg) Carbodiimide FCA back 
FCA or alternative FCA (6 x 
Goubau et al., Analogues; C 1 OVA (C1) & ESA adjuvants: Havlogen, 0.5ml; intra-1989b RAS, DDA, dermal) or 2x & C10 GnRH (C10) Alhydrogel or 1-1.5ml Lm. 
Regressin neck 
Finnerty et al., GnRH HSA Not stated Not stated 1991 
Adams & 
Adams, 1992; GnRH KLH FCA 2x2ml Adams et al., (0.65mg) (1.0mg) Neck (dorsal) 
1993; 1996 
Lobey et al., GnRH; Egg albumin! Morris's NUA & 4x 1ml 1992 Octapeptide (3- (Corybacterium near iliac 
10; 1.25mg) carbodiimide parvum Primarr only} nodes 
Teague et al., 
1992 GnRH HSA Not stated . Not stated 
KLH! 
Carson et al., Synthetic Carbodiimide Alum (1.5ml) & 2ml s.c. 
1994 GnRH (4.0, 1.0, 0.25, Saponin (2mg) Brisket 
0.05 and Omg) 
Finnerty et aI., Synthetic Has (analogue NUFCA (C. Parvum) 1994; 1995; 2x 1.5ml s.c. 
1998) analogue: and HAS dose: or DEAE-D); FA or neck (brisket) Cys-Gly-GnRH 0, 0.1 or 1.0mg) DEAE-D 1998 
Jago et al., Carboxyl 
containing DEAE-O in mineral 2 x 2.5ml s.c. 1995; 1997b GnRH OVA oil (Vaxstrate®) neck 
analogue 
Huxsoll et al., GnRH KLH 2 x 1ml 1998 (0.65mg) (1.0mg) FCA& FA neck 
Cook et al., . Recombinant Leukotoxin by Unknown, but 2000 'commercially Neck fusion protein P. haemolytica 
acceptable' 
D'Occhio et DEAE-D, AriOcel80 
al., 2001 GnRH OVA & Ondena mineral oil Neck (dorsal) 
l'laxstrate®) 
45 
Chapter 1: Review of Literature 
Table 1.2 Summary of previous GnRH vaccination studies in heifers 
Author(s) Carrier proteinl Dose I Hapten conjugating Adjuvant injection year agent site 
FCA(M. 
paratuberculosis), 6VR-
Johnson et OVA (Ouillaha Saponin(OS; 2 x 1ms.c. 
al., 1988 GnRH carbodiimide 1 mg/ml), 5% oil & 95% Dewlap H2O. 
M103-(OS; 63% OIL & 
37% H2O. 
Wetteman & 
Castree, GnRH HSA FCA& FA Not stated 
1988 
Adams & 
Adams, 1990; Synthetic 2mls.c. Adams et al., - KLH FCA& FA Neck 
1990 GnRH (dorsal) 
Hoskinson et DEAE-D, Arlocel80 & 5ml s.c. 
al., 1990 GnRH OVA (Chicken) Ondena mineral oil Neck (Vaxstrate®) 
D'Occhio et DEAE-D, Arlocel 80 & GnRH OVA Ondena mineral oil Not stated 
al., 1992 (Vaxstrate®) 
Sejrsen et al., GnRH HSA Not stated Not stated 1994 
Vizcarra & 
Wetteman, GnRH OVA FA& DEAE-D 2 sites 1994 Neck 
Prendiville et 2 x 2.5ml 
al., 1995a; Cys-Gly- HSA DEAE-D s.c. 1996 GnRH Neck 
Prendiville et Cys-Gly- DEAE-D &/or NUFA 2 x 2.5ml 
al., 1995b GnRH HSA (C.parvum:primary) s.c. Neck 
Finnertyet Synthetic Has (analogue NUFCA (C. Parvum) or 2x 1.5ml aI., 1994; analogue: 
1995; 1998) Cys-Gly- and HAS dose: DEAE-D); FA or DEAE-D s.c. neck 
GnRH 0, 0.1 or 1.0mg) 1998 (brisket) 
Jeffrey et al., DEAE-D, Arlocel 80 & 5ml s.c. 1997 GnRH OVA Ondena mineral oil 
(Vaxstrate®) Neck 
B.ell et al., KLH 2 sites 1997 . GnRH FCA Neck 
Sosa et al., GnRH-7 GnRH-OVA Z-Max adjuvant, His-Tag Intra-2000 (recombinant 
protein) (recombinant) compatible mammary 
Crowe et al., Cys-Gly- 2 x 1.5ml 2001a;b HSA DEAE-D s.c. Neck GnRH (brisket) 
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Prendville et al., 1995a, 1995b, 1996; Clarke et al., 1998; Finnerty et al., 1991; 
Finnerty, Enright and Roche, 1998; Cook et al., 2000; D'Occhio, 1993; 1994; 
D'Occhio, Aspden and Trigg, 2001). Subsequently, in the post-pubertal male, 
testicular size is reduced, while prepubertal animals exhibit arrested and/or reduced 
growth rates (Jeffcoate, Lucas and Crighton, 1982; Lobey et al., 1992; Adams et al., 
1993; 1996; Finnerty et al., 1994; Jago et al., 1995; Huxsoll, Price and Adams, 1998; 
Cook et al., 2000). As a result spermatogenesis is reduced (Robertson, Wilson and 
Fraser, 1979; Carson, McCaughey and Steen, 1994; Cook et al., 2000), testosterone 
concentrations fall (Finnerty et al., 1994; Jago et al., 1995; Finnerty, Enright and 
Roche, 1998; Huxsoll, Price and Adams, 1998; Cook et al., 2000) causing reduced 
accessory gland growth and/or function. Libido is also inhibited and more docile 
(steer like) behaviours ensued (Robertson, Wilson and Fraser, 1979; Robertson et 
al., 1981; 1982; Finnerty et af, 1996; Jago, Bass and Matthews, 1997; Huxsoll, Price 
and Adams, 1998). 
In the female, follicular development is. arrested or reduced (Johnson et al., 1988; 
Adams and Adams, 1990; Prendiville et al., 1995a; 1996; Crowe et al., 2001a; b) and 
ovaries (Johnson et al., 1988) and uterii are reduced in size (Adams and Adams, 
1990). Due to the absence of oestradiol, animals become anoestrus and ovulation is 
inhibited (Johnson et al., 1988). However, early studies in adult animals indicated that 
the suppressive effects of GnRH immunisation were reversible, at least to some 
extent, with time in cattle and sheep (Robertson et al., 1981; 1982; Keeling and 
Crighton, 1984; Wetteman and Castree, 1988; 1994). 
Anabolic effects have also been reported and are discussed in more detail in 
Chapters 3 and 4. Briefly, the evidence for an anabolic effect of GnRH immunisation 
is often conflicting in some studies reduced growth rates relative to bulls were found 
(Lobley et al., 1992; Cook et al., 2000), but not in all trials (Robertson et al., 1982; 
Huxsoll, Price and Adams, 1998). Furthermore, Adams et al. (1993a; 1996) observed 
improved feedlot gain in bulls immunised against GnRH at 3.6 months of age. As 
d i s c ~ s s e d d comparisons are difficult between trials due to the myriad of factors, which 
can cause variations e.g., vaccine response, the extent of immunosuppression, 
interval from last vaccination to slaughter, nutrition, breed, stress, climate etc. 
Furthermore, comparisons are made more difficult by variations between research 
groups in the parameters used to assess carcass characteristics and the fact that 
some parameters are subjective, and based only on observer opinion. Generally, 
high responding animals, with suppressed reproductive function, tend to have more 
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'steer-like' growth rates and carcass compositions, whereas poor responders have 
bullish characteristics (Lobley et a/., 1992; Thompson Jr, 2000). Most 
immunocastrates show growth and carcass compositions intermediary between bulls 
and steers (Jago et a/., 1995). For example, average daily gains (ADG) for intact 
bulls, immunocastrates and steers are typically, 0.91, 0.88-0.91 and 0.78-0.81 kg 
day-1, respectively (Robertson et a/., 1982; Bonneau and Enright,1995). 
1.5.3.2 Neonatal immunocastration 
Neonatal passive GnRH immunisation studies in rats demonstrated that normal 
development of pituitary (Bercu and Jackson, 1980) and gonadal function requires 
the presence of GnRH from day one of life (Bercu et a/., 1977). GnRH immunisation 
led to a permanent impairment of seminiferous tubular size and function, although 
puberty was not delayed and adult gonadotrophin and testosterone concentrations 
were similar to control animals. Sexual behaviour was also unaffected, however the 
authors found in-complete catch-up of penile and vesicular gland growth (Bercu et 
a/., 1977), and probably as a result of the latter, a reduced volume of ejaculate (Bercu 
and Jackson, 1980). Bercu et a/. (1977) stated that a decrease in neonatal FSH could 
be of key importance to gonadal function. Furthermore LH antiserum treatments 
(Goldman et a/., 1972) resulted in adults with reduced penis size and poor mating 
behaviour, but typical testicular weights. This indicates that neonatal deficiency in LH 
and/or testosterone does not affect adult testicular size in the rat (Bercu et a/., 1977). 
Although passive immunisation in neonatal rats permanently affected sexual 
development in males and females (Bercu et a/., 1977; Bercu and Jackson, 1980; 
Vilchez-Martinez and Martin de Lopez, 1980), Keeling and Crighton, (1984), 
concluded that, similar effects would be unlikely in sheep as growth and ~ e x u a l l
development proceeded at the same rate in lambs born to control and GnRH 
immunised ewes. However, the studies in rats employed high titre antiserum and it 
remains to be seen whether the levels of antibodies, which were present in colostrum 
would be sufficient to impair reproductive development in this species (Keeling and 
Crighton, 1984). It should be considered however that, although intake might vary, 
colostrum IgG concentrations are four-fold higher than in serum just prior to 
~ ~ . 
parturition (Halliday, 1974). The effects observed in the neonatal rat can probably be 
attributed to the fact that, differentiation of the neural tissues in both sexes occurs 
during neonatal life (Harris, 1964). Thus, blocking GnRH during this critical period 
inhibits differentiation of the HPG axis. In contrast, these events occur prenatally in 
the sheep (Short, 1974; Caldani et a/., 1995) and consequently ingestion of GnRH 
antibodies neonatally is unlikely to affect subsequent patterns of HPG axis 
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development (Keeling and Crighton, 1984). The situation in other species, such as 
the cow, appears similar (Wise, Rodgriguez and Kelly, 1987), but remains to be 
studied in detail. . 
Keeling and Crighton, (1984) conducted several experiments and found that, some 
sheep appeared to be particularly responsive to GnRH vaccinati.on, as reproductive 
function could be inhibited 2 years after immunisation when antibody titres were 
undetectable, however, the majority of rams returned to fertility between 6-12 months 
after immunisation, and similar findings were reported in ewes, although the period of 
in fertility was more variable (Keeling and Crighton, 1984). 
More recently, active immunisation against GnRH in male lambs, at 3-4 (neonatal) 
and 20-21 (peri-pubertal) weeks of age, resulted in long-term suppression of 
reproductive function. A proportion of rams had juvenile-like reproductive organs and 
a complete lack of libido 2 years after GnRH vaccination, when antibody titres are 
undetectable (Brown et al., 1994). However, low gonadotrophin output in most GnRH 
immunised rams was sufficient to allow exhibition of some sexual behaviour and 
gonadal function (including spermatogenesis) by 2 years of age (Brown et al., 1994). 
A follow up study (Brown et al., 1995) published results of an almost identical trial 
carried out on ewe lambs. Gonadotrophin concentrations in the majority of 
immunocastrated ewes were insufficient to support reproductive function by two 
years. Both the degree and longevity of reproductive suppression appeared more 
severe in GnRH immunised ewes. The fact that the ewes appeared to be more 
susceptible to the effects of GnRH immunisation than the rams (Brown et al., 1995), 
may indicate a gender difference in the "window of maximum susceptibility to GnRH 
antibodies", which corresponds to sex differences in the maturation of the HPG unit. 
Alternatively, this observation may indicate that basal gonadotrophin output is 
adequate to maintain reproductive function in males, but not females. More recently 
still, Clarke et aI, (1998) studied 3-4 year old sheep that had previously taken part in a 
neonatal GnRH immunisation programme (Brown et al., 1994, 1995). Following a 
GnR!-f challenge at 90 weeks of age by which time anti-GnRH titres had dissipated 
the pituitary gland was unresponsive to GnRH, producing abnormally low 
gonadotrophin levels. This suggests that GnRH vaccination i n d ~ c e s s some degree of 
impairment to pituitary function, resulting in a reduced capacity of the gland to either 
respond to GnRH (e.g., down regulation of GnRH receptors) or in reduced synthesis 
and lor release of LH and FSH (Brown et al., 1994). Many of the sheep displayed a 
permanent suppression of reproductive function. The authors concluded that 
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neonatal GnRH immunisation may not be reversible in all treated animals (Brown et 
al., 1994; 1995; Clarke et al., 1998). A recent GnRH immunisation study in Zebu bulls 
(D'Occhio, Aspden and Trigg, 2001) found that a similar proportion of animals to the 
earlier trial in rams (Brown et al., 1994) presented with a long-term suppression of 
reproductive function. Furthermore, the age (6 vs. 22 months) and status of the bulls 
(pre- and post-pubertal) had no influence on the proportion of animals, which failed to 
regain reproductive function. 
1.5.4 GnRH immune response: mechanism(s) of action 
GnRH only travels a few millimetres in the hypophyseal portal blood vessels before 
reaching its primary target, the pituitary gland receptors (see McArdle et al., 2002; 
section 1.3.1.3). Antibodies could therefore act at the level of the gonadotrophin cell 
membrane, (Fraser, 1980), or they may even gain entry to the median eminence 
. (Hokfelt et al., 1976), as GnRH neurons terminate within the median eminence (ME) 
and thus, are outside the blood-brain barrier (Molenaar et al., 1993; D'Occhio, 
Aspden and Trigg, 2001). Furthermore, hypothalamic neurons are capable of taking 
up macromolecules such as horseradish peroxidase, dextran and latex beads from 
the blood in to the ME. These substances are then transported retrograde to their 
perikarya (Van der Krans and Hoogland, 1983; Gross et al., 1986; Leong and Ling, 
1990; Molenaar et al., 1993). GnRH antibodies in solution are therefore likely to gain 
access to GnRH neurones (Molenaar et al., 1993). Studies by Brimijoin and Lennon, 
(1990) and Tilders et al. (1990) demonstrated that direct exposure of neurones to 
antibodies against their own secretion products, results in the destruction of the 
neurone or their processes. However, no reports on the effects of GnRH antibodies in 
vitro on ME GnRH neuron terminals have been published. Recent findings stren,gthen 
the evidence that the basal hypothalamus- ME is a primary target site for anti-GnRH 
antibodies. Molenaar et al. (1993) studied the hypothalami of 25 boars, selected on 
the basis of a testes response to GnRH immunisation, using histological and 
immuno-cytochemical techniques. When compared to control animals, they reported: 
dystrophy in the perikarya and reduced immunocytochemical activity in the GnRH 
neuron terminals within the ME, thus indicative of impaired ability of the neurons to 
- . 
release GnRH. Also inflammation (oedema, capillary collapse, fibrosis and fibroblast 
infiltration), neurosecretum accumulation and hypertrophy of magnocellular neurons 
were witnessed at the ME, suggesting damage to GnRH neurons resulting from 
immune cell infiltration. The lesion incidence was correlated to the GnRH and 
physiological response to vaccination, as indicated by GnRH titres and gonadal size 
and function (Molenaar et al., 1993). Furthermore, these lesions were restricted to the 
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ME and did not involve other parts of the hypothalamus, suggesting that GnRH 
antibodies and immune cells do not cross the blood brain barrier, but were entering 
neurons at terminals. This observation is surprising in view of a recent publication by 
Namer and Steibel (2000). These authors reported that Freund's complete adjuvant 
(FCA), as used by Molenaar et al. (1993), contains a compound called mannan, 
which arises from the cell wall of Mycobacterium tuberculosis. Administration of FCA 
raises anti-mannan antibodies, which induce an immediate, but reversible breakdown 
of the blood brain barrier in rats (Namer and Steibel, 2000). 
Studies on the effects of GnRH immunisation in neonatal cattle are absent and for 
this reason and the evidence of increased HPU susceptibility to GnRH antibodies 
during the neonatal period the study in Chapter 3 was conducted. Furthermore the 
Chapters 3 and 4 trials take a more holistic approach in assessing the effects of 
vaccination than· the majority of publications and investigates the long-term 
vaccination responses before, during and well beyond puberty simultaneously in both 
bulls and heifers, which again is seen to be lacking in the current literature. Studies 
into how GnRH antibodies act to suppress reproductive function, i.e., the 
mechanism(s) of action and the effects of GnRH antibodies on GnRH neurons are 
also lacking, despite 25 years of GnRH immunisation in cattle. 
1.6 PROLIFICACY 
Farmers and scientists have adopted numerous approaches in attempts to increase 
litter size in sheep and twinning rates in cattle. A thorough review of all these 
approaches is however, not possible due to the limitations of this thesis. Therefore 
the approaches will be summarised and the reader referred to relevant ~ e v i e w w
publications where necessary. Although inhibin immunisation will be reviewed in 
more detail, the review is by no means exhaustive as this approach to increasing 
prolificacy is discussed further in Chapters 5 and 6. 
1.6.1 Nutrition and Metabolic Hormones 
The enhanced ovine follicular development and ovulation rates observed after dietary 
impr.ovements (see Robinson, 1990), i.e., nutritional 'flushing' has been reported to 
occur by increasing gonadotrophin release (Smith, 1988). However, Downing and 
Scaramuzzi (1991) found that enhanced follicular development occurred 
independently of changes in peripheral FSH levels. Therefore it was concluded that 
the increase in follicular number must be under the control of factors other than those 
of the hypothalamo-pituitary gland-ovarian axis. Numerous metabolic factors have 
been implicated in modulating folliculogenesis at the ovarian level (see O'Caliaghan 
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and Boland, 1999; Webb et al., 1999c; Webb et al., 2003 in press). Diets which 
increase insulin concentrations have resulted in an increased up-take of glucose, 
which may reduce the capacity of the dominant follicle to suppress the development 
of subordinate follicles, thus leading to increased ovulation rates (Scaramuzzi, 1994). 
Insulin like growth factor-I (IGF-I) is synthesised and secreted by a range of cell 
types, but the liver is acknowledged as the primary producer of this factor. As 
discussed IGF-I has been shown to stimUlate cell proliferation and hormone 
production in both granulosa and theca cells in vitro, and stimulated ovarian follicular 
development and ovarian androgen and oestradiol secretion in vivo (Campbell, 
1999). Furthermore, rbGH treatment increased the numbers of 2.0 - 5.0mm and the 
2.1-3.0mm follicle populations in heifers (Gong, Bramley and Webb, 1991; 1993; 
Gong et al., 1996c; 1997) and ewes (Gong et al., 1996b), respectively. Growth 
hormone (GH) is believed to act by increasing peripheral concentrations of IGF-I and 
insulin (Gong et al., 1997). Rather than by a direct effect at the ovarian level, since 
follicle GH receptors have been difficult to detect (Lucy et al., 1999; Lucy, 2000). 
Species differences in the response to recombinant GH (rGH) have been 
demonstrated. For example, following rGH treatment of heifers follicle recruitment is 
enhanced due to an increase in the number of small follicles and the total antral 
follicle pool increased, whereas in ewes rGH t r ~ a t m e n t t enhanced the development of 
follicles from the gonadotrophin-sensitive pool into the gonadotrophin dependent 
stages, resulting in an increase in the number of medium-sized follicles without 
affecting total antral follicle number (Gong et al., 1996b;c). Multiple mechanisms are 
involved in the regulation of folliculogenesis and the relative importance of each 
mechanism may be species specific (see Webb et al., 1992b; Campbell, Scaramuzzi 
and Webb, 1995). 
In a twinning population established at the Meat Animal Research Centre (MARC) in 
Nebraska the current rate of multiple ovulation is approximately 25%, in 12-18 month 
old heifers, and the current twinning rate for' the herd exceeds 350/0 (Echternkamp 
and Gregory, 1999a;b). Current results suggest that a gene(s) exists on chromosome 
5 that affects ovulation rate in cattle (Kappes et al., 2000), i.e., close to the IGF-I 
~ ~ . 
gene (Lien et al., 2000). 
Studies of follicular growth in these cattle genetically selected for twinning lend some 
support to an IGF-I role. Echternkamp et aI, (1990b) demonstrated that, multiple 
ovulating or twin bearing cows have increased serum and follicular fluid IGF-I, and it 
was reported that these cattle have increased follicles ~ 4 m m m (Echternkamp et al., 
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1990a; Echternkamp, 1992; 1993; Echternkamp and Gregory, 1998), indicative of 
enhanced recruitment. In contrast, Cushman et al. (2000) concluded that, dams 
predisposed to yielding twin calves do so by keeping more follicles growing during the 
recruitment and selection processes, rather than by activating more follicles from the 
primordial or gonadotrophin-sensitive pools. 
1.6.2 Hormone Administration 
Experiments using exogenous hormone treatments have also been carried out in 
attempts to increase ovulation rate (see Armstrong, 1993). Ovarian activity has been 
stimulated using porcine FSH (Hasler et al., 1983; Takedomi et al., 1995b) or 
follitropin (an FSH preparation with 80% LH activity removed; Wu et al., 1988), 
equine chorionic gonadotrophin (eCG) with (Wang et al., 1988; Zeitoun et al., 1988; 
Dieleman et' al., 1993; Silva, da Casta and Silva, 2002), or without (Monniaux, 
Mariana and Gibson, 1984; Boland, Goulding and Roche, 1991; Goulding et al., 
1996) anti-eCG antibodies. FSH treatment increases the window of opportunity in 
which gonadotrophin dependent follicles may develop, while eCG may also prevent 
atresia and enhance recruitment (see Scaramuzzi et al., 1993). However, variation in 
response between animals was huge (see Monniaux, Chupin and Saumande, 1983; 
Boland, Goulding and Roche, 1991) and therefore, such treatments are only useful to 
" 
induce multiple ovulation for embryo transfer programmes. Interestingly, pre-
treatment of heifers with either rbGH ,enhanced the superovulatory response and 
quality of embryos to FSH treatments in cattle (Gong et al., 1996c; Nolan et al., 1998; 
see Armstrong, Gong and Webb, 2003) and sheep (O'Callaghan et al., 2000). 
1.6.3 Steroid Immunisation 
Scaramuzzi, Davidson and Van Look, published a pioneering report in 1977, stating 
that active immunisation against androstenedione increased ovulation rate in Welsh 
mountain ewes. In 1983, a vaccine against androstenedione was released 
commercially as Fecundin®. The vaccine increased LH secretion, but had little or no 
affect on FSH (McNatty et al., 1988; Campbell et al., 1991 a; see Scaramuzzi et al., 
1 9 9 ~ ) . . Therefore, androstenedione immunisation only affects large antral follicles 
(Scaramuzzi et al., 1980; Draincourt, Cahill and Bindon, 1985), possibly, increasing 
ovulation rate by reducing atresia (Bister et al., 1999), although flat proven. However, 
low concentrations of biologically active androgen may have an effect, which is 
independent of that of LH (see Scaramuzzi et al., 1993; Terqui et al., 1995). Several 
other steroids including oestradiol, oestrone and testosterone, or combinations have 
been targeted in immunomodulation studies (see Scaramuzzi and Hoskinson, 1984; 
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Smith, 1985; Philipon and Draincourt, 1987; Croker et al., 1988; Scaramuzzi et al., 
1993; Terqui et al., 1995). 
Attempts to induce twinning in cattle through immunisation against steroids have 
been less successful than in sheep (see Hillard et al., 1995). For example, the effects 
of androstenedione immunisation in heifers are conflicting. Wise and Schanbacher 
(1983) reported increased twinning rates, whereas others (Sreenan, 1984; Walton, 
1985; Hoskinson et al., 1986) observed ovarian dysfunction. In addition, active 
immunisation against testosterone increased ovulation rate, but was associated with 
a high incidence of anoestrous (Price, Morris and Webb, 1987). 
1.6.4 Inhibin Active Immunisation in Sheep and Cattle 
Cummings et al. (1983) found the ovaries of the prolific Booroola Merino to be 
deficient in bioactive inhibin. As a result, it was postulated that immunoneutralization 
of inhibin would lead to elevated levels of FSH, which during the follicular phase, 
would increase the number of large, ovulatory follicles. 
1.6.4.1 Inhibin active immunisation in the ewe 
The earliest attempts to immunise animals against inhibin utilised partially purified 
fractions of follicular fluid as immunogens. Heterologous follicular fluid was used in 
sheep and cattle, to enhance the immunogenic response relative to homologous 
follicular fluid (see Findlay et al., 1993).· The fluid was stripped of steroids using either 
charcoal (Henderson et al., 1989) or subjected to chromatography on a Matrex Red A 
dye column (O'Shea et al., 1984; Henderson et al. 1989) or immuno-affinity column 
(O'Shea et al., 1989b; Findlay et al., 1993) to increase the inhibin activity. Following 
immunisation in the ewe, researchers reported increased ovulation rates and litter 
size (O'Shea et al., 1982; 1984; Henderson et al. 1984; Cummins et al., 1986). In 
cattle, ovine follicular fluid preparations also increased ovulation rate (Cummins, 
O'Shea and Bindon, 1986; Price et al., 1987b; Bindon et al., 1988). However, FSH 
response was variable and inconsistent (AI-Obaidi et al., 1987a:b) as was ovulation 
rate. This is important because elevated FSH in some animals, and no increase in 
FSH in others may be the reason for variations in the number of recruited follicles and 
ultimately ovulation rate. The relative impurity of the immunogen was held 
responsible for this variation in response (O'Shea et al., 1989b). As a result some 
researchers began producing inhibin subunits by recombinant DNA technology. 
Fusion proteins expressed by the bacterium Escherichia Coli (E. Coli), comprising 
either the bovine (Forage et al., 1987a:b) or human a-subunit, have been used as 
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immunogens in sheep (see Findlay et a/., 1993). Ovulation rates of 2-4 (Border 
Leicester x Merino) and 4-6 (Rambouillet) times those of controls were reported using 
bovine a43-subunit (Forage et al., 1987a; Tsonis et a/., 1989) and human recombinant 
inhibin (Mizumachi et a/., 1990), respectively. The latter study reported elevated FSH 
(pre- and post-ovulation), but not LH concentrations, and an extended FSH surge. 
Furthermore, these increases in ovulation rates equated to a 60 - 700/0 increase in 
lambs born (Tsonis et a/., 1989; Findlay et a/., 1993) after only a primary vaccination 
(Tsonis et a/., 1989; see Terqui et a/., 1995). Findlay et a/. (1989) reported increased 
basal and GnRH stimulated FSH release during the luteal phase, while LH was 
unaffected. Neither gonadotrophin was affected by immunisation during anoestrus. A 
positive correlation between inhibin antibody titre and ovulation rate was noted in 
some stUdies (Tsonis et a/., 1989; Findlay et a/., 1989), although Forage et a/. 
(1987a;b) found no such relationship. 
Other research teams made synthetic porcine (Schanbacher, 1988a; Schanbacher, 
Schemm and Rhind, 1991), ovine (Meyer et a/., 1991; Wheaton, Carlson and Kusina, 
1992) and bovine (Wrathall et a/., 1990, 1992) a-subunit and peptide fragments 
(based on N-terminal portion) conjugated to carrier proteins to enhance 
immunogenicity. Wrathall et a/. (1990) demonstrated that immunisation against the 
bovine synthetic peptide resulted in antibodies which bound native (32kD) inhibin, not 
just the labelled peptide as other authors reported (O'Shea et a/., 1989c; Wheaton, 
Carlson and Kusina, 1992). Following immunisation with synthetic peptide vaccines, 
2-4 fold increases in ovulation rate were typical (see Terqui et a/., 1995). Puberty was 
eventually advanced in the Booroola Merino (O'Shea et a/., 1989a), despite failure in 
pubertal advancement in earlier trials (O'Shea et a/., 1987; see Findlay et aI, 1993) . 
. However, as with the earlier 'crude' vaccines, changes in serum gonadotrophin 
concentrations were still inconsistent between studies (see O'Shea et a/., 1994). For 
example, during the breeding season, immunisation (Romney) against an N-terminal 
(1-29) bovine inhibin a-subunit (B-ln-a-N-1-29) tuberculin conjugate, resulted in a 
doubling of ovulation rate and a 37% increase in FSH, relative to controls, around the 
. time of r e c r u i t m e ~ t t (Wrathall et a/., 1990). During seasonal anoestrus, ~ h e e number of 
pre-ovulatory, oestrogenic antral follicles that ovulated following GnRH treatment 
increased (McLeod et a/., 1992). In Mule ewes, immunised against B-ln-a-N-1-29, 
ovulation rates also increased two fold and FSH levels increased 250/0 compared with 
controls, after the second booster. Furthermore, immunisation increased the number 
of lambs born per ewe mated by 370/0. Although immunisation had no adverse affects 
on conception rate and gestation length, lower birth weight and more 'stillborns' were 
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presented at lambing, thus no increase in viable lamb crop was attained (Wrathall et 
al., 1992). In contrast, active immunisation against porcine a-subunit in Suffolk ewes 
had no affect on FSH levels, although FSH release patterns differed relative to 
controls. In addition the amplitude of the LH surge was reduced (Schanbacher, 
Schemm and Rhind, 1991). This may have been due to increased negative feedback 
of ovarian steroids. 
Following inhibin immunisation in Romney ewes, LH pulse amplitude and frequency 
were unaffected indicating that inhibin does not inhibit LH, although some limited 
inhibition of basal LH was reduced, as was LH response to GnRH challenge (Wrathall 
et al., 1990). However, increased ovarian steroid release, due to increased follicle 
numbers, may be responsible for these changes. For example, plasma progesterone 
levels are elevated during the luteal phase due to more CLs in some (Wrathall et al., 
1990; McLeod et al., 1992; see Terqui et al., 1995), but not all (Campbell et al., 1995) 
inhibin immunisation experiments. 
In long-term inhibin immunised ewes, elevated FSH eventually fell back to control 
levels (Knight et al., 1991). Fray, Wrathall and Knight (1994) observed that following 
(B-ln-a-N-1-29) immunisation, the ewes from an earlier trial (Wrathall et al., 1992) 
exhibited detectable antibody titre and increased lambing rates several years after 
the last booster. Interestingly, however, increased FSH output in treated ewes only 
remained elevated above that of controls for the first breeding season. This 
strengthens the case for an intra-ovarian role of inhibin (see Baird and Smith, 1993; 
Chapters 5 and 6), independent of the established long-loop negative feedback effect 
on pituitary gland FSH release (Kaneko et al., 1993a;b; 1995; Kusina et al., 1994; 
1995; Akagi et al., 1997; Takedomi et al., 1997). Knight et al. (1991) suggested that 
increased ovarian oestradiol output eventually reduces FSH to typical levels, i.e., 
oestrogens act in a compensatory feedback mechanism (Mann et al., 1989). 
1.6.4.2 Active immunisation in the cow 
Active immunisation against various synthetic bovine or porcine inhibin a-subunit 
. fragments has resulted in increases (30-1000/0) in follicle number, ovulation rate, 
(Glencross et al., 1992; 1994; Morris et al., 1993; Wood et al., 1993; Scanlon et al., 
1993; Bleach et al., 1996) and subsequent twinning rates (Morris et al., 1993). 
Despite a 520/0 increase in FSH concentrations, Glencross et al. (1994) reported no 
change in LH, oestradiol or progesterone throughout the oestrous cycle. These 
findings lead Terqui et al. (1995) to suggest that inhibin immunisation in cattle 
increases follicular gevelopment. and ovulation rate by increasing FSH secretion. 
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More recently several authors have suggested, and provided evidence, which 
suggests that pituitary FSH levels are not the sole determinant of ovulation rate, and 
that an intra-ovarian role of inhibin exists. For example, Bleach et al. (1996) studied 
the response of ovalbumin conjugated to synthetic peptide fragments of the bovine ac 
-sub-unit, selected by computer analysis of antigenic prediction methods (,antigenic 
index'; Jameson and Wolf, 1988). Bleach et al. (1996) reported that bovine inhibin ac 
(blac) fragments (1-29, 63-72 and (1-29 and 63-72 combined» showed relatively high 
titres and increased incidence of multiple ovulation (18-65%). However, using (1-16 
and 108-123 blac) peptides, binding was relatively low and the researchers witnessed 
little or no increase (0-10% ) in multiple ovulations. Although only a small number of 
animals (n=5) were used in each group, the results were interesting. Significant linear 
relationships were found (r=Q.42; p<0.02) between antibody titre and plasma FSH 
concentration and titre and increased ovulation rate (r=0.89; P<0.0001). However, 
partial correlation analysis showed a highly significant association between anti-
inhibin titre and ovulation response, which was independent of changes in mean 
plasma FSH concentrations. This provided more evidence of an intra-ovarian role of 
inhibin. Morris et al. (1993), using 107-122 blac, reported raised titres and a 16-180/0 
increase in multiple ovulations. Bleach et al. (1996) proposed that the use of different 
carrier proteins, or small differences in peptide sequence were responsible for the 
reported variations. Much variation between individuals (n=9), with respect to 
antibody titres and ovulation rates, in animals immunised against 1-29 peptide, were 
also reported. For example, with 1-29 and 63-72 peptides combined, antibody 
responses were less than with 1-29 alone, perhaps due to 'antibody competition' 
(Bleach et al., 1996) where binding of 63-72 directed antibodies to native inhibin 
sterically hinders the binding of 1-29 directed antibodies (Bleach et al., 1996). 
Evidence to date indicates that following immunisation, heifers showing moderate 
increases in antibody titres (10-25%) and moderate increases in the incidence of 
multiple ovulation, will have small increases in the number of ovulations per cyC?le (2 
or 3). This could be useful for increasing the twinning rate in commercial situations 
. (Morris et al., 1993; Bleach et al., 1996). However, large variations in both immune 
and physiological responses to vaccinations and the very undesirable situation of >2 
calves means that this technology is unlikely to be successful in this species. 
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1.6.5 Inhibin Passive Immunisation 
Compared with the ovarian response to active immunisation against inhibin, whereby 
the response is gradual and varies with immunogen, vaccine protocol, breed, species 
and individual. Passive immunisation can be more precise. 
1.6.5.1 Inhibin passive immunisation in the ewe 
After passive immunisation of anoestrous (Mule x Suffolk) ewes, an abrupt and dose-
dependent increase in plasma FSH has been reported using antiserum to human a-
subunit fragment (Wrathall et al., 1990). This indicates that ovarian inhibin production 
continues during seasonal anoestrus, during which time it inhibits pituitary FSH 
release. Furthermore, following the administration of antiserum raised against 
synthetic porcine and ovine a-subunit fragments, plasma FSH was elevated in 
Scottish Blackface (Mann, 1990; Mann et al., 1989; 1990; 1992; 1993) and Suffolk 
cross (Wheaton et al., 1992) ewes, respectively. Ovulation rate increased (Mann et 
al., 1989; Wheaton et al., 1992), while plasma LH levels were unaffected (Mann et 
al., 1989; 1992; Wrathall et al., 1990). Concomitant passive immunisation against 
oestradiol and inhibin elicited a considerably greater FSH response than inhibin 
immunisation alone (Mann et al., 1992), indicating the dual involvement of inhibin and 
oestradiol in the control of FSH release and follicular development. 
1.6.5.2 Inhibin passive i m m u n i s a ~ i o n n in the cow 
Recently passive inhibin immunisation studies have been carried out in cattle with a 
view to improving MOET responses. Takedomi et al. (1997) experimented with 
passive immunisation in Holstein heifers. Goat anti-bovine 32kDa purified inhibin 
antiserum was administered (75ml bolus) on day 9-10 of a synchronised luteal phase, 
with animals receiving PG injections at 48 and 60 hrs after immunisation. Fixed time 
A.1. at 12 and 24h (post oestrus) was used at the subsequent oestrus. Oestrus 
occurred earlier in immunised (77.5 ± 3.2h) compared to control heifers (120 ± 1.1 h). 
Treatment did not affect small «5mm) follicle number, but increased the number of 
medium-sized ( ~ 5 5 to <10mm) follicles 48-96h after bolus injection. At oestrus treated 
h e i f e ~ s s had a higher mean number 4.8 ± 2.4 (range 0-16) of large (>10mm) follicles. 
Furthermore, treafed heifers exhibited more ovulations (mean 6.6 ± 2.5) for several 
weeks after treatment. FSH concentrations increased betyleen 12-60h after 
treatment, although there was no effect on FSH surge magnitude. A variation in 
ovulation rate may partly result from a difference in FSH response between heifers, 
and/or follicles, or to the stage of development of the dominant follicle at the time of 
antiserum administration (Guilbault et al., 1991; Huhtinen et al., 1992). 
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Although the total number of antral follicles ( ~ 4 m m ) ) was not different, Akagi et a/. 
(1997) reported a dose-dependent increase in the number of large ( ~ 1 1Omm) follicles 
at oestrus with increased anti-inhibin antiserum dose. The mean ovulation rate in 
25ml, 37.5ml and 50ml inhibin antiserum dose groups was 1.0, 3.0 ± 0.9 and 3.4 ± 
0.9 respectively. Akagi et a/. (1997) observed a further increase in mean ovulation 
rate (6.6 ± 2.5) and variability of response with a 75ml inhibin 'antiserum dose. In 
these studies the number of large follicles and ovulations were affected by dosage of 
inhibin antiserum and correlated with persistence of increased FSH levels and 
circulating antibody titre (Akagi et a/., 1997). 
1.6.6 Mechanism of Action and Summary 
Theoretically, as discussed, inhibin immunisation enhances recruitment of small 
follicles by increasing the ma'gnitude of the FSH wave and delaying the fall in FSH 
concentration, which follows recruitment due to increased DF inhibin and oestradiol 
negative feedback at the pituitary gland level. This mechanism of action has been 
confirmed in studies in which, active (Glencross et a/., 1994) and passive (Kaneko et 
a/., 1993b; 1995; Campbell et a/., 1995) immunisation against inhibin increased 
plasma FSH concentrations. Conversely, in cattle, Price et a/. (1987); Glencross et a/. 
(1992); Morris and Grealy, (1993) and in sheep (Bindon et a/., 1994; Anderson et a/., 
1996), found no significant rise in plasma FSH subsequent to inhibin immunisation. 
More recently, Bleach et a/., (1996) discovered that the FSH rise alone did not 
account for the ovulatory response observed. In the ewe, Campbell et a/., (1995) 
concluded that, the observed 3-4 fold increases in FSH, were responsible for the 
initial stimulation of follicle development and steroid secretion. However, over time, 
due to increased oestradiol, and presumably inhibin production, FSH levels declined 
. yet follicle development was sustained, despite continued high antibody titres. On a 
long-term basis inhibin immunisation may stimulate ovarian function by interfering 
with the modulation of follicle development by inhibin at the ovarian level (Campbell 
et a/., 1995). An intra-ovarian effect of inhibin immunisation, in conjunction with 
elevated FSH is likely to be responsible for significant increases in ovulation rate 
. (Campbell, 1999; personal communication) seen in both sheep (Henderson et a/., 
- . 
1984; Cummins et a/., 1986) and cattle (Bleach et a/., 1996). 
1.7 THESIS OBJECTIVES 
As discussed, GnRH immunisation has economic, ethical and environmental 
advantages over conventional castration (see Bonneau and Enright, 1995; Section 
1.7; Chapters 3 and 4). Therefore a successful GnRH vaccine and protocol would be 
59 
Chapter 1: Review of Literature 
of enormous benefit to beef farmers in a diverse range of production systems. 
However, the primary reason for the lack of commercial adoption of this technology is 
the reversibility of immunocastration effects on reproductive inhibition. Findings in 
sheep however, suggest that a permanent suppression of reproductive function may 
be achieved after neonatal GnRH immunisation (Brown et al., 1994; 1995; Clarke et 
al., 1998). It is apparent from the literature that a study of the long-term effects of 
neonatal GnRH immunisation in cattle is absent. Therefore, our objective was to 
determine the effects of neonatal immunisation against GnRH on reproductive 
function and anabolic response in both the bull and heifer calf. 
In addition, as discussed, another method of improving efficiency of beef production 
is by increasing the twinning rate in beef suckler cattle. The growing body of evidence 
in the literature indicates thafboth GH/IGF and inhibin act as intra-ovarian regulators 
of folliculogenesis. Therefore, the second objective of this thesis was to investigate 
the interaction between inhibin and GHIIGF. Using ewes, a study was conducted to 
increase current knowledge of inhibin· and GHIIGF affects on precocious follicle 
development, while simultaneously producing polyclonal inhibin antiserum for our 
final investigation. As discussed, passive inhibin immunisation may be an optimum 
method for inducing twin ovulation in cattle. Based on the literature and an earlier 
preliminary study (Campbell, Gong and Webb unpublished), our final objective was to 
investigate the effects of a passive inhibin immunisation regime on follicle 
development and ovulation rate in beef heifers. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 EXPERIMENTAL ANIMALS 
2.1.1 Sheep 
Sixteen ewe lambs (North country mule x Charolais sire) born in March 1999 were 
obtained from the University of Nottingham's commercial flock. Prior to 
experimentation, the animals were managed as part of the flock and kept on pasture. 
Experiments on these animals were carried out between August 1999 and April 2000. 
During experimental procedures (see Chapter 3) the animals were group housed and 
fed grass nuts twice daily and had access to ad-libitum hay and water. 
2.1.2 Cattle 
Thirty-six spring born beef x dairy calves (heifers, n=18; bulls, n =18) were obtained 
from Melton Mowbray Market, Leicestershire, aged between seven and sixteen days. 
The animals were housed on straw and left to acclimatise for approximately 1 week 
before experimentation (see Chapters 4,5 and 6). Until weaning (8-10 weeks of age), 
the calves were fed Volac milk (via an artificial milk feeder), Volac quicklets and hay 
ad libitum. Thereafter, they were fed a post-weaner diet (190/0 protein) twice daily and 
ad libitum hay and water (except for 3 weeks in September 2000 when hay was 
substituted for grass). At 6 months of age animals were fed protein cake (140/0) and 
hay twice daily with ad libitum barley straw. The bulls remained housed and were fed 
on the above diet (minus hay) until slaughter at 16.5 months. The heifers were put 
out to pasture at 12 months where they remained until October 2001 when they were 
again housed and fed until slaughter in March I April 2002. 
2.2 OESTROUS CYCLE SYNCHRONISATION 
2.2.1 Follicular Synchronisation of Anoestrus Ewe Lambs 
Follicular waves were synchronised with a single subcutaneous injection (1 ml) of a 
GnRH analogue Receptal® .containing 4.2Jlg mr1 buserelin acetate; equivalent to 
0.004 mg mr1 buserelin (Intervet International. www.intervet.com ). 
61 
Chapter 2: Materials and Methods 
2.2.2. Oestrous Cycle Synchronisation of Heifers 
Oestrous cycles were synchronised using doprostenol (S26mg) a synthetic 
prostaglandin F2a analogue (Estrumate 1M, Scherling-Plough Animal Health). 
Administration was by intramuscular injection (2ml) into the rump. 
2.3 VACCINE PREPARATION 
2.3.1 Inhibin Vaccine 
Keyhole Limpet Haemocyanin (KLH; Pierce, N<>'771 00, Imject® lyophilized powder 
form) was reconstituted with 6ml of T. C. grade water (filtered 2 ~ m m filter) to give 10mg 
mr1. The a-C 1-26 porcine inhibin subunit (2.88mg) was dissolved in 1.2ml of PBS 
(0.1 M) to give 2.4mg of peptide per ml of solution. Subsequently, 1 ml of this peptide 
solution was added to Sml of the KLH solution and placed on ice for 20 minutes. 
Thereafter, 1.Smg of 1.S% gluteraldehyde solution (previously chilled) was added; 
drop wise while shaking on ice, to yield a total volume of 7.Sml, which was stored, 
overnight at 4°C. For the control group a similar preparation was made which 
excluded the inhibin peptide. 
Using a mixer (Kinematica AG polytron PT 3000) with sterile probe, to both control 
and treatment group preparations, NUFCA (a water in oil emulsion containing killed 
mycobacterium) was added (7.Sml) slowly while the probe was mixing at 12,000 to 
17,000 rpm. Once all the NUFCA was added, the speed was set at 27,000 for 20 to 
30 seconds. The stability of the emulsion was tested in a petri dish of water, and 
judged fit for administration when a droplet was able to maintain its form. For booster 
vaccine preparations NUFCA was substituted for NUFA (as NUFCA without 
mycobacterium). The vaccine was administered to the ewes within 1 hour of 
preparation as described in Chapter S. 
2.3.2 GnRH Vaccine 
GnRH vaccine was provided by Dr. A. R. Peters (andy peters@sandwich.pfizer.com) 
from Pfizer Animal Health (www.pfizer.co.uk). Details of the vaccine components and 
administration are given in Chapters 3. 
2.4 GROWTH HORMONE PREPARATION 
Recombinant bovine growth hormone (36mg) was dissolved in 36ml of a vehicle 
containing, (O.S% NaCL, NaHC03 (0.02SM) and Na2C03 (0.02SM) pHS.6). 
Subsequently, eight Sml syringes, for treatment group, were loaded with the 
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rBGH/vehicle solution (>4ml syringe-1), and 4ml injected s.c. The procedure was 
repeated, minus the rBGH for the eight controls. 
2.5 BLOOD SAMPLE COLLECTION 
Three methods were used for blood collection: venepuncture or cannulation of live 
animals and exsanguination ensuing slaughter. Blood samples .. were processed as 
serum following venepuncture and exsanguination. This involved leaving the blood 
over-night at 4°C to allow the clot to retract. Subsequently, samples were centrifuged 
at 3000 rpm for 15 minutes. Serum was then collected and stored at -20°C. Following 
collection via cannulae, blood samples were processed as plasma. The samples 
were transferred to tubes containing spinning granules, to aid separation and pouring 
off, and heparin (1,000 iu mr1) to inhibit coagulation, before centrifugation at 3000 
rpm for 15 minutes. Plasma was then poured off and stored at -20°C until assayed. 
2.5.1 Venepuncture 
When blood sampling frequency was once per day, blood was collected by jugular 
venepuncture using a vacutainer (Precision Glide TM, Becton Dickinson, Plymouth PL6 
7BP, U.K.), and 21G needle. A chlorohexidine swab was used to clean the sample 
site, prior to sample collection. For this procedure cattle, greater than 3 months of 
age, were restrained in a crush with their heads tied up by means of a halter to 
expose the jugular vein. Sheep and calves, less than three months were manually 
restrained. Pressure was applied to the jugular vein below the injection site and a 
21 G vacutainer needle, fitted to a vacutainer tube guide, was inserted into the vein in 
cranial direction. The required volume of blood was then collected into a pre-
vacuumed tube. 
2.5.2 Cannulation 
Where more frequent sampling was required the jugular vein was chronically 
cannulated. Two cannulation methods were used. The Braunula method was used in 
calves 6 months of age or younger, this was substituted for the Seldinger method in 
cattle older than 6 months, since the cannulae were longer, more robust and easier 
~ ~ . 
to repair or replace when required. During both methods of cannulation animals were 
restrained in a crush, using a calf adapter when required. To minimise the effects of 
stress in animals younger than 14 months, cannulation was carried out 24 hours prior 
to sample collection. In animals older than 14 months cannulation was carried out 
between two to three hours prior to sample collection. In the case of both methods, 
blood samples were withdrawn through the cannulae using a syringe. The patency of 
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the cannulae was maintained by an injection of 1.Sml of heparin-saline solution (SO iu 
mr1) was withdrawn and discarded prior to the subsequent sample collection. 
2.S.2.1 Braunula method 
The neck was shaved on one side, washed with warm water containing surgical 
scrub (HYDREX®, Chlorhexidine gluconate 4% w/v), dried and swabbed (VERNAID®, 
gauze swabs) with chlorohexidine gluconate O.S%w/v in 70% w/v Industrial strength 
mentholated spirit (lMS). Local anaesthetic (Lignavet, 1 % lignocaine, C-Vet 
veterinary products L a n c a s ~ i r e e PRS 3QN) was injected (2ml; s.c.) at three sites, one 
on either side of the jugular vein and one· above the cannulation entry wound. After 
several minutes, when the lignocaine had taken effect, the cannula (VYGON® 14G, 
80mm) was inserted into the jugular vein. A catheter (VYGON 1.S - 2.Smm, LSOcm), 
-
a three way stop cock and a 10ml syringe, containing heparin saline (0.9%) solution 
SO IUml-1, was attached and patency tested. The cannula was secured with three 
sutures ( M E R S I L ~ , , ETHICON®, black silk braided, non-absorbable, 45mm, 3/8 c, 
reverse cutting, Johnson & Johnson, International), patency was tested again, and a 
cap with an injectable membrane added (VYGON® Ref. 891.00). The cannula was 
then flushed with 1,000 IU mr1 heparin saline injected through the cap membrane. 
Vet rap bandages were used to cover the cannulae and protect against inadvertent 
removal and antibiotic (Duphapen® L.A.; Lm. 1 ml 2Skg body weighr1containing; 
Benzathine penicillin/procaine penicillin), was administered (19G needle and 10ml 
syringe) prior to the animals being released overnight. 
2.S.2.2 Seldinger method 
The skin over the jugular vein was shaved, washed and swabbed (Chlorohexidine). 
Local anaesthetic (Lignavet, 1 % lignocaine, C-Vet veterinary products Lancashire 
PRS 3QN) was administered (3-5 ml; s.c.) to the cannulation site. A cannulating 
needle was then inserted into the jugular vein. A Seldinger guide wire was passed 
through the cannulating needle to a depth of approximately 2Scm. The needle was 
then withdrawn leaving the guide wire in place. A sterile cannulae (Vygon®: 1.S-
2.0mm; 14G; L.3?cm), with Elastoplasts tape covering the hub to i m p r ~ v e e suture grip, 
was threaded over the guide wire and into the jugular vein. The guide wire was 
withdrawn and the cannulae tested for patency using heparin saline solution, (501U 
mr1). The cannula was then sutured in place (Mersilk®, Ethicon® black silk braided, 
non-absorbable, 4Smm; 3/8c; reverse cutting, Johnson and Johnson, International). 
Vet rap bandages were used to cover the cannula and protect against inadvertent 
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removal. A catheter extension was added to the cannulae and a Vygon® 3-way stop-
cock (valve) added to that to act as a tap. 
2.5.3 Exsanguination 
Details of blood collection at the time of slaughter are given in the specific 
experimental chapters. 
2.6 ULTRASOUND SCANNING OF THE REPRODUCTIVE TRACT 
Ultrasound scanning was used to monitor ovarian follicle development (Pierson and 
Ginther, 1984; 1988) and testes and vesicular glands (Chandolia et al., 1997b). 
Trans-rectal scanning was conducted using a real-time B-mode, linear array 
ultrasound scanner fitted with an Aloka prostate probe, which was adapted 
accordingly (see Figure 2.1) as the animals matured. As the heifers matured the 
prostate probe was substituted for an adapted (see Figure 2.2) 7.5 MHz rectal 
transducer (Aloka SSD500; Aloka, Tokyo, Japan), while the prostate probe was 
adequate for the bulls. 
In mature heifers (Chapter 6) the use of the adapted probe (Figure 2.2) was 
discontinLied, as the probe was hand held within the rectum. Animals were restrained 
in a crush and faeces removed from the rectum. The location of the uterus and 
ovaries was determined by rectal palp.ation prior to the introduction of the scanning 
probe. The presence of all antral follicles on each ovary (Chapter 6) and all follicles 
with a diameter ~ 4 m m m (Chapter 4) were recorded. The diameters of follicles up to 
10mm were estimated against the centimetre scale on the monitor. Follicles >10mm 
were measured using the electronic calliper feature (see Figure 4.1) on the machine 
along the longest and shortest axis of the follicle. The mean of these two 
measurements was the recorded size. 
Trans-cutaneous scanning of the testes was initially performed using a Doppler probe 
(7.5MH2) and Aloka SSD500 scanner. At 28-32 weeks of age a back-fat probe (Kretz 
Technik® AG Austria; L2-5x120mm) and SA600V scanner (Kretz Technik@) was 
used. 
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Figure 2.1 Adapted Aloka prostate probe used to scan vesicular glands in bulls 
and ovaries in young pre-pubertal heifers. Note the hose extension to the handle 
(covered by black tape), which improved manoeuvrability and control and enabled 
deeper rectal penetration. Adapted by Mr. M. Archer. 
Figure 2.2 Hose adapted rectal transducer probe enabled the ovaries of heifers to 
be scanned prior to the animals achieving sufficient body size to allow the insertion of 
the human arm. Adapted by Mr. M. Archer. 
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2.7 HORMONE RADIOIMMUNOASSAYS 
The assays used for the determination of hormone concentrations are described 
below. The chloromine-T method of iodination was used for all hormone and anti-
body assays unless otherwise stated. An experienced Technician carried out all 
iodinations with the Author's assistance. Intra and inter assay coefficients of variation 
and lower sensitivity calculation methods are presented in Appendix 2. 
2.7.1 Chloromine-T Iodination 
To reduce non-specific binding of inhibin subunit to the column, O.OS% CHAPS (3-
[(3Cholamidopropyl) dimethylammonio ]-1-propane-sulphonate; Sigma® C-S070) was 
added to O.OSM P04 buffer (30mg in 60ml; pH 7.4). This solution was transferred into 
a conical flask and 6g of Sephadex G-25-BO (fine; SIGMA ®; beads of gel filtration 
produced by cross-linking Gextran with epichlorohydrin; fractionation range MW: 
globular proteins 1,000-S,000, dextrans 100-S,000, dry bead diameter 2 0 - B O ~ m , , bead 
volume 4-6g mr1; www.sigma-aldrich.com) was added and stored overnight at 4°C. 
Sephadex solution was poured into a 2Scm column and allowed to settle. A tap at 
the bottom of the column was opened and 2S ml of O.OSM P04 (O.OS% CHAPS) was 
slowly flushed through. Chloramine T. and Na2S205 (sodium metabisulphite; MW 
190.13; ICN Biochemicals Inc., Ohio) were dissolved in 20ml O.SM P04 and O.OSM 
P04 buffer solutions, respectively. 
In a fume cupboard behind radiation shields, 1251 was added to the inhibin peptide 
and mixed. Subsequently chloramine T. (1mg mr1) was added to start the iodination 
reaction and the solution was mixed for 60 seconds. Sodium metabisulphate (1 mg mr 
1) was then added to the column to stop the reaction. The iodinated peptide was then 
added to the column, which was subsequently eluted with O.OSM P04 (O.OS% 
CHAPS). Approximately O.Sml of buffer solution was maintained above the top of the 
Sephadex column and fractions of O.Bml were collected in 40 LP3 tubes and the 
radioactivity counted using an automatic gamma counter (1277 Gammamaster, LKB, 
Wallace, Stockholm, Sweden). The iodinated peptide was maximal in tubes 1S-17, 
followed by free iodine in tubes 30-3S. The iodination peak samples were pooled and 
stored at 4°C until use. 
2.7.2 LH Radioimmunoassay 
Plasma LH concentrations were determined using a direct iodinated 
radioimmunoassay based on the method of Mann et a/. (2000) using NIDDK-rabbit 
anti-oLH-1, iodinated NIDDK-oLH-I-2 and bovine LH standards (bLH AFP11743B) 
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supplied by DR AF Parlow (Pituitary Hormones and Antisera Centre, Harbor UCLA 
Medical Centre, 1000 West Carson Street, Torrance, California 90509, USA). 
A set of LH standards, serially diluted from 50ng.mr1 to 0.05ng.mr\ in 1001-11 assay 
buffer, were prepared in triplicate along with duplicate 1001-11 volumes of sample or 
quality control plasma. These were made up to a total volume of 3001-11 with assay 
buffer (0.05M P04 buffered saline with 101<> BSA) before the addition of 1001-11 of the 
first antibody (NIDDK-anti-oLH-1: 1 :200,000 dilution in assay buffer). All tubes were 
incubated for 48h at 4°C before receiving 1001-11 of radioactive tracer (NIDDK-oLH-I-2; 
15000 counts per minute (cpm) in buffer) and undergoing further 48h incubation at 4 
°C. A volume of 1001-11 normal rabbit serum (NRS; 1: 1 400 dilution), and 1001-11 donkey 
anti-rabbit antisera (1 :40 dilution) (both obtained from the Scottish Antibody 
Production Unit, SAPU, Lanarkshire, UK) were added to each tube as a precipitant 
for the first antibody. The tubes were incubated for 24 hours at 4°C. A 1 ml volume of 
cold phosphate buffered saline (PBS) was added to all tubes prior to centrifugation at 
2,OOO-x gravity (G). Gravity was calculated using the formula 1.12 x 10-5 x centrifuge 
radius (cm) x rpm2. The supernatant was then aspirated and the radioactivity of the 
precipitate counted using an automatic gamma counter (1277 Gammamaster, LKB, 
Wallace, Stockholm, Sweden). Assay data was processed using Multicalc (Wallac 
OY, Finland) employing log transformation of the binding data for all standards. 
Figure 2.3 The composite standard curve from the 32 LH assays. The mean 
sensitivity (minimum detectable amount) was 0.15 ng.mr1. The mean inter- and intra-
assay coefficients of variation were 9.70/0 and 7.20/0, respectively. 
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2.7.3 Plasma Progesterone RIA 
A direct double antibody [1251] radioimmunoassay, based on the method of Corrie et 
al. (1981) and validated for use on the cow by Law et al. (1992), was used. The 
progesterone (Sigma Chemical company, Poole, UK) standard curve was made 
using repeated double dilutions from 20.0 to 0.156 ng mr1. Charcoal Stripped Plasma 
(CSP; 100 JlI) was added to non-specific binding tubes (NSBs) together with 200JlI of 
assay buffer (Phosphate Citrate Buffer with Gelatine (PCGB); pH 7.4), to 
ReferencefTotal Binding tubes (TBs) with 100JlI assay buffer and to the standards. 
Duplicate 100JlI aliquots of either sample plasma or quality controls (QCs) were 
diluted with 100JlI of assay buffer. 1251-progesterone (Amersham International Pic, 
Amersham, UK) in tracer assay buffer (ANS 8-Anilio-1-Naphthalene Sulphonic acid 
(ANS» was added (100JlI; J mg mr1 ANS; 15,000cpm) to aid the separation of 
progesterone from its plasma binding protein. The first antibody, rabbit anti-
progesterone (Batch 7044x; Scottish Antibody Production Unit (SAPU), Lanarkshire, 
UK) was diluted to 1 :30,000 with assay buffer. 
1251-progesterone (100JlI; 1 mg mr1 ANS; 15,000cpm) was added to all tubes, and 
100JlI of first antibody was added to all tubes except TC and NSBs. These were 
incubated for 4h at room temperature (RT). Free and antibody bound tracer were 
separated by inCUbation with 200JlI of the second antibody, donkey anti-rabbit IgG 
(DAR; SAPU, Lanarkshire, UK), diluted in assay buffer to 1 :240 + 1 :900 NRS (SAPU) 
overnight at 4°C. Total volume of all tubes was diluted and error reduced by the 
addition of 1 ml separation solution (cold assay buffer) before centrifugation at 3,500-x 
G for 45 minutes. The supernatant was then aspirated and the radioactivity of the 
precipitate counted using an automatic gamma counter (1277 Gammamaster, LKB, 
Wallace, Stockholm, Sweden). Assay data was processed using Multicalc (Wallac, 
Finland) employing log transformation of the binding data for all standards. 
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Figure 2.4 The composite standard curve from 3 progesterone assays. The assay 
sensitivity (minimal detectable amount) was 0.31 ng.mr1. The mean inter- and intra-
assay coefficients of variation were 14.90/0 and 11.00/0, respectively. 
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2.7.4 Testosterone 
Serum testosterone concentrations were measured using a solvent extracted 
radioimmunoassay based on the method and validation by Webb et a/. (198S). 
In 1.Sml eppindorf tubes, S0f.11 of serum was added to 9S0f.11 of assay buffer (Sodium 
Phosphate with Gelatin; pH 7.0) and vortexed. A 100f.11 volume of diluted sample was 
then added to a glass extraction tube, which had previously been baked at 200°C 
overnight. Subsequently, 2ml of diethyl ether (Romil-SpSTM super purity solvent, 
Water Beach, Cambridge GB-CBS 90n was added to each extraction tube. Tubes 
were capped and vortexed for 10 minutes, subsequently the aqueous and solvent 
layers were allowed to separate. The tubes were then placed in a dry ice/diethyl ether 
bath "to a depth of approximately 2cm. When the aqueous layer was frozen, the ether 
was decanted into glass assay tubes (12 x 7Smm; F i s h e ~ ) ) and evaporated to 
dryness under air at 37°C. The extracted steroid was then reconstituted in SOOul of 
assay buffer and heated in a water bath at 30°C for 1S-20 minutes, before being 
vortexed for 1 minute. The extraction efficiency was estimated by adding 100f.11 of 3H-
testosterone (5, OOOcpm) into 3 glass scintillation vials and 5 extraction tubes. 
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3H Testosterone (Amersham®) in ethanol was dried onto the tube overnight. For hot 
recovery totals (HRT), to enable the counter to read tritium (3H), Ultima Gold™ 
scintillation fluid (2ml) was added to scintillation vials. For hot recovery estimates 
(HRE), the dried hormone was re-suspended by adding blank plasma to the 
extraction tubes, prior to vortexing and incubating for 20 minutes at 37°C. Extraction 
was carried out as previously described, but the solvent was poured of into 
scintillation vials following snap freezing. Scintillation vials were then dried down 
overnight. Ultima Gold™ was added to scintillation vials, which along with the 
extraction vials, were capped and allowed to settle on the beta counter (Packard Tri-
CARB 2100 TR liquid scintillation analyser) for 2h before counting. 
HRE / HRT x 100 = % extraction efficiency. 
Readings were corrected for the efficiency of extraction, which was ' § _ 6 J ~ o / 9 . _ ( n = 8 8
assays). 
Duplicate 500JlI aliquots of the reconstituted sample were taken for 
radioimmunoassay. A volume of 100J.l1 1251-Testosterone, diluted in assay buffer to 
give 8-10,000cpm was added to all assay tubes. Ovine testosterone antisera (200J.l1; 
sheep 505), diluted 1 :700, 000 in assay buffer was added to all tubes except TCs and 
NSBs. The tubes were then incubated at Room Temperature (RT) for 3-4h. The 
bound and free fractions were separated by incubation overnight at 4°C, with 200J.l1 of 
Donkey anti-sheep/goat (DASG; SAPU), diluted 1 :25 in EDT A PBS gelatin buffer and 
Normal Sheep Serum (NSS; 1: 1,000; SAPU). The following day, 1 ml of cold assay 
buffer was added to all tubes (except TC's) and all tubes were centrifuged at 3,500-x 
G for 35 mins at 4°C in a Sorvall® RC 3B centrifuge. 
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Figure 2.5 The composite standard curve for 8 assays of testosterone. The 
sensitivity (minimal detectable amount) for the testosterone assay was 0.11 ng.mr1. 
The mean inter-assay and intra-assay coefficients of variation were 14.70/0 and 3.8%, 
respectively. 
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Peripheral FSH concentrations were determined using a direct iodinated radio-
immuno assay based on the method of Campbell et a/. (1990) using rabbit NIDDK 
anti-oFSH-1, NIDDK-oFSH-I-SIAFP-21 (for iodination) and USDA-bFSH-I-2 
(standards). A set of FSH standards serially diluted from 1Sng mr1 to 0.06ng.mr1 in 
200lli assay buffer, was prepared in triplicate along with duplicate 200J-lI volumes of 
either serum samples or QC plasma. These were all made up to a total volume of 
400J-lI with assay buffer (0.1M PBS with 0.10/0 BSA and 0.10/0 sodium azide; pH 7.4) 
before the simultaneous addition of SOJ-lI of 1251 FSH (NIDDK-oFSH-I-SIAFP-21; 
1S,000cpm in assay buffer) and SOJ-lI of primary antibody (NIDDK-anti-oFSH-1; rabbit) 
at a 1:16,000 dilution in assay buffer. Note, before pooling the two solutions, SOJ-lI of 
1251 'FSH (NIDDK-oFSH-I-SIAFP-21) was added to NSB and TC tubes. All tubes were 
incubated at RT for 24h. A volume of 200J-lI of DAR (SAPU; 1 :60 dilution) and NRS 
(SAPU; 1:1200 dilution) was added to all tubes except TC and incubated for 1-3 days 
at 4°C. Cold 0.90/0 saline (SOOIlI) was added to all tubes prior to centrifugation at 
2,000-xG for 3S minutes (4°C). The supernatant was aspirated and the radioactivity in 
the precipitate counted using an ~ u t o m a t i c c gamma counter (1277 Gammamaster, 
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LKB, Wallace, Stockholm, Sweden). Assay data was processed using Multicalc 
(Wallac OY, Finland) employing log transformation of the binding data for all 
standards. 
Figure 2.6 A composite standard curve from 14 FSH assays. Assay sensitivity 
(minimum detectable amount) was 0.09 ng.mr1. The mean inter- and intra-assay 
coefficients of variation were 6.9% and 4.0% respectively. 
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2.7.6 Oestradiol in Culture Media 
100 
A set of oestradiol standards, were serially diluted from 78 pg.mr1 to 10,000 pg.mr1 in 
1 0 0 ~ 1 1 assay buffer (O.05M PBS (pH 7.4) with 0.1% gelatin, 0.1% sodium azide). 
Standards were prepared in triplicate along with duplicate 1 O O ~ I I volumes of sample 
and QC culture media (150, 750 and 3,000 pg mr1). These were all made up to a 
total volume of 3 0 0 ~ 1 1 with assay buffer before the addition of 1 O O ~ I I of the first 
antibody (in house, Webb; 1: 10,000 in assay buffer) to all tubes except TCs and 
NSBs. Subsequently, iodinated tracer 12,000cpm in assay buffer was added to all 
tubes prior to vortexing. Tubes were then left at RT overnight at 4°C. 
A volume of 2 5 0 ~ 1 1 of NRS (SAPU; 1 :400) and 2 5 0 ~ 1 1 of donkey anti-sheep/goatlrabbit 
(DASGR; SAPU; 1 :40) was added to all tubes except TCs. Tubes were vortexed and 
stored at 4°C overnight. Subsequently, 2 5 0 ~ 1 1 of assay buffer containing 1 % Tween 
20 (polyoxyethylene-sorbitan monolaurate; Sigma®, USA) was added to all tubes 
except the TCs prior to centrifugation at 2,000-xG for 40 minutes at 4°C. The 
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supernatant was decanted and tubes were left inverted to drain. Pellets were then 
counted on the automatic gamma counter (1277 Gammamaster, LKB, Wallace, 
Stockholm, Sweden). Assay data was processed using Multicalc (Wallac OY, 
Finland) employing log transformation of the binding data for all standards. 
Figure 2.7 The composite standard curve (n=4 assays) for the measurement of 
oestradiol in culture media. The mean sensitivity (minimum detectable amount) was 
0.15 ng mr1. The mean inter- and intra-assay coefficients of variation were 9.10/0 and 
2.60/0 respectively. 
100 
90 -~ ~80 
70 ~ ~
0> 
c 
"C 
. ~ ~
m 
~ ~0 
60 
50 
40 
30 
20 
10 
o 
0.01 
I 
0.1 
2.7.7 Oestradiol in plasma 
"a 
" 
, 
" "'-. ~ ~
J 
1 
Oestradiol (ng/ml) 
--......... 
I 
10 100 
The assay used to determine the plasma oestradiol concentration was a solvent 
extracted radioimmunoassay (Mann, Lamming and Fray, 1995), supplied in an assay 
kit produced by Serono Diagnostics (E2 MAlA, Serono Diagnostics Ltd., Woking, 
UK). 
D ~ p l i c a t e e 500fll aliquots of either sample or reference plasma was extracted by 
vortexing for 5-minutes in 3ml diethyl ether, in glass tubes previously washed with 
3ml ether. The plasma phase was then frozen and the ether phase decanted, dried 
down and then reconstituted in 2501-11 of assay buffer (0.1M PBS (pH 7.4) with 0.1% w 
Iv gelatine, 0.20/0 sodium azide (NaN3) and 0.3% EDTA, pH 7.6). O e s t r a d i o l - 1 7 ~ ~
standard (Sigma Chemicals Ltd., Poole, UK) was used in the range 0.0625 to 16pg 
per tube made up to 2501-11 in assay buffer. The first antibody supplied in the kit was 
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diluted 1:6 with assay buffer before use and the lyophilized [1251]_E2 tracer diluted to 
10,000cpm/50JlI in assay buffer. Aliquots of 501-11 of antibody and tracer were then 
added to sample and standard tubes, giving a final reaction volume of 3501-11. The 
assay was incubated for 2h at RT and then 100JlI of goat anti-rabbit 2nd antibody 
provided in the kit and diluted 120JlI 20mr1 buffer (without gelatine). Tubes were 
incubated at RT for a further 10" minutes and then 1 ml of assay buffer (without 
gelatine) was added before centrifugation at 2,000-xG at 4°C for 10 minutes. The 
supernatant was then aspirated and the bound precipitate counted. Extraction 
efficiency was 93%) and the intra-assay coefficient of variation, calculated from the 
mean coefficients of variation of individual samples, was 8.20/0. The lower sensitivity 
of the assay was 0.07pg mr1. 
2.8 ANTIBODY TITRE ASSAYS 
2.8.1 Inhibin Antibodies 
Inhibin antibody titre in the serum of immunised ewes was determined by measuring 
the binding of 1251-labelled inhibin in a range of serum dilutions. Serum from control 
animals and NSS (in house batch) and ewe OE378 was used as negative and 
positive controls, respectively. Incubations were carried out in assay buffer 0.05M 
PBS with 0.05% BSA and 0.01 M Ethylenediaminetetra acetic acid (EDTA; pH 7.4). 
The 1251-labelled inhibin was made up to 20,000cpm per 100JlI in PBS (pH 7.4). A 
volume of 1001-11 tracer, 1001-11 of either diluted sample or positive control (OE378; see 
Figures 5.3 and 5.4 for titre; 1 in 100; 500; 1,000; 2,000; 4,000; 8,000; 16,000; 
32,000) and 1001-11 buffer (final volume 3001-11) was vortexed and incubated overnight 
at 4°C. 
A volume of 1001-11 of NSS (University of Nottingham; 1: 1,000 in assay buffer) and 
1001-11 of DASG serum (SAPU; 1 :25 in assay buffer) was added to each tube (except 
TCs) as a precipitant for the first antibody. The tubes were vortexed and incubated for 
24 hours at 4°C. Thereafter, 1ml of assay buffer was added to all tubes (except TCs) 
prior to c e n t r i f ~ g a t i o n n at 2,000-xG for 40 minutes. The supernatant f ~ o m m all tubes was 
aspirated and the radioactivity of the precipitate counted on an automatic Gamma 
counter (1277 Gammamaster; LKB, Wallace, Stockholm, Sweden). Assay count data 
was read using Ultraterm and the titres were calculated by expressing binding of 
labelled inhibin as the percentage of total labelled inhibin available after subtracting 
NSBs. 
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2.8.2 GnRH Antibody Titres 
GnRH antibody titre in the serum of immunised cattle was determined by measuring 
the binding of 12510dine labelled GnRH. 
2.8.2.1 GnRH Iodination 
Dr. Tony Bramley, University of Edinburgh, provided the iodination method for GnRH 
iodination, which was developed by Dr. H. Fraser. 
Superfine sephadex (G25; SIGMA TM) was soaked in acetic acid (0.01 M). Sephadex 
was poured into a 30cm clamped column, pre-washed with assay buffer (0.1 % BSA 
in 0.01M acetic acid; pH7.4), and containing glass wool to prevent the Sephadex 
solution leaving the column. This was allowed to settle before priming with 10 ml of 
50/0 BSA in acetic acid (0.01 M; pH7.4) and eluted with 40-50 ml of assay buffer. For 
the iodination 5 ~ g g GnRH (1mg mr1 in assay buffer), 4 0 ~ 1 1 of 0.05M PBS (pH 7.4), 5 ~ 1 1
lactoperoxidase (1 O O ~ g g mr1 0.1 M Sodium Acetate buffer (pH 5.6» and 5 ~ 1 1 of glucose 
oxidase (1000fll mr1 PBS) was added to an LP3 tube, together with 2 0 ~ 1 1 of 1251 (74 
Mega Becquerels) and 2 0 ~ 1 1 of 0.1250/0 glucose solution (100mg 80mr1 H20). The final 
solution was mixed and left for 4 minutes, before 3 0 0 ~ 1 1 of 0.01M acetic acid was 
added Thereafter, the mixture was added to the pre-primed column. The column was 
eluted with assay buffer and fractions were counted. Peak 1251-GnRH fractions from 
the 3rd peak (Figure 2.8) were pooled and stored at 4°C until required. 
Figure 2.8 A GnRH iodination profile example. Damaged peptide fragments are first 
to emerge from the column, then free iodine and finally iodinated GnRH after -2h. 
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2.8.3 GnRH Antibody RIA 
Serum incubations were carried out in assay buffer (0.05M PBS containing 1 % BSA, 
0.20/0 gelatin and 0.01 M EDTA (pH 7.4». 1251-labelled GnRH was made up to 
30,OOOcpm in assay buffer. A volume of 1001-11 tracer, together with either 1001-11 of 
diluted sample (1 in 10, 100, 500,1,000, 2,000, 4,000) or positive control (courtesy of 
., 
Dr. H. Fraser) was vortexed and incubated overnight at 4°C. A volume of 1001-11 of 
Normal Calf Serum (University of Nottingham; 1 :1,000 in assay buffer) and 1001-11 of 
donkey anti-bovine IgG (Sigma TM; 1 :25 in assay buffer) was added to each tube 
(except TCs and the positive controls) as a precipitant for the first antibody. The 
positive controls received 1001-11 of NSS (University of Nottingham; 1: 1,000 in assay 
buffer) and 1001-11 of DASG serum (SAPU; 1 :25 in assay buffer). The tubes were 
vortexed and incubated for 24h at 4°C. A 1 ml volume of ice cold assay buffer 
containing 12.5%) PEG and 2%) porcine y-globulin, was added to all tubes (except 
TCs) prior to centrifugation at 2,OOO-xG for 40 minutes. The supernatant from all 
tubes (except TCs) was aspirated and the radioactivity of the precipitate counted on 
an automatic Gamma counter (1277 Gammamaster; LKB, Wallace, Stockholm, 
Sweden). The use of PEG and porcine y-globulin was on the advice of Dr. Bramley, 
and successfully increased the pellet size, making aspiration easier and more 
efficient. Assay data was counted using Ultraterm. The antibody titres were 
calculated by expressing binding of labelled GnRH as the percentage of TCs after 
subtracting non-specific binding. 
2.9 BEHAVIOUR OBSERVATION 
2.9.1 Heifer Behaviour 
Oestrus behaviour was monitored twice daily for 20-30 minutes for 1 month between 
52 and 56 weeks of age following turnout. Observations were conducted from a 
distance using field glasses to ensure normal behaviour was not interrupted. 
2.9.2 Bull Behaviour 
~ ~
Sexual and aggressive behaviour (see Table 2.1) was monitored during group 
housing in the bulls between 38 and 70 weeks of age using s.imilar methods to those 
described by Price and Wallach (1991a;b; c). Bulls were observed for 90 minutes on 
Days 1, 7 and 14 of a two-week sampling period. Animals were housed in treatment 
groups and behaviours were observed simultaneously. Behaviour was recorded by 
tallying the incidence of specific behaviours (Table 2.1) for each group. 
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Table 2.1 Definitions of behaviours as previously used by Price and Wallach, (1991a; 
b; c; d) and Jago, Bass and Matthews, (1997). 
Behavioural Definition 
Term 
Flehman (FL) Upward and backward curling of the upper lip t.o aid, and in response to, pheromone investigation 
Relatively sudden movement of the head and neck in the direction of 
Head throw (HT) a target animal, with little or no movement of the body. This behaviour 
may be perceived as a weak MI by the target stimulus animal 
Head and shoulders are raised and weight is shifted to the rear as if 
Mount intention the animal is about to mount, but at least one front foot remains on 
(MI) the ground. Intense chin resting accompanied by vocalising are also 
indicative of MI 
Mount attempt Both front feet simultaneously leave the ground, but the animal does 
(MA) not become firmly planted on the mountee's rump 
Mount (M) Animal becomes firmly planted on the mountee's rump. (With or 
without ejaculation) 
Bunt I butts (B) Bunts and bunt attempts directed at another animal 
Sparring (SP) Head-to-head butting and pushing 
Threats Pawing the ground, rubbing chin and I or head on ground or object. Snorting. Any or all of the above directed towards human handlers. 
2.10 SPERM ANALYSES 
Mr. I. Sfontouris, an experience and skilled technician, with no previous knowledge of 
the experimental objectives, carried out tests described in sections 2.10.2-2.10.4. 
2.10.1 Sperm Collection 
Immediately post-mortem, the testes of each bull were removed from the scrotum 
and the remnants of the parietal tunica vaginalis and the visceral tunica vaginalis 
removed by dissection. Following an incision into the caudal epididymis, sperm were 
aspirated from each testis using a glass pipette. The aspirate was placed into 1 ml of 
warm (34.6°q) Earle's balanced salt solution (EBSS; Sigma™; Cat.No.E2888), 
supplemented with 1 g Iitre-1 BSA. 
2.10.2 Sperm Motility 
A volume of 51J1 of sperm suspension was placed on a clean, pre-warmed slide and 
covered with a cover slip and observed at 100-x magnification. Sperm were graded 
by Mr. Sfontouris and placed into 1 of 4 motility classification categories: 
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Grade A: fast progressive (swimming >5 times a head length second-1) 
Grade B: slow progressive (swimming 1 to 5 times a head length second-1) 
Grade C: twitching on the spot, but not progressive. 
Grade D: immotile sperm 
At least 200 sperm were counted from each testis and a percentage of sperm in each 
classification calculated. 
2.10.3 Sperm Viability 
The two tests are widely used to assess sperm viability (World Health Organisation, 
1999). 
2.10.3.1 Eosin-nigrosin Staining 
A volume of 5 ~ 1 1 of sperm s ~ s p e n s i o n n was mixed with 5 ~ 1 1 of eosin-negrosin stain on a 
slide. Using a second slide, the mixture was smeared (spread thinly) over the first 
slide and left at RT to dry. The slides were mounted with DPX mounting medium 
(Nustain, Dept. Pathology, University Hospital Nottingham) and a cover slip, and 
observed at 400-x magnification. Live sperm are known to have a functional 
membrane, enabling them to exclude the dye and remained white. Dead sperm are 
unable to exclude the dye and therefore exhibit dark-stained heads. 
2.10.3.2 Hypo-osmotic Swelling (HOS) Test. 
A volume of 5 ~ 1 1 of sperm suspension was diluted with 1 O O ~ I I of EBSS in a 1 ml 
eppendorf tube. The suspension was incubated at 37°C for 1 h. Thereafter 5 ~ 1 1 of HOS 
suspension was placed on a slide, a cover slip was added and the sperm were 
observed at 400-x magnification. Swelling of sperm was identified as changes in the 
shape of the tail, and the number of swollen tails in a total of 200 sperm was counted 
and a percentage calculated. The HOS test sample is considered normal if >600/0 of 
sperm undergo tail swelling. Before exposure to the HOS solution it is essential that 
the ejaculate is observed, and sperm which already possess curled and swollen tails 
be counted and the percentage of sperm these sperm should then be subtracted 
from the percentage obtained after treatment to obtain the true percentage of sperm 
that reacted in the HOS test. 
2.10.4 Sperm Morphology 
A volume of 5 ~ 1 1 of the original suspension was placed on a slide, smeared and 
allowed to dry. Once dry, the slide was stained using the Diff-Quik® staining set 
(DADE® Switzerland; Cat.No.130832). The staining procedure consisted of a series 
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of submersions: firstly, the slide was submersed for 15 seconds (s) in fixative (O.002g 
r1 Fast green in methanol); secondly, 5 dips (1s each) in Eosin buffer (Eosin G; 1.22g 
r1 in PBS pH6.6); and finally, 5 dips (1 s each) in Thiazine buffer (Thiazine dye 1.1 g r1 
in PBS pH6.6). The slide was then mounted with DPX and a cover slip, before 
observing sperm at 1,000-x magnification using a phase contrast microscope. Sperm 
were then categorised according to morphological appearance. Categories included: 
normal form, pyriform heads, elongated heads, round heads, amorphous heads (Le., 
abnormal heads that do not fall in one of· the previous categories), coiled tails, no 
tails, multiple tails etc. At least 200 sperm were counted per testis, and percentages 
for each category calculated (WHO, 1999). 
Due to low numbers of sperm exhibiting some abnormalities, and for statistical 
analysis, the results from individual animals were pooled and the category number 
reduced to three: normal, pyriform head abnormalities and other abnormalities. 
2.11 FOLLICLE CULTURE 
In the abattoir, immediately post mortem, left ovaries were prepared for molecular 
studies (see 5.2.7.1), and right ovaries were placed in a flask containing warm (37°C) 
M199 culture media (Sigma®; M2154). Subsequently, ovaries were transported to the 
laboratory where they were rinsed with fresh warmed (37°C) saline, trimmed of 
extraneous tissue, and placed in. a Petri dish containing M199 media (37°C). 
Experienced Technicians then manually dissected all antral follicles estimated to be 
~ 2 m m m in diameter using 22g syringe needles, under cover of a Laminar flow cabinet. 
After dissection, follicles counts and diameter measurements were recorded. Burst 
follicles were put in separate labelled eppendorf tubes, before being snap frozen and 
stored at -80°C to await molecular studies. Intact antral ( ~ 2 m m ) ) follicles were placed 
into 24 well culture plates (Nunclon Life Technologies; 1 follicle per well). Each 
culture-well contained 2ml of equilibrated M199 media. Follicles were incubated 
(Forma Scientific Inc. USA) for 2h at 37°C in an atmosphere of 95% O2 and 50/0 CO2 • 
After incubation follicles from each well was placed in separate labelled eppendorf 
tubes and sto!ed at -80°C (as described above). The culture-well .media was stored 
at -20°C until RIA for oestradiol content (Section 2.7.6). 
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CHAPTER THREE 
THE EFFECTS OF ACTIVE IMMUNISATION AGAINST GnRH ON 
REPRODUCTIVE FUNCTION IN BULL CALVES 
3.1 INTRODUCTION 
The rearing of gonad-intact male cattle in beef production systems is associated with 
management problems. As a result of gonadal steroid influences on behaviour and 
sexual competence post-puberty (Price and Wallach, 1991 a), bulls are a danger to 
humans, cause pasture and fencing damage through increased activity and must be 
separated from heifers at arouod 7-8 months of age, before the attainment of puberty 
(Price and Tennesson, 1981; Gregory and Ford, 1983; Bonneau and Enright, 1995). 
In contrast to the adverse effects of gonadal steroids on behaviour, these hormones 
are economically valuable to the beef industry. For example, as discussed by Field 
(1971), androgens promote lean tissue growth and reduce fat deposition, increase 
growth rates in bulls by -17% relative to steers (Harte, Curran and Vial, 1965; 
Seideman et al., 1982) and increase feed conversion efficiency (FCE) by -13%. This 
coupled with a reduction in feed costs and environmental pollutants (nitrogen excreta 
and methane), because the animals reach their mature slaughter weight sooner. 
Surgical castration has long been the solution to these problems. However, this 
results in a loss of the beneficial effects of androgens and a post-operative growth 
check. Furthermore, animal welfare and ethical questions are raised as castrati,on is 
. traumatic and stressful (Fisher et al., 1996; Carragher et al., 1997), it increases the 
risks of morbidity and mortality and is widely perceived as mutilation (see Bonneau 
and Enright, 1995). 
Active immunisation against GnRH inhibits reproductive function by inducing a hypo-
gonadotrophic condition associated with gonadal atrophy (Adams and Adams, 1992; 
Teague et al., 1992; Carson, McCaughley and Steen, 1994; Finnerty et al., 1994; 
Finnerty et al., 1995; Jago et al., 1995; Jago, Bass and M a t t h e ~ , , 1997; Jago et al., 
1997; Finnerty, Enright and Roche, 1998; Huxsoll, Price and Adams, 1998; Cook et 
al., 2000; O'Occhio, 1993; 1994; O'Occhio, Aspden and Trigg, 2001). Whilst 
unwanted behaviour and fertility are suppressed, FCE and growth rates are typically 
intermediate between bulls and steers. Hence GnRH immunocastration is generally 
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accepted as the most promising alternative to conventional castration and is more 
favourably perceived by consumers than surgical castration (see Bonneau and 
Enright, 1995). However, one major reason for the limited commercial application of 
this technology is that with active GnRH immunisation suppression of reproductive 
function is only temporary in most individuals, lasting approximately 6 to 8 months 
(Robertson, Wilson and Fraser, 1979; Keeling and Crighton, 1984; Wetteman and 
Castree, 1988; 1994). After this time animals return to normal reproductive function 
(D'Occhio 1993, 1994), subsequent to a. decline in circulating anti-GnRH antibodies 
below a threshold required to neutralise GnRH in the hypophysial portal blood 
(D'Occhio, Aspden and Trigg, 2001). However, despite numerous studies on 
immunocastration in cattle, most have been of too short a duration to report on the 
incidence of permanent suppression. Moreover, the earliest administration of a 
GnRH vaccine was at 4 weeks-(Jeffcoate, Lucas and Crighton, 1982}. 
An alternative approach to immunocastration is pre-pubertal immunisation. Brown et 
al. (1994) reported that in 20-25% of ram lambs immunised against GnRH, testicular 
atrophy was evident at 2 years of age. In similar studies with ewe lambs, 80% failed 
to display oestrus behaviour at 2 years of age (Brown et al., 1995). Despite the 
absence of GnRH antibodies in the circulation, ewes immunised before 2 months of 
age showed reduced GnRH secretion at 3-4' years of age (Clarke et al., 1998). 
Furthermore, morphological studies in. boars immunised against GnRH around 4 
months of age, demonstrated abnormalities of the median eminence at 6 months of 
age (Molenaar et al., 1993). D'Occhio et al. (2001) investigated the effects of 
transient GnRH immunisation protocols in cattle at 6 and 22 months of age, on the 
longevity of reproductive inhibition and reported that, like neonatal rams (Brown et 
"al., 1994), between 16 and 35% of pre-pubertal bulls displayed long-term 
suppression of LH and testosterone and reduced testes size and function. However, 
mature bulls had similar levels of long-term reproductive inhibition to calves. The 
explanation for the apparent reversibility of GnRH immunisation in pre-pubertal 
calves in contrast to findings in sheep may lie in the different types of vaccine, and 
vaccine mechanisms of action, or immunisation schedules used. However, by 6 
months the hypothalamic pituitary unit would be more mature than that of neonatal 
sheep. It has been suggested that a gender (Clarke et al., 1998), or species specific 
time period, may exist during which the exposure of the hypothalamic-pituitary unit to 
GnRH antibodies may result in permanent impairment of reproductive function. 
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The hypothesis for the current study was that the relatively immature hypothalamic-
pituitary unit of the neonatal bull, may be more susceptible to GnRH antibodies than 
that of older calves or adults. Therefore, with an adequate antibody response to 
GnRH vaccination in the neonate, a permanent impairment of reproductive function 
may result. Hence, the objective of the present study was to investigate the effects of 
neonatal immunisation against GnRH in bull calves on either the permanent or long-
term suppression of reproductive function over a period of 16 months. Using a new 
and reputedly improved GnRH construct vaccine developed using recombinant 
technology, combined with an early immunisation (14-20 days of age) protocol we 
investigated the effects on: 1) pituitary gland function (LH and FSH); 2) testosterone 
output and sexual behaviour; 3) potential fertility (sperm quality), testicular and 
seminal vesicle development and 4) growth rate. 
3.2 MATERIALS AND METHODS 
A detailed description of assay statistics, animals and management and experimental 
protocols are given in Chapter 2. 
3.2.1 Experimental Animals 
The experimental animals used in the current s.tudy consisted of eighteen beef cross 
bull calves monitored from 2 to 72 weeks of age. 
3.2.2 Experimental Protocol 
The experimental period ran from May 2000 to October 2001. On February 19th 2001 
all planned procedures were postponed for approximately 1 month because of the 
outbreak of foot and mouth disease in the UK. 
Responses to vaccinations in groups of infants are generally low relative to those in 
adults (Section 1.4), with higher proportions of poor and non-responding animals 
(Hauser, Koob and Roth, 1986; Pollock et al., 1991; Roden et al., 1992; Adams et al., 
1996). However, despite the immaturity of the neonatal immune system, the decision 
to aqtively immunise calves was taken for several reasons. Firstly, studies in sheep 
suggested that it was during the neonatal period that the HPU was maximally 
susceptible to GnRH antibodies, and during this period the hypothalamus is still 
maturing in both cattle and sheep (as discussed 1.2.1.1). For our studies to be more 
comparable to those in sheep (Brown et al., 1994; 1995), it was necessary to 
vaccinate at this time. Secondly, publications at the time of study stated that, 
newborns were immunocompetent (Chappuis, 1998), and therefore, inducing a 
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neonatal immune response was possible (Kovarick and Siegrist, 1997). Thirdly, our 
commercial sponsor (Pfizer®) provided a newly developed vaccine, which had been 
designed to enhance the immune response to vaccination, and Pfizer® supported our 
experimental protocol. Fourthly, due to the limitations of the PhO Studentship, we 
could only keep the animals for a maximum of 18 months i.e., the typical period of 
time taken to fatten beef animals. However, as we intended to investigate the long-
term effects of immunisation after GnRH antibody titres had fallen, it was necessary 
to carry out all the immunisations relatively early in life as based on the literature, 
titres can take up to 8 months to. dissipate after the final booster vaccination 
(Robertson, Wilson and Fraser, 1979; Robertson et al., 1981; 1984). A final reason 
for early immunisation was that, we originally intended to compare 
hypothalamic/pituitary gland morphological examinations between groups after titres 
-had dissipated, however, this was not possible due to BSE restrictions. 
Pfizer® did not provide a "control vaccine" i.e., one containing all components of the 
GnRH vaccine, minus the GnRH-construct and on the sponsor's advice, saline was 
administered to control animals. Furthermore, a group of steers to compare their 
performance with those of immunocastrates and bulls under the same experimental 
conditions, was not included, because of limited funding and because this was not in 
the interests of our commercial sponsor. 
3.2.2.1 Immunisation 
Nine calves were immunised (s.c.; brisket) against a GnRH construct conjugated to a 
42KO gO carrier protein, subunit of recombinant bovine herpes virus 1 (BHV1) in 
adjuvant consisting of cholesterol, quil A (saponin), amphigen (refined miner?,1 oil) 
. and cholesterol. A primary injection, first and second booster were administered 
(brisket; s.c.) at 16 ± 0.6 (2ml), 44 ± 0.6 (2ml) and 94.8 ± 0.1 (1.7ml) days of age 
respectively. Following injection, pressure was applied to the injection site for 15 
seconds using a sterile swab to prevent leakage of vaccine from the skin. 
3.2.2.2. 1 Response site assessment 
The granuloma (spherical shaped lump at injection site) diameter was measured 
(length, width and breadth; using callipers) on day: 1, 3, 7, 10 a.nd 14 following each 
administration on vaccine. Subsequently the volume of the granuloma was calculated 
by taking the mean of the three diameters and employing the formula: 4/31t r. 
3.2.2.2 Blood sampling 
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Blood samples were collected by venepunture every 10-14 days to measure 
circulating GnRH antibody titres, and FSH and testosterone concentrations. In 
addition, to characterise peripheral pulsatile LH concentrations between the neonatal 
and post-pubertal, a series of 5 serial sampling periods (every 15 min for 8h) were 
conducted at the following ages (mean ± s.e.): 0.8 ± 0.02,3.7 ± 0.03,6.5 ± 0.03,10.9 
± 0.03, and 15.3 ± 0.03 months. These ages were rounded up to .the nearest week, 
for ease of presentation, to give: 4, 16, 28, 47 and 66 weeks of age. During serial 
bleeds blood samples were collected via an indwelling jugular cannula (see Chapter 
2). Table 3.1 defines the 4 LH parameters measured from the serial bleeds using 
MUNRO@ (Taylor, 1987). 
Table 3.1 A description of all LH parameters analysed in each 8-hour serial bleed. 
LH parameter Definition 
Lowest point within a 35-minute (2 data point) time window. A 
Basal LH (nadir) 60 min (4 samples animar1) smoothing window was used to 
calculate the moving average in the baseline calculation. 
Number of LH pulses. A pulse was measured when LH level 
Pulse frequency was elevated C!2 s.d. above the mean baseline (nadir) with a 
minimum pulse interval of 30 min. 
Pulse amplitude Size of the pulse (ng mr1) above the nadir. 
Mean LH 
Mean LH concentration in all samples throughout the 
sampling period. .. 
3.2.2.3 Real-time ultrasound scanning 
Testes circumference (Figure 3.1) and vesicular gland dimensions (Figure 3.2) were 
measured at approximately 4 weekly intervals throughout the experiment from 10-72 
weeks. For each testis the scanner calculated circumference, area and volume 
- . 
automatically after measuring the horizontal, vertical and diagonal diameters as 
shown in Figure 3.1. Vesicular gland width was displayed as tt)e distance between 
markers (+; see Figure 3.2.), while the length of each gland was measured using the 
scale on the top of the screen. 
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Figure 3.1 Testis measurement using ultra-sound scanning (transverse plane 
scanned cranially). Results are displayed to the right of the image. Note the 
mediastinum (rete testis), which appears as a white spot at the centre of each gonad. 
Figure 3.2 Ultra-sound image of a vesicular gland with diameter measurement 
(median plane, scanned ventrally). Note the lobular structure of the gland and part of 
the fluid filled duct, which appears as a dark medial line. 
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3.2.2.4 Live weight 
Animals were weighed at 10-14 day intervals, (typically at time of blood sample 
collection). 
3.2.2.5 Behaviour assessment 
Sexual and aggressive behaviours, as defined in Chapter 2, w ~ r e e scored during 
group housing of the bulls between 38-70 weeks of age. Three observation sessions 
of 90 min were conducted during each study period. Study periods lasted two weeks, 
with observations sessions of 90 minutes carried out on Days, 1, 7 and 14. After 
each study period an interval of 14 days followed in which animals were not observed 
for behaviours. Treated and control bulls were observed during housing in two 
separate pens (each approx. 8m x 20m), respectively. Observed behaviours were 
categorised and tallied for each group. For statistical analysis, categories were 
pooled into either sexual or aggressive behaviour, or total "bullish" behaviours. 
Individual behaviour scores were not collected due to practical difficulties (animal 
identification) and time constraints. The study period at 42-44 weeks of age was 
abandoned due to the FMD outbreak. 
3.2.2.6 Post-mortem assessment 
Animals were slaughtered at 72 weeks of age and a body weight of 477.33 ± 10.06 
kg (mean ± s.e; n=18). Assessments of semen quality, reproductive tract and 
accessory glands and carcass characteristics are described below. 
3.2.2.6.1 Sperm quality 
Immediately post-mortem a semen sample was collected from the caudal epididymis. 
The motility, viability and morphology of the sperm were assessed (see Chapter 2). 
3.2.2.6.2 Reproductive tract and accessory glands 
Testes and accessory glands (epididymi, seminal vesicles, bulbo-urethral, prostate, 
penis) were dissected from the carcass, weighed and measured. Tissue samples for 
future analysis were collected, "snap frozen" in liquid nitrogen and stored at -20°C. 
Further samples \yere preserved in Para formaldehyde. 
3.2.2.6.3 Carcass characteristics 
The carcass (left and right sides) was weighed, killing-out percentage (saleable 
carcass wt I total dead weight x 100) calculated, and measures of rib-eye muscle and 
subcutaneous fat taken to determine the carcass quality. The carcass of each bull 
was given a fat score and conformation grade by an independent Meat and Livestock 
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Commission (MLC) meat inspector. Conformation grades were based on the 
established SEUROP classification system (S: superior; E: excellent; U: very good; 
R: good; 0: fair and P: poor). A plus (+) or minus (-) sign is used to provide further 
information on the quality of the carcass within each grade. Similarly, fat scores are 
often issued with a high or low status, e.g., 3H, 4L, etc. 
3.2.3 Statistical Analyses 
MUNROCC>, a data analysis program (developed by Dr. P. L. Taylor, Edinburgh 1987, 
was used to identify LH pulses and calculate LH mean and basal levels, pulse 
frequency and amplitude (see appendix for calibration details). The resulting statistics 
I 
were analysed using Genstat 6.1, split-plot analysis of variance (ANOVA) with 
repeated measures, and degrees of freedom adjusted for the Greenhouse-Geisser 
epsilon effect. 
Repeated measures, reduces the errors in data where data at a point in time may be 
influenced by the previous time-point data. How dependent a point is, is scored 
between 0 (extremely dependent) and 1 (independent). The Greenhouse-Geisser 
adjustment results in degrees of freedom being reduced further, in repeated 
measures ANOVA. The degrees of freedom in an ANOVA represent the number of 
independent data that are included in the Sum of Squares for each row of an ANOVA 
table. The random error in one value may be similar to the error in the next value. Put 
.-
another way, the closer together in time that one measures something, e.g., hormone 
concentrations, the more likely one is to measure the same thing twice, rather than 
separate hormone releases. Thus, each value is obviously not independent, and 
would only be independent if one waited long enough between each sample . 
. However, the values are not totally dependent either. Indeed, repeated measures 
data is somewhere in between 0 and 1 .. The Greenhouse-Geisser approach estimate 
the degree of non-independence in a time series data set and gives one an 
adjustment factor to estimate the degrees of freedom, which is somewhere between 
1 and the number of times -1 (J. Craigon, personal communication). 
- . 
FSH data was log transformed (In) before analysis to normalise the distribution. 
Subsequently, FSH was analysed using split-plot analysis with .repeated measures. 
Degrees of freedom were adjusted for the Greenhouse - Geisser epsilon effect. 
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Carcass conformation and fat grades were analysed using a Chi squared test in 
Microsoft Excel. All other ANOVA analyses were carried out using Genstat 6.1 
(Lawes Agricultural Trust, 2001, IACR Rothamsted). 
3.3 RESULTS 
3.3.1 Data Description 
Where data have been transformed to a logarithmic scale to normalise the 
distribution (e.g., FSH), the textual deSCription and statistical significances are based 
on transformed data. However, for ease of presentation and for presenting standard 
errors, the tables and figures display the untransformed data unless stated. 
Age had a highly significant effect (P<0.001) upon live weight. The slope of the 
regression for live weight on age (Figure 3.3) indicates an average growth rate of all 
bulls of 6.12kg per week. Growth rates were not significantly different (P>O.OS), with 
daily average growth of 0.82kg and 0.8Skg for control and immunised bulls, 
respectively. The live weight (mean ± s.e.) of bulls at S time points throughout the 
trial is presented in Table 3.2. 
Figure 3.3 Regression of weight on age in bulls (n=18). The equation of this 
regression line is; y= 6.12x + 17.24 ( ~ = 0 . 9 2 ) . .
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Table 3.2 Mean live weights of control and GnRH immunised bulls at 5 ages (± s.e.). 
Immunisation against GnRH had no significant (P>0.05) effect on live weight. 
Age Control Mean Immunised Mean Overall Mean 
(weeks) (n=9) (n=9) (n=18) 
4 58.3 (2.2) 56.1 (2.2) 57.20 (1.5) 
16 118.6 (5.8) 109.3(7.1) 113.7 (4.3) 
28 186.6 (11.2) 176.8 (11.3) 181.7 (7.3) 
47 295.1 (13.9) 300.4 (17.2) 297.3 (10.7) 
66 435.7 (13.6) 439.1 (16.8) 437.4 (10.5) 
-
3.3.2 Immune Response to GnRH Immunisation 
Inflammation at the site of vaccination and antibody titre, in response to GnRH 
immunisation, were monitored throughout the study period as described below. 
3.3.2.1 Injection site response 
The injection site response, measured as the. volume of subcutaneous granuloma 
over time following immunisation (primary vaccination and two boosters), was 
significant (P<0.001) when compared to the response site in control animals, where 
there was no response. The response to the 2nd booster vaccine was of greater 
magnitude (see Figure 3.4) than that seen following the primary and 1st booster 
vaccinations (P<0.001). Pooled data is presented in bulls and heifers (see Chapter 4 
for other results of GnRH immunisation in heifers). Due to an accident, which 
.. resulted in a loss of data, results from three bulls and two heifers are missing. 
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Figure 3.4 Local subcutaneous injection site response to GnRH immunisation in 
bulls (n=6) and heifers (n=7). After all three vaccinations, granuloma size was largest 
(P<0.001) on day 3 compared to other monitoring days. Animal gender had no effect 
(P=0.73) on response site oedema. 
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Antibody titre response to primary vaccination was low, and only tended to increase 
(P=0.14) relative to control animals. Responses to 1st and 2nd booster vaccinations 
resulted in significant (P<0.001) antibody titres to GnRH (17.20/0 ± 7.4 and 26.5% ± 
4.60/0 at 1 in 1,000 dilution) and persisted above 150/0 binding for 2.5 and 4 weeks, 
respectively (see Figure 3.5). Binding of iodinated GnRH in control bulls was 
negligible (0.380/0 ± 0.04) and did not significantly (P>0.05) change over time. 
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Figure 3.5 Mean (± s.e.) GnRH antibody titre (1 in 1,000 dilution) profiles over time 
for GnRH immunised bulls. GnRH antibody titres increased (P<0.001) after booster 
injections. 
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3.3.3 Reproductive Hormones 
3.3.3.1 LH 
Four parameters of LH output were investigated and are defined in Table 3.1. 
3.3.3.1.1 LH pulse frequency 
Mean number of LH pulses at 5 time pOints, are illustrated in Figure 3.6. Although LH 
pulse frequency was significantly (P<0.05) affected by age, GnRH immunisation had 
no significant effect (P=0.67). Although immunised bulls at 4 and 16 weeks of age 
tended to have reduced pulse frequency, there was no time/treatment interaction 
(P=0.27). 
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Figure 3.6 A comparison between plasma LH pulse frequency in GnRH immunised 
and control bulls over time. Standard error of the differences (s.e.d.) of means was 
0.804, 0.537 and 1.150 for time, treatment and time/treatment, respectively. 
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Mean LH pulse amplitude is illustrated in Figure 3.7. In addition to a significant 
(P<0.005) age effect, GnRH immunisation reduced (P<0.02) LH pulse amplitude 
throughout the course of the experiment. This reduction in pulse amplitude in 
immunised animals appeared most pronounced at 4, 16 and 28 weeks of age, 
although there was only a suggestion (P=0.14) of a time/treatment interaction. The 
effect is greatest at 16 weeks, which corresponds with peak GnRH antibody 
response to immunisation (see Figure 3.5). 
Figure 3.7 Mean LH pulse amplitude in GnRH immunised and control bulls. Standard 
error of the differences (s.e.d.) of means was 0.144, 0.106 and 0.211 for time, 
treatment and time/treatment, respectively. 
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3.3.3.1.3 Basal (nadir) LH 
Mean basal (nadir) LH concentrations throughout the experimental period are 
illustrated in Figure 3.8. The age of bulls at the time of sample collection did not 
significantly (P=0.15) affect basal LH levels. There was no effect (P=0.13) of GnRH 
immunisation over the whole trial. However, there was a suggestion (P=0.06) of a 
time/treatment interaction, with the effects of GnRH immunisation most apparent at 
16 weeks. Furthermore, basal LH concentrations also appear to be reduced in 
treated animals at 66 weeks compared with controls, by which time all animals had 
attained puberty. 
Figure 3.8 Mean basal LH (nadir) in GnRH immunised and control bulls. The s.e.d. 
of means were 0.083, 0.078 and 0.131 for time, status and time/treatment, 
respectively. 
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Figure 3.9 illustrates the mean plasma LH concentrations in GnRH immunised and 
control bulls. Mean LH concentrations did not change (P=0.21) throughout the trial. 
Overall mean LH concentration was not significantly (P=0.21) reduced by 
immunisation. There was a significant (P<0.05) time/treatment interaction. 
Treatment e f f e c t t ~ w e r e e again evident at 16 weeks of age, with immunised animals 
having reduced mean LH levels at this age. 
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Figure 3.9 Mean plasma LH in GnRH immunised and control bulls. The s.e.d. of 
means were 0.104, 0.112 and 0.173 for time, status and time/treatment, 
respectively. 
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Mean (± s.e.m.) serum FSH concentrations in GnRH immunised and control bulls are 
illustrated in Figure 3.10. FSH levels were significantly affected by age (P<0.05), but 
not by GnRH immunisation at any time (P=0.42), or overall (P=0.86). 
Figure 3.10 Mean (± s.e.m.) serum FSH in GnRH immunised (n=9) and control 
(n=9) bulls. FSH levels were significantly affected by age (P<O.05). 
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3.3.3.3 Testosterone 
Two testosterone parameters were investigated in the current study: I) mean (± 
s.e.m.) testosterone concentrations throughout the whole study period and ii) 
testosterone concentrations during the period of peak antibody titre (26.50/0 ± 4.6% at 
1 in 1,000 dilution). 
3.3.3.3.1 Mean testosterone concentrations 
Mean (± s.e.m.) testosterone concentrations over the entire experiment, the first 28 
weeks and from 32-72 weeks are illustrated in Figures 3.11, 3.12 and 3.13, 
respectively for clarity of presentation. In addition, due to group differences in the 
acquisition of puberty and the possible resultant confounding of data, the 
testosterone concentrations of each group are also presented relative to puberty in 
Figure 3.14. 
Testosterone concentrations were significantly affected by age (P<0.0001; see 
Figures 3.11 and 3.12), with low testosterone concentrations up to 16 weeks, an 
increase from 16-25 weeks, (see Figure 3.12.), with a further increase in bulls >28 
weeks of age (see Figure 3.13.). Although GnRH immunisation did not significantly 
(P=0.3) reduce serum testosterone concentrations over the entire trial, (see Figure 
3.11.), or overall during the first 28 weeks of life (P=0.48; Figure 3.12), there was a 
significant (P<0.001) time/treatment interaction suggesting that the affects of 
immunisation altered over time. For example, a reduction in mean testosterone 
concentrations in GnRH vaccinated bulls occurs briefly (P<0.05) following the 1st 
booster at 7 weeks (for about 5 weeks), following the 2nd booster (P<0.001; 15-20 
weeks of age; see Figure 3.12.) and from 36-44 weeks (P<0.01; Figure 3.13; at least 
4.5 months after the last vaccination), despite undetectable GnRH antibody titres 
(Figure 3.5). Thereafter, mean testosterone concentrations in GnRH immunised bulls 
were similar to those of control bulls. Testosterone concentrations tended to be lower 
on serial pulse bleed days than on days when a single sample was collected (see 
Figures 3.12 and 3.13). 
Figure 3.15 illustrates the mean serum testosterone concentrations plotted relative to 
puberty. Despite a significant (P<0.001) reduction in testosterone .in the treated group 
6 weeks prior to puberty, the testosterone levels were not (P>0.05) affected by 
treatment from 4 weeks prior to puberty until the end of the trial. 
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Figure 3.11 Mean testosterone (± s.e.m) profiles in GnRH immunised (n=9) and 
control bulls (n=9) throughout the whole experimental period. 
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Figure 3.12 Mean testosterone (± s.e.m) concentrations in immunised (n=9) and 
control bulls (n=9) during the first 28 weeks after birth. Key: Pale blue arrows indicate 
the approximate time of vaccinations. Red arrows = time of LH pulse bleeds in weeks 
(P.B.). GnRH antibody titres (1 in 1,000 dilution), are indicated by both pale blue bars 
(2! 50/0 binding) and pale blue bars with red border (2! 150/0 binding). 
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Figure 3.13 Mean testosterone (± s.e.m.) concentrations in GnRH immunised and 
control bulls from 30-72 weeks. Key: Red arrows = time of LH pulse bleeds at 47 and 
66 weeks of age. Black arrows = Puberty (based on testicular measurements). 
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3.3.3.3.2 Testosterone levels at peak GnRH antibody titre (16 weeks) 
Further confirmation of a reduction of plasma testosterone following GnRH 
immunisation is shown in Figure 3.14, which illustrates a significant (P<0.05) 
reduction in plasma testosterone throughout the 8h serial blood sampling at 16 
weeks of age, which was conducted two weeks after the 2nd booster, when anti-
GnRH titres peaked. During this period, testosterone levels were unaffected by time 
(P=0.17). 
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Figure 3.14 Mean plasma testosterone concentrations during pulse bleed in GnRH 
immunised (n=8) and control (n=9) bulls aged 16 weeks. 
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Figure 3.15 Mean testosterone concentrations in GnRH immunised and control 
bulls presented relative to puberty. 
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3.3.4 Reproductive Organs and Sperm Analysis 
3.3.4.1 Testis circumference 
Figure 3.16. Illustrates the effect of GnRH immunisation on testicular development as 
monitored by testes circumference. Testes circumference increased significantly 
(P<O.001) with age. GnRH vaccination significantly reduced testis circumference 
(P<0.02). It appears that GnRH immunisation delayed puberty by approximately 8 
weeks as determined by a testes circumference of 14cm. However, by week 72 the 
testes of the treated bulls were not significantly different in circumference (see Figure 
3.16), weight or length (see Table 3.3). 
Figure 3.16 Mean (± s.e.m.) testes circumference in GnRH immunised and control 
bulls. Key: Blue arrows = the approximate times of GnRH immunisation. 
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3.3.4.2 Vesicular glands 
Vesicular gland length (mean ± s.e.m.) in GnRH immunised and control bulls, is 
illustrated in Figure 3.17. Vesicular gland (VG) width and length increased 
significantly (P<0.001) with age. The vesicular glands of GnRH immunised bulls were 
Significantly (P<0.02) shorter than those of control bulls between 11 and 35 weeks of 
age. Vesicular gland width did not Significantly change after GnRH immunisation 
(P>0.05). but tended (P=0.07) to be greater at around 20 weeks of age than those of 
GnRH immunised bulls. 
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Figure 3.17 Vesicular gland length (mean ± s.e.m.) in GnRH immunised and control 
bulls. Key: White arrow = approximate time of peak anti-GnRH titres. 
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Figure 3.18 Vesicular gland width (mean ± s.e.m.) in GnRH immunised (n=9) and 
control (n=9) bulls. 
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Table 3.3 Comparative weights and measures of gonads and accessory glands in 
GnRH immunised (n=9) and control (n=9) bulls. GnRH immunisation had no 
significant (P<O.05) effect on gonads or accessory glands at 72 weeks of age. 
Mean Testes Testes Total Total Mean Total Prostate Cowper's Penis Treatment testis wt% Epididymal VG VG VG and Gland 
IP value length Weight Body Weight Length Width Weight Urethral Weight Length 
(em) (grams) weight (grams) (em) (em) (grams) muscle (grams) (em) 
Control 11.14 480 0.10 46.8 19.06 2.92 62.2 95.6 6.22 75.2 
Irnrnunised 11.12 448 0.09 51 .3 18.22 3.02 64.5 104.6 5.4 74.2 
s.e.d. 0.38 42.2 0.01 5.38 1.19 0.2 7.75 7.42 0.64 2.01 
P-value 0.97 0.47 0.278 0.42 0.49 0.63 0.77 0.25 0.22 0.61 
3.3.4.3 Semen Analysis 
The percentage of sperm in each of 4 motility grade classes are compared between 
control and immunised bulls in Figure 3.19. GnRH immunisation had no significant 
affect on sperm motility (P>O.05). 
Figure 3.19 Sperm motility in GnRH immunised (n=9) and control (n=9) bulls. 
Grade A: fast progressive motility (moving >5 time a head length per second), grade 
B: slow progressive motility (1 -5 times a head length per second), grade C: twitching 
on the spot, but not progressive, grade 0: immotile sperm. GnRH immunisation did 
not significantly (P>O.05) affect sperm motility. 
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The relative proportions of live and viable sperm in control and GnRH immunised 
bulls are presented in Figure 3.20. GnRH immunisation had no significant (P>0.05) 
effect on the number of live and viable sperm. 
Figure 3.20 Percentage of live and viable sperm in control (n=9) and GnRH 
immunised (n=9) bulls, based on results from the eosin-nigrosin stain test and hypo-
osmotic swelling test (HOST), respectively. 
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The percentages (± s.e.m.) of morpholocically normal and abnormal spermatozoa in 
GnRH immunised and control groups of bulls are presented in Table 3.4. 
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Table 3.4 Percentage of morphologically normal and abnormal spermatozoa 
immediately post mortem in GnRH immunised (n=9) and control bulls (n=9). 
Abnormalities include the tail (coiled tail, multiple tails or no tail) and head, other than 
pyroform (such as elongated head, round head and amorphous heads i.e., head 
abnormalities that do not fall into one of the previous catagories). GnRH 
immunisation resulted in a marginal decrease in the percentage of morphologically 
normal sperm and a tendency for an increase in morphologically abnormal sperm. 
The majority of the increased abnormalities result from a higher proportion of sperm 
with pyroform heads. 
Treatment Normal Pyroform Other Abnormalities 
Control 92.1 ± 0.8 5.2 ± 0.6 2.7 ± 0.6 
Immunised 86.4 ± 1.9 9.4 ± 1.9 4.2 ± 0.4 
P Value 0.06 0.06 0.08 
3.3.4.4 Sexual and aggressive behaviour 
The mean (± s.e.m.) sexual and aggressive behaviours between GnRH immunised 
(n=9) and control (n=9) bulls are presented in Figures 3.21 and 3.22. GnRH 
immunisation had no effect on sexual (P=0.5), aggressive (P=0.78), or total bullish 
behaviours (sexual and aggressive combined; P=1.0), although time significantly 
.. (P<0.001) affected all behaviours (P<0.05; P<0.01; P<0.01), respectively. There was 
no significant time/treatment interaction in sexual (P=0.39), aggressive (P=0.52) and 
total bullish behaviours (P=0.56). 
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Figure 3.21 Mean (± s.e.m.) sexual behaviours in control (n=9) and GnRH 
immunised (n=9) bulls. 
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Figure 3.22 Compares mean (± s.e.m) aggressive behaviours in the two treatment 
groups. 
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3.3.4 Anabolic Response 
Comparative assessment of bull carcasses from GnRH immunised and control 
animals is presented in Table 3.5. GnRH immunisation significantly increased the rib-
eye muscle width (P<O.05) at the 10th rib. Tables 3.5 and 3.6 show carcass 
conformation and fat grades of control and immunised bulls, respectively. GnRH 
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immunisation significantly (P<0.02) improved carcass conformation grades, but failed 
to improve fat grades (P=0.16). 
Table 3.5 Comparative carcass weights and measures in GnRH immunised 
(Treated; n=9) and control (n=9) bulls. Cold carcass weight was the weight after 
hanging for two weeks at 4°C. Killing ~ u t t % is the percentage of ~ ~ I e a b l e e meat and 
was calculated by employing the formula: cold carcass weight/live weight x 100. 
Group/ Live Cold Killing out Rib-eye Rib-eye Rib-eye 
P-value weight carcass % depth width area (cm2) 
(kg) weight (mm) (mm) 
(kg) 
Control 474 223.0 46.96 130.6 55.47 59.7 
Treated 482 230.3 47.77 136.5 60.02 62.9 
s.e.d. 20.9 10.92 0.84 4.69 1.99 3.51 
P-value 0.70 0.52 0.35 0.23 0.036* 0.373 
Table 3.6 Comparison of carcass conformation and fat grades in control (n=9) and 
GnRH immunised bulls (n=9). GnRH immunisation significantly (P<0.02) improved 
carcass conformation grades, but had no affect (P=0.16) on fat scores. 
Conformation Grade Average/Good (0+) Poor/Average (0-) Poor (P) 
Control bulls 1 4 4 
Immunised bulls 1 8 0 
Fat Grade Three Two One 
Control bulls 0 7 2 
Immunised bulls 0 1 8 
3.4 . DISCUSSION 
The present study clearly shows that GnRH immunisation in neonatal bulls did not 
permanently impair reproductive function as was the case in similar studies in sheep 
(Brown et al., 1994; 1995; Clarke et al., 1998), and a study in bulls (D'Occhio, 
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Aspden and Trigg, 2001). However, GnRH immunisation at approximately 2 weeks of 
age did result in a temporary suppression in reproductive function and delayed 
puberty. This was evident through the disruption of pituitary gland function, as 
indicated by the reduction of LH pulse amplitude and mean plasma LH 
concentrations, a reduction in testes circumference, plasma testosterone output, 
vesicular gland length and a reduction of aggressive behaviours, as based on early 
subjective behavioural' observations. This is in agreement with the findings of 
Jeffcoate, Lucas and Crighton (1982), Keeling and Crighton (1984) and Prendeville 
et al. (1995a). In addition, some beneficial anabolic effects were observed. These 
changes all occurred subsequent to increased GnRH antibody titres in immunised 
bulls. Despite some evidence of prolonged ,effects after anti-GnRH titres had 
dissipated, all suppressed parameters, such as LH amplitude, testosterone, testes 
and vesicular gland growth recovered to levels comparable to those of the control 
bulls by 16.6 months of age, with the exception of carcass quality. 
3.4.1 GnRH Immune Response 
The GnRH immunogen successfully induced the production of significant GnRH 
antibody titres in all vaccinated animals. At a 1: 1000 dilution, mean peak titre in bulls 
was 26.5% (see Figure 3.6). These,' as classified by Adams et al. (1996), are "good 
responders" (>10% binding at 1: 1 000 dilution). 'Although the titres were higher than 
those reported by both Johnson et al. (1988; >20% binding at 1 :1,000) and 
Prendiville et al. (1995a; 15% binding at 1 :640) who reported antibody titres 
adequate to inhibit cyclicity and reproduction function in heifers, they did not reach 
target titres (>30% at 1: 1,000) required for total suppression of reproductive function 
as suggested by Fraser (1980) and Adams and Adams (1990). However, calculating 
__ the exact threshold antibody titre required to suppress reproductive function, based 
on results from trials with different GnRH immunogens is difficult (Finnerty et al., 
1994), because antibody titres per se give little information about the neutralising 
ability of the antibodies on their target hormone. For example, in the boar following 
GnRH immunisation fully regressed testicles have been observed in the presence of 
low antibody binding activity, while also the reverse is seen (Meloen, 1995). 
. . 
Furthermore, despite significant GnRH antibody titres the biological effects of GnRH 
immunisation on hormone parameters decreased over time in in.fant bulls (Finnerty, 
Enright and Roche, 1998). Possibly due to compensatory GnRH output. 
Recent studies have reported that the site of GnRH conjugation can influence 
antibody titre levels, specificity and ability to cause the desired physiological effect 
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(Silversides et al., 1988; Goubau et al., 1989; Ladd et al., 1990; Ferro et al., 
2002a;b). Furthermore, Ghosh and Jackson (1999) suggested that GnRH 
immunisation induced suppression of fertility is not related to the size of the peak 
antibody titre, IgG isotypes or affinity of antibodies for GnRH, but is due to the length 
of time antibodies are in the circulation. However, Ferro et al., (2002a,b) disagreed, 
stating that antibody avidity for binding free GnRH is more important than antibody 
titre. These authors found that when immunising rats against modified dimerised 
GnRH peptides, conjugation with tetanus toxoid at the N-terminal induced antibodies 
of high affinity for free GnRH (Le., non-modified decapeptide), which suppressed 
fertility. C-terminal conjugation, however, had reduced affinity to GnRH, despite high 
antibody titres to the modified GnRH peptide, but no adverse effect on fertility was 
observed (Ferro et al., 2002b). This may be the case with more complex 
modifications of GnRH. As the so called, "second generation" (Sosa et al., 2000) 
antigens are synthesised using recombinant DNA technologies, the resultant 
constructs may become more distant from the GnRH decapeptide. Furthermore, in 
some trials (Ferro et al., 2002a;b) antibodies are measured to the conjugate, rather 
than to GnRH. Therefore resulting titres may not actually correlate with physiological 
effects (see Meleon, 1995). However, for the majority of studies there is a significant 
correlation between anti-GnRH antibody titres a.nd the degree to which reproductive 
function is inhibited (Lincoln and Fraser, 1979; Molenaar et al., 1993; Wetteman and 
Castree, 1994; Prendiville et al., 1995a; Parthasarathy et al., 2002). 
Bulls in the current study were approximately 8 weeks of age before they produced 
significant antibodies to GnRH after the 1 st booster. This pattern of immune response 
was in agreement with previous vaccination programmes, which have reported ,little 
response to primary vaccination, with the exception of Adams et al. (1996), but 
increased responses to subsequent boosters (Robertson, Wilson and Fraser, 1979; 
Robertson et al., 1981; 1982; 1984). Although the antibody titre profile in this trial 
shows a typical immune response, the lack of initial response and generally poor to 
moderate response overall is more likely to be due to the immaturity of the immune 
system in younger calves, and possibly blocking effects of maternally derived 
-
antibodies (see Sections x and y), than a deficiency in the vaccine. A large individual 
variation was observed in the current study, with responses to b.ooster vaccinations 
varying between <5 to >700/0 binding, as seen in other studies (Prendiville et al., 
1995a). However, one bull responded well (>50%) to both booster injections 
suggesting that age may not be entirely responsible for the generally poor-to-
moderate immune response. 
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3.4.2 Gonadotrophic Drive 
A better indication of the effectiveness of a GnRH immunogen may be obtained by 
investigating physiological parameters such as, gonadotrophic output from the 
pituitary gland and particularly LH release. As previously discussed in the literature 
review, GnRH pulses induce the episodic release of LH pulses, promote GnRH 
receptor expression (Fraser et al., 1982; Popkin and Fraser, 1985) and stimulate 
gonadotrophin production by the gonadotroph cells of the anterior pituitary gland 
(Huckle and Conn, 1988; Hawes et al., 1992). LH is immediately responsive to 
changes in GnRH stimulation, while FSH is largely unresponsive in the short-term, its 
release being slower and more sustained (Clarke and Cummins, 1982; Levine et al., 
1982; Levine and Ramirez, 1982; Fraser and McNeilly, 1983). Furthermore, a GnRH 
pulse in the portal system always precedes each peripheral LH episode however; 
every GnRH pulse is not necessarily followed by an LH episode (Clarke and 
Cummins, 1982; see Clarke, 2002). 
In control bulls the observed increase in LH pulse frequency (P<O.05) and pulse 
amplitude (P<O.005) between 4 and 16 weeks of age, (peaking at 16 weeks) and the 
subsequent decrease in pulse frequency at 28 weeks of age, resulting from 
increased testosterone negative feedback, agrees with previous reports (McCarthy, 
Convey and Hafs, 1979; McCarthy, Hafs and Convey, 1979; Amann, 1983; Evans, 
Currie and Rawlings, 1993; Evans et al., 1995; Rawlings and Evans, 1995; 
Chandolia et al., 1997b; Chandolia, Evans and Rawlings, 1997; Finnerty, Enright and 
Roche, 1998; Aravindakshan et al., 2000). This pattern of LH release, although 
reflected in GnRH immunised bulls, was delayed, peaking at 28 weeks of age, rather 
than at 16 weeks as occurred in the control animals. This finding suggests that due to 
.. reduced LH output at around 16 weeks of age, testicular growth and testosterone 
negative feedback were delayed. 
Finnerty, Enright and Roche (1998) reported reduced LH pulse amplitude, as 
occurred in the current study, and frequency at 16 weeks following GnRH vaccination 
b e t w ~ e n n 8-10 weeks of age. In the current trial, however, LH pulse frequency was 
not significantly re·duced hence LH pulse amplitude appears to be the more sensitive 
parameter. The effects of immunocastration on LH pulse amplitude in the present 
study was significant (P<0.02) with the suppression of amplitude evident at the "16 
week" serial bleed, 7-9 days after the primary vaccination, despite undetectable 
GnRH antibody titres in all bulls at this time (1:1,000 dilution). At peak GnRH 
antibody titre (-16 weeks of age) the suppression of LH pulse amplitude was 
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greatest. Interestingly, despite antibody titres falling to very low levels at 28 weeks of 
age, the effects of immunisation on LH pulse amplitude are still evident. This long-
term suppression of pulse amplitude may indicate an inability of the pituitary gland to 
produce adequate LH, following a period of reduced GnRH priming. However, since 
only 10-20% of LH is released following GnRH stimulation (McNeilly et al., 2003) it 
may be due to increased sensitivity of the gonadotrophs to steroidal negative 
feedback, which can modify the responsiveness of gonadotrophs to GnRH 
stimulation. Thus the amplitude of an LH pulse may not reflect the amplitude of a 
GnRH pulse (see Clarke, 2002). 
Despite the presence of maximal GnRH antibody titres at 16 weeks of age, LH pulse 
frequency did not alter significantly (P>0.05) suggesting that GnRH and LH pulse 
release was relatively unaffected. In contrast the LH pulse amplitude was reduced. 
This suggests that: I.) GnRH secretion is inhibited, and smaller pulses induce smaller 
LH amplitude or that ii.) GnRH secretion is normal, but antibodies sequester/ bind 
GnRH and inhibit receptor binding, causing a reduction in pulse amplitude, iii.) Both 
of these effects occur, IV.) gonadotroph sensitivity to testosterone has changed, V.) 
immune responses between studies may be acting through different mechanisms to 
suppress LH parameters. In the current study, it appears that titres are not of 
sufficient magnitude to cause a total cessation of LH release in most animals, 
whereas it was interesting to note that, in samples from the highest responding bull 
(GnRH antibody titres >50% binding. (1:1000» at 16 weeks of age no LH was 
detectable during the entire 8-hour pulse bleed. 
As with LH pulse amplitude and frequency, mean LH levels in the GnRH 
immunisation group were suppressed at peak GnRH antibody titre (-16 weekS)', but 
in addition, mean LH concentrations tended to be reduced at 66 weeks of age, 
indicating a possible long-term effect. Previous reports have shown that mean LH 
concentrations are decreased after 4-5 months in bulls (MacMillan and Hafs, .1968; 
Evans et al., 1993; Finnerty et al., 1998). The reason for the tendency for reduced 
basal and mean LH concentrations at 66 weeks in immunised bulls is unclear. 
However, the sertal bleed took place in mid-summer on a day during which the 
temperature peaked at 29°C. It is possible that neonatal GnRH immunisation, made 
the GnRH immunised bulls more susceptible to heat stress, although we are 
unaware of any previous publications on heat stress and immunocastration. 
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The lack of effect of GnRH immunisation on FSH concentrations may be due to the 
short-term nature of the elevated GnRH antibody titre, as FSH suppression by GnRH 
immunisation (Miller, Fraser and Brooks, 1998) or GnRH agonist treatment (Gong et 
al., 1995; 1996a) in cattle takes longer than suppression of LH. As discussed 
(Chapter 1), FSH release it is not dependent on short term changes in GnRH 
release. However, with long-term GnRH agonist treatment FSH concentrations did 
'fall after 4 weeks. Despite anti-GnRH titres >100/0 binding (1:1,000 dilution) lasting for 
about 10 weeks, no fall in FSH concentrations in GnRH immunised bulls was 
detected. These results, like many previous studies also report conflicting patterns of 
FSH release. For example, it has been reported that FSH release increases between 
4-16 weeks, before the onset of spermatogenesis (Lee et al., 1976; Amann and 
Schanbacher, 1983; Evans, Currie and Rawlings, 1993; Evans et al., 1995; 1996) 
and Evans, Currie and Rawlings (1993), in sheep studies, went on to report that FSH 
concentrations peaked at 20 weeks. However, McCarthy, Convey and Hafs (1979b) 
and D'Occhio et al. (1987) did not observe a change in FSH concentrations between 
4-44 and 16-40 weeks of age, respectively. Due to low frequency of blood sampling 
in this and other studies (McCarthy, Hafs and Convey, 1979; Schanbacher, 1979), 
findings may vary. Data from serial blood sampling (Finnerty, Enright and Roche, 
,1998) showed that FSH concentrations decr,eased at around 28-32 weeks, in 
agreement with previous studies (MacMillan and Hafs, 1968; Evans et al., 1995; 
1996). The current data are in contrast with these findings, showing that FSH 
increased between 28-36 weeks, before falling to lower levels thereafter. 
The lack of a GnRH immunisation effect on FSH in this trial may be due to a number 
of factors including a wide variation in FSH concentrations between bulls,' or 
inadequate GnRH antibody titres, and longevity of those titres, which again may be a 
consequence of an immature immune response (Bot and Bona, 2002). In addition, 
gonadotroph cells and pathways involved in LH synthesis, storage and release may 
be more sensitive to a reduction in GnRH stimulation compared with FSH synthesis 
and release (see McNeilly et al., 2003). 
3.4.3 Gonadal afld Accessory Gland Responses 
3.4.3.1 Testosterone profiles 
In control bulls mean plasma testosterone concentrations increased significantly with 
age (16-28 weeks), as previously reported (McCarthy, Convey and Hafs, 1979), to 
the lower physiological range seen in adult bulls (Finnerty, Enright and Roche, 1998) . 
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before finally reaching adult concentrations. The oscillating mean testosterone 
concentrations (1.5 to >11 ng/ml) reflect the pulsatile pattern of steroid release. In 
immunised bulls, mean testosterone concentrations were reduced at around 8 and 
16 weeks (following 1 st and 2nd boosters respectively) in agreement with those 
previously published (Finnerty et al., 1996), although in the current study the rise in 
testosterone at 24-28 weeks was not·· delayed. Despite the lack of GnRH antibody 
titre between 36-44 weeks immunised bulls exhibited lower testosterone levels than 
the control bulls, suggesting that even after antibody titres had fallen significantly 
there was some degree of long-term impairment in the ability to produce 
testosterone. Unfortunately, it was not possible to determine whether the testes were 
capable of responding to LH stimulation during this period since no LH serial bleeds 
were carried out. Alternatively the observations at 36-44 weeks may simply be due 
age differences relative to the acquisition of puberty. Indeed, when testosterone 
concentrations in both groups are plotted relative to age at puberty (Figure 3.15), the 
duration of the long-term effects of treatment on testosterone was reduced. However, 
the effect of GnRH immunisation was evident, as between 6-4.5 weeks prior to 
puberty testosterone was reduced (P<0.001). 
The fall in testosterone concentrations in the immunised bulls coincides with the 
previously reported fall in testosterone in control bulls between 36-58 weeks of age 
(Swanson et al., 1971; Rawlings, Hafs and Swanson, 1972; Sundby and Velie, 
1980). This pattern may be influenced by the season in which the bulls reach this age 
(Foote, Munkenbeck and Green, 1976; Stumpf et al., 1993; Finnerty, Enright and 
Roche, 1998). It is possible that during this period the testes are particularly sensitive 
to perturbations in LH output. Indeed, Rawlings et al. (1978) noted that .. the 
relationship between plasma LH and testosterone was maximal from around 9-11 
months of age. Hence this suppression of testosterone may be the result of long-term 
suppression of LH pulse amplitude at a time when the testes are maximally sensitive 
to changes in gonadotrophin concentrations. Alternatively, the smaller testes in 
immunised bulls compared with control bulls may not have been able to maintain 
testosterone concentrations. The delay in attainment of puberty also coincides with 
-
the lower testosterone concentrations between 36-44 weeks in the immunised group. 
3.4.3.2 Testicular growth 
Onset of rapid testicular growth occurred at around 16-21 weeks, slightly earlier than 
Amman and Walker (1983) witnessed. The rise in gonadotrophins at around 16 
weeks, also observed in the current trial, is believed to initiate testicular growth and 
112 
Chapter 3: GnRH Vaccination in Bull Calves 
development (McCarthy, Convey and Hafs 1979; McCarthy, Hafs and Convey, 1979; 
Amman and Walker, 1983). Previously, Evans et al. (1995) demonstrated that calves 
with highest LH level between 6-20 weeks reached puberty earlier than those with 
lower LH. Furthermore, suppression of LH between 7.5-24 weeks with oestradiol 
implants reduced testes mass. More recently, using a GnRH agonist to suppress 
gonadotrophins and testosterone, prior to rapid testicular growth, (Chandolia, Evans 
and Rawlings, 1997) testes growth rates were suppressed. The testes of treated 
calves had not caught up with those of controls by the end of the trial at week 50, 
despite a rebound effect of gonadotrophins by week 24. Thus, early gonadotrophin 
secretion, by 24 weeks of age is a critical step in the establishment and timing of 
normal testicular development in bull calves (Chandolia, Evans and Rawlings, 1997). 
In the current trial GnRH titres were sufficient to reduce LH pulse amplitude and 
mean LH concentrations causing a delay in the rise in testosterone. In agreement 
with previous studies, the rate of testicular growth also slowed significantly (P<0.02). 
By week 72, approximately 58.5 weeks after the 2nd booster injection and 48 weeks 
after the titres fell to <5% binding (1: 1000), the GnRH immunised bulls testes 
circumference was not different to the controls. Thus testes growth and development 
was significantly reduced, but increased gonadotrophin secretion from 20 weeks 
onward appears important to sustain testicular growth (see Schanbacher, 1981). 
Our results are also similar to those of Adams et al. (1993; 1996), Finnerty et al. 
(1996), Finnerty, Enright and Roche, (1998) D'Occhio, (1993), D'Occhio, Aspden and 
Trigg, (2001) in which testicular growth was reduced after pre-pubertal immunisation. 
Whereas in peri- and post-pubertal bulls, testicular atrophy following immunisation 
(Robertson, Wilson and Fraser, 1979; Adams and Adams, 1992; Cook et al., 20,00). 
After a transient suppression of testes growth in earlier studies in bulls (Adams et al., 
1993; Finnerty et al., 1996) and rams (Brown et al., 1994), the testes of GnRH 
immunised animals were eventually able to compensate for the reduction in size and 
produce normal concentrations of testosterone. The current study agrees with 
previous reports overall, however as discussed (Section 3.4.3.1), during some stages 
of development testosterone concentrations were reduced in the treated animals. 
3.4.3.3 Vesicular gland response 
As with the testes vesicular gland length was significantly affected by age in this and 
earlier studies (Rocha et al., 1994; Chandolia et al., 1997b). During the first 14 weeks 
of life, coinciding with increased LH output, fluid accumulates in the gland (Chandolia 
et al., 1997b). The rapid growth rate from 12-28 weeks in the current trial agrees with 
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previous reports of increased cellular proliferation from 16-28 weeks (Chandolia et 
al., 1997b). During this period, and up to week 36, we observed for the first time, a 
reduction in vesicular gland length in GnRH immunised bulls, which we attribute to 
the reduced testosterone between 16-20 weeks of age. We speculate that, during 
this period of transient vesicular gland growth retardation, seminal fluid f ~ u c t o s e e and 
citric acid concentrations would have been reduced, as was the case following GnRH 
immunisation in pubertal bulls (Robertson, Wilson and Fraser, 1979). After week 28 
we observed a marginally significant (P<0.09) and previously unreported fall in 
vesicular gland length followed by a plateau in vesicular gland size in control bulls, 
while vesicular gland growth in immunised bulls plateau. This apparent growth check 
is probably due to the dramatic increase in vesicular gland secretions (Mann et al., 
1967; Chandolia et al., 1997b), which are induced by increased testosterone 
concentrations at this time (Rawlings et al., 1972; Amann and Walker, 1983). 
Alternatively, the halt to vesicular gland growth may be due to testosterone negative 
feedback reducing LH secretion. However, the latter suggestion is unlikely as both 
vesicular gland weight and fructose and citric acid content are significantly correlated 
with testosterone (Mann, 1964; Macmillan and Hafs, 1969; Chandolia et al., 1997b). 
By 40 weeks of age, vesicular gland size was similar in both groups, despite 
significantly higher testosterone concentrations !n control animals from 36-44 weeks 
of age. Although testosterone concentrations were reduced in immunised bulls, they 
were still within the typical range for bulls of this age. This suggests that there may 
be a threshold testosterone level at which the vesicular gland is maximally 
stimulated. Also this indicates that the vesicular gland was able to recover much 
more quickly than the testes, following gonadotrophic deprivation. This finding agrees 
with earlier observations in bulls following GnRH immunisation (Robertson et al., 
1982; 1984), in which only small numbers of mostly dead sperm were recovered from 
each vas deferens and epididymis, but the accessory glands, were observed to be 
well developed. Vesicular gland width in our study was significantly affected by age 
however a significant reduction in vesicular gland width following GnRH immunisation 
was only evident at around 20 weeks of age. The vesicular gland at 11 weeks was 
20% of the adult ~ i d t h h and only 8 % of the adult length. Throughout the trial the 
growth phases may be divided into the "proliferation phase" 11-28 weeks and the 
"secretory growth phase" >28-72 weeks. During these phases· the percentage of 
vesicular gland growth was 66.30/0 and 33.7%, for the length, and 36.7% and 63.30/0 
for the width, respectively. 
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Several other reproductive organs including the penis, epididymis, prostate, bulbo-
urethral and vesicular glands, which are testosterone dependent for normal 
development (section 1.4.4), were examined at week 72. No effects of GnRH 
immunisation were observed on any of these accessory organs at this time, thus 
these organs were either not significantly effected by immunisation, or they were, but 
the effects were reversible. 
3.4.4 Behaviour 
The increase in testosterone concentrations at around 6 months is accompanied by a 
dramatic increase in both sexual and aggressive behaviours (McCarthy, Convey and 
Hafs, 1979). In the current trial, GnRH immunised bull calves were easier to manage 
and more docile between 22-30 weeks of age. These observations agree with those 
published by Robertson, Wilson and Fraser, (1979) and Robertson et al. (1981). 
However, a more objective study (Jago et al., 1995) reported increased mounting 
behaviour after GnRH immunisation, though these findings are likely due to a 
"rebound effect" of increased GnRH pulses and gonadotrophic output, which resulted 
in increased testosterone in the immunised animals following the fall in GnRH 
antibody titres. In contrast, more recent studies (Finnerty et al., 1996; Jago, Bass and 
Matthews, 1997; Huxsoll, Price and Adams, 1,998) observed reduced sexual and 
aggressive behaviours following GnRH immunisation in bulls. More objective bull 
behaviour observations began at 38 weeks of age in the current study, by which time 
both groups were exhibiting the full array of sexual and aggressive behaviours as 
defined by Price and Wallach, (1991 a;b;c). The fact that the behaviour of both groups 
was indistinguishable is indicative of the absence of any long-term effect on 
behaviour after GnRH immunisation. Our findings agree with previous (Jago, Bass 
. and Matthews, 1997) observations on sexual behaviour, however they are in conflict 
with antagonistic behaviours, which were still reduced at 17 months of age after pre-
pubertal GnRH immunisation. This apparent prolonged effect of immunisation (Jago, 
Bass and Matthews, 1997) may result from a third booster injection and from some 
animals having reduced testosterone at the time of behavioural assessment. The 
absen'ce of a suppression in behavioural characteristics in the current study also 
contrasts with previous work in Ireland (Finnerty et al., 1996), which reported long-
term suppressive effects on both sexual and aggressive behaviours 14 months after 
testosterone concentrations had returned to normal following GnRH immunisation in 
infant bull calves (8-10 weeks of age). The reason for such contrasting results is 
unclear, but may involve the fact that, sparring behaviour was not recognised as 
antagonistic and chin resting and Flehmen were not counted as sexual behaviours 
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(Finnerty et a/., 1996). Furthermore, assessment of behaviours from 8-11 months of 
age was carried out at pasture were animals had significantly more space than our 
housed animal study. The aforementioned reasons may also go some way to 
explaining a further conflicting observation. In the current study, the incidence of 
sexual and aggressive behaviours was similar overall, with a tendency for increased 
aggressive behaviours at 68 to 70 weeks. Whereas previously it was observed that 
1.4 times more sexual behaviour occurred than aggressive behaviour (Finnerty et a/., 
1996). 
Subsequent to GnRH immunisation, it has previously (Jago, Bass and Matthews, 
1997; Jago et a/., 1997) been reported that normal HPG function between 2-10 
months of age is not necessary for the development or latter expression of these 
behaviours. Based on the CUirent findings and previous data (Jago, Bass and 
Matthews, 1997; Jago et a/., 1997) we suggest that normal HPG function between 3 
weeks to 10 months of age is not necessary for the development or latter expression 
of these behaviours. This is in contrast to several other species including pigs and 
sheep, in which the absence of testosterone during specific periods between birth 
and puberty prevent the development of typical male behaviours (Ford and D'Occhio, 
1989). Recently, it has been suggested that exposure of bull calves to testosterone at 
an early age (neonatal or pre-natal) may be essential for the expression of normal 
reproductive behaviours in the adult bull (Inwalle and Schillo, 2002). Evidence in 
other species (Sachs and Meisel, 1988) indicates that testosterone (or it's 
oestrogenic metabolites) may organise neural substrates critical to the regulation of 
reproductive behaviour (Inwalle and Schillo, 2002). Indeed, exposure of neonatal 
male rodents to oestradiol results in prolonged/permanent reproductive s u p p r e s ~ i o n n
(Ulibarri and Yahr, 1996). Research into this area in cattle is lacking and we suggest 
that passive GnRH immunisation studies in bull calf foetuses would be a good 
approach to understanding the role of testosterone in early development on bull 
behaviours. 
3.4.3.4 Sperm quality 
Caudal epididymal·sperm volume appeared to be smaller in some of the immunised 
bulls, making sperm collection more difficult in these animals. Unfortunately, with our 
method of collection, it was not possible to obtain an accurate sperm count. 
Previously however, during periods of increased GnRH antibody titres it was 
observed that spermatogenesis was arrested or significantly reduced (Robertson et 
a/., 1982). Furthermore, while some degree of behavioural suppression was still 
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evident, most sperm collected from these bulls were dead (Robertson et al., 1982). In 
the present trial no significant difference in the numbers of live and motile sperm 
were observed between control and immunised bulls. However, control bulls tended 
to have a greater proportion (P=O.055; 92.1 vs. 86.4%) of morphologically normal 
sperm, with the majority of the abnormal sperm (9.4%) from immunised bulls 
presenting with pyroform head abnormalities. As sperm quality improves rapidly after 
puberty (Chicoteau et al., 1990), one could argue that this finding is the result of a 
delay in the attainment of puberty in GnRH immunised bulls relative to controls. This 
type of abnormality has also been observed subsequent to an interruption in 
spermatogenesis (Williams and Savage, 1925; Lagerlof, 1938, Hancock, 1959, 
Thundathil et al., 1999). However, as the motility and viability of the sperm from 
immunised bulls was unaffected by treatment and as 860/0 of sperm were 
morphologically normal, the immunised bulls at 72 weeks would be fertile (Barth and 
Oko, 1989; Thundathil et al., 1999). These data, together with previous reports 
(Robertson, Wilson and Fraser, 1979; Robertson et al., 1981; 1982), suggest that the 
recovery of spermatogenesis takes place several months after the recovery in 
testosterone concentration. This is not suppressing as the process of 
spermatogenesis takes 61 days in bulls (Johnson, 1991). The present study, for the 
first time, shows that although recovery ,of spermatogenesis occurs after 
immunisation, this recovery appears to take about 56 weeks, i.e., 20-22 weeks after 
re-establishment of typical male behaviours. 
3.4.4 Anabolic Response 
Despite the transient reductions in peripheral testosterone, there was no difference in 
growth rates between bulls. Possibly due to long periods of time during w ~ i c h h
testosterone concentrations in treated animals were similar to those in controls. 
Despite the fact that the bulls were culled about 4 weeks prior to finishing, there was 
some evidence of a beneficial effect of GnRH immunisation on carcass conformation 
in agreement with Cook et al. (2000). Rib-eye width was improved (P<0.05) in GnRH 
immunised bulls, as was the carcass conformation grades (P<0.05) allocated by an 
independent meat ~ n s p e c t o r . . These findings are in agreement with Huxs,?lI, Price and 
Adams, (1998). Hence future work should either include immunisation with a more 
responsive adjuvant or at an earlier age, or both. 
3.4.5 Future Work 
Research in the ovine foetus has shown that the HPG axis undergoes development 
and maturational changes in response to gonadotrophic stimulation. Elevated 
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gonadotrophin output during mid-gestation, is critical in normal reproductive 
development, and may be important in the attainment of puberty in the adult (Brooks, 
McNeilly and Thomas, 1995). For example, the suppression of foetal gonadotrophins 
with GnRH agonist implants can lead to reduced testes size and Sertoli cell 
populations at birth (Thomas et a/., 1994). Furthermore, testosterone exposure from 
day 30-90 in sheep induces the sex specific organisation of the GnRH neural network 
(see Robinson et a/., 2003), which results in sex differences in response to steroid 
feedback, and may also have a role in behaviour (R. Birch, personal communication). 
Maternal passive immunisation to GnRH may therefore prove useful as a non-
invasive procedure for studying the development of the foetal reproductive axis, as 
IgGs have been shown to cross the foetal-placental barrier in several species, 
including sheep (Miller, Fraser and Brooks, 1998). The bovine hypothalamic-pituitary-
gonadal axis may be sufficiently mature at birth that the removal of GnRH or 
exposure to GnRH antibodies has no permanent effect on reproductive development 
or function. However, this would require further investigation. Immunisation of the 
pregnant cow may be a useful approach for the study of hypothalamic/pituitary gland 
maturation and for investigating whether or not a window of susceptibility to GnRH 
antibodies exists. Alternatively, passive immunisation, or a combination of passive 
immunisation, followed by GnRH treatment to reduce antibody levels before active 
immunisation may prove useful future approaches, which may increase the likelihood 
of exposure of the maturing hypothalamus and pituitary gland to elevated GnRH 
antibodies, and would reduce the variability of exposure to GnRH antibodies, as 
occurs after active immunisation. 
New innovative vaccines including genetic adjuvants (Pertmer et a/., 2001; Bot ,and 
Bona, 2002) and antigen beads, with surface-conjugated or Iiposome containing 
encapsulated antigen, which stimulate Th 1 type responses (Vogel and Hem, 2003), 
and variable speed antigen delivery (Stevens, 1993) may be required for successful 
stimulation of the immature immune system. In the short term however, 'prime-boost 
GnRH vaccination (using different adjuvants or constructs in the primary and booster 
vaccines) might be advantageous (see Woodland, 2004). Such vaccines could also 
. . 
provide further benefits by reducing diseases in calves. In addition, formulation of 
diets in neonatal calves should take into account decreased feed intake associated 
with stress (Galyean, Perino and Duff, 1999). The development of calf diets, which 
enhance immune function, but protect against immune cytokine-induced catabolism 
(Cook and Pariza, 1998) may further accelerate the wide-scale adoption of this 
potentially excellent alternative to conventional castration. 
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In conclusion, the use of neonatal GnRH immunisation is currently not a practical 
management tool ,for the suppression of reproductive function in beef cattle, due to 
the reversibility of the physiological effects. A more prolonged or permanent 
suppression of reproductive function may be possible following an earlier, greater 
and more sustained elevation of antibody titres during the neonatal period, making it 
a more viable option. Repeating such a trial and giving the 1st booster earlier is 
problematic as the evidence (Finnerty et a/., 1994) suggests that a 56, rather than 28 
day interval between primary and 1 st booster is optimal. Therefore, further 
development of GnRH vaccines and protocols, and studies of performance in cattle 
are required. In the mean time, the vaccine used in this trial may be used to delay 
puberty in older calves (>28 weeks of age), or transiently suppress reproductive 
function in cattle to aid management, e.g. during periods of grazing and/or housing, 
especially with animals of the opposite sex. 
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CHAPTER 4 
THE EFFECTS OF ACTIVE IMMUNISATION AGAINST GnRH ON 
REPRODUCTIVE FUNCTION IN HEIFER CALVES 
4.1 INTRODUCTION 
Estimates from feedlots in the United States indicate that at the time of slaughter up 
to 25% of beef heifers are pregnant (Kreikemeier and Unruh, 1993). Moreover, in 
extensive range systems of northern Australia, studies report even higher rates of 
unwanted pregnancies, between 50-800/0 (Hoskinson et al., 1990). As the calf is of no 
market value, the slaughter of pregnant cattle for meat represents a major (5-100/0) 
loss of production (Bell et al., 1997). Furthermore, increased activity associated with 
recurrent oestrus increases energy expenditure (Horstman et al., 1982), heightens 
the risk of injury, and results in up to 100/0 reduction in feed conversion efficiency 
(FCE) and growth relative to steers (Johnson et al., 1988). In addition, oestrus around 
the time of slaughter also increases the incidence of dark-cutting meat (O'Brian, 
Bloss and Nicks, 1968; Young, Cundiff and Bradley, 1969; Adams et al., 1990). As a 
result, heifer calves achieve lower prices at sale than steers of similar age and 
carcass weight (Todd and Cowell, 1981; Meyer, 1987; Jeffery et al., 1997; Be" et al., 
1997). 
Traditionally, the only options available to the farmer to prevent unwanted 
pregnancies have been either surgical spaying or PGF2a injections, to abort 
pregnant heifers entering the feedlot (Johnson et a/., 1988). Flank spaying is 
" 
effective, but the resulting carcass scaring may further reduce market price (Jeffery et 
al., 1997). While vaginally castrated heifers escape such scars, the operation is "done 
blind" and residlJal ovarian tissue, inadvertently left in the animal, is enough to 
maintain oestrus and fertility (Adams et al., 1990). Hence these approaches are 
inefficient, expensive (Johnson eta/., 1988) and increase the risk of morbidity and 
rportality (Johnson et a/., 1988; Trigg, 1994). They also compromise animal welfare 
and good ethical farming practice. 
Another method is the separation of heifers from bulls (Rudder and Corlis, 1974; 
Jeffrey et al., 1997), but this is often impractical. Once pregnant, heifers could be held 
back and allowed to calve, however, this is not usually an economically viable option 
as it may take up to a year after calving to recover lost body condition (Jeffrey et al., 
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1997). In addition to unwanted pregnancies, recurrent oestrus behaviour in feedlot 
heifers has been blamed for compromising carcass quantity and quality because of 
reduced growth (8ell et al., 1997) and increased injuries associated with elevated 
activity. 
Numerous attempts have been ~ a d e e to prevent oestrus and pregnancy in the bovine 
female. For example, feeding synthetic progestagen, to prevent oestrus (81055 et al., 
1966; Bell et al., 1997), immunisation against ovarian steroids such as o e s t r a d i o l - 1 7 ~ ~
to prevent oestrus (Martin et al., 1978; Martensz, 1980; Wise and Ferrell, 1984; 
Hoskinson et al., 1990), immunisation against PGF2a (Scaramuzzi and Baird, 1976; 
Chang, McFarland and Reeves, 1987; Crowe, Enright and Roche, 1995), 
immunisation against LH (sheep: Schanbacher, 1985; Roberts and Reeves, 1989; 
cattle: De Silva et al., 1986; Grieger and Reeves, 1988; 1990; Johnson et al., 1988; 
Grieger et al., 1990; Roberts et al., 1990) and human chorionic gonadotrophin 
(Johnson et al., 1988). In addition, passive immunisation against eCG (Yadav et al., 
1986) has also been investigated. Despite Johnson et al. (1988) reporting that, 
immunisation against an LH-ovalbumin conjugate produced better results than a 
GnRH-ovalbumin conjugate, using three different adjuvants, GnRH is the preferred 
approach. This is on account of the role of GnRH in driving reproductive function and 
its conservation between species. Hence it is widely accepted that GnRH would be 
the most appropriate hormone to neutralise (8ell et al., 1997). 
GnRH immunisation in the post-pubertal bovine female induces a hypogonadotrophic 
state (Prendiville et al., 1996), which in turn suppresses recurrent ovarian follicular 
waves (Adams and Adams, 1990; Prendiville et al., 1995a; Crowe et al., 2001a; 
Roche and Crowe, 2004) and induces ovarian (Johnson et al., 1988; Adams and 
Adams, 1990) and uterine atrophy (Adams and Adams, 1990). GnRH immunisation in 
the young heifer' delays the onset of puberty (Wetteman and Castree, 1988; 
D'Occhio, 1993; Sejrsen, Enright and Prendiville, 1994; Prendiville et al., 1995b), 
while in the post-pubertal animal oestrus and ovulation are inhibited and pregnancy 
~ a t e s s reduced (Hoskinson et al., 1990; Vizcarra and Wettemann, 1994; 8ell et al., 
1997; Jeffery et al., 1997; Sosa et al., 2000). These effects are only temporary, 
typically lasting 6-8 months (D'Occhio, 1993). Reversibility ?f immunocastration may 
be considered advantageous under certain circumstances. However, it is not 
desirable in production systems where cull females have to be retained for extended 
periods, often in mixed herds (Hoskinson et al., 1990), before they reach a 
marketable condition (D'Occhio, 1993). Repeated booster vaccinations may be given 
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to extend the period of immunocastration, however, this option is seldom viable due 
to the requirement for increased vaccine costs and mustering. Hence, the reversibility 
of immunocastration is largely responsible for the lack of wide-scale adoption of this 
technology. 
Recent studies in ewes, however, have reported that following GnRH immunisation in 
the neonatal or pre-pubertal period, a permanent suppression of reproductive 
function may be achieved in -800/0 of animals (Brown et al., 1995; Clarke et al., 
1998). Presumably, this is because exposure of the immature median eminence (ME) 
/pituitary gland to GnRH antibodies may impair normal maturation of the 
hypothalamic/pituitary unit during a critical period of development (Clarke et al., 
1998). Furthermore, evidence in sheep suggests that these effects and the degree of 
reproductive suppression-may be more pronounced in the female, than in the male 
(Brown et al., 1995; Clarke et al., 1998). 
The objective of this study (which ran concomitantly with the study in bull calves 
described in Chapter 3) was to investigate the effects of neonatal immunisation 
against GnRH in female calves and the longevity of these effects. Using a newly 
developed GnRH vaccine, combined with an early immunisation (14-19 days of age) 
protocol, we investigated the effects of GnRH vaccination on reproductive function . 
. 4.2 MATERIALS AND METHODS 
4.2.1 Experimental Animals 
The experimental animals used in the current study consisted of 18 beef cross heifer 
calves. They were monitored between 2-56 weeks of age; with additional, LH pulse 
bleeds at 63 and 65 weeks of age. Animals were weighed at 10-14 day intervals 
(typically at the time of blood sample collection). The management of animals was as 
described in Chapter 2. 
4.2.2 Experimental Protocol 
~ h e e experimental protocol and justification of protocol has been described in section 
3.2.2. The experimental period ran from May 2000 to August 2001". The heifers were 
kept as described in Chapter 2. Where possible, all p r o c e d u ~ e s s on heifer calves were 
carried out concomitantly with those of the bull calves (see Chapter 3). However, in 
contrast to the experiment described in Chapter 3, the animals in this trial were re-
used in an experiment described in Chapter 6, subsequently they were culled in 
March 2002. 
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4.2.2.1 Immunisation 
Vaccine was administered (single s.c. injection) to the brisket area in nine calves. 
Primary, first and second booster injections were administered at 16 ± 0.5 (2ml), 44 ± 
0.5 (2ml) and 95 ± 0.9 (1.7ml) days of age respectively. Nine control animals received 
saline on the same days. For vaccine details see Section 3.2.2.1. 
4.2.2.1.1 Vaccination site assessment 
The granuloma (swelling at the injection site) was measured using callipers on days: 
1, 3, 7, 10 and 14 following each vaccination. The vaccination site results are 
presented in Chapter 3. 
4.2.2.2 Blood sampling 
Blood samples were collected by venepuncture every 10-14 days to measure GnRH 
antibody titres, FSH concentrations and every 7 days from week 35-55 to measure 
progesterone and the display of ~ e s t r o u s s cycles. To characterise peripheral LH 
concentrations, serial bleeds (every 15 min for Bh; via cannulae) were conducted at 
the following ages (mean ± s.e.m.): O.B ± 0.01, 3.7 ± 0.0, 6.7 ± 0.03, 11.1 ± 0.03, 14.4 
± 0.03 and 14.B ± 0.03 months. These ages were rounded up or down to the nearest 
week for ease of presentation to give: 4, 16, 29, 4B, 62 and 64 weeks of age. The 
serial bleeds at 62 and 64 weeks of age were carried out during a synchronised 
follicular phase and subsequent luteal phase, respectively. Oestrous cycles were 
synchronised by administering two PG injections, 11 days apart. The follicular and 
luteal phase bleeds took place 1 and 15 days after the 2nd PG injection, respectively. 
4.2.2.3 Real-time ultrasound scanning 
Ovarian follicular development was measured monthly from 11.5 to 57 weeks of age 
using real-time ultrasonography (Figure 5.1). Following rectal palpation of the ovaries, 
trans rectal scanning was conducted, in multiple planes, in order to count antral 
follicle numbers. Counts were made of medium-sized (4-7.9mm diameter) and large 
( ~ ~ Bmm ) ovarian follicles. 
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Figure 4.1 Dominant follicle measurement using ultrasound scanning. The fluid filled 
antral cavity is non-echogenic and appears black (Pierson and Ginther, 1984). The 
image below contains one large dominant follicle and several smaller subordinate 
follicles, however the exact number of smaller follicles is difficult to decipher in this 
still image. The diameter of the large follicle is displayed as the distance between (+) 
markers. 
4.2.2.4 Behaviour assessment 
To support the progesterone (onset of cyclicity) data and to examine heat intensity 
oestrous behaviour was monitored for 20 min twice daily, between 52-56 weeks of 
age (following turnout), from a distance using field glasses. Due to practical 
limitations and foot and mouth disease prevention measures, more thorough 
monitoring of oestrus was not possible. 
4.2.2.5 Post-mortem 
The heifers used in this study were culled at 22 months of age, some 82 weeks after 
the final boosJer GnRH vaccination and 62 weeks after GnRH antibody titres were 
last raised above 5% binding at 1 in 1,000. The carcass results are presented in this 
study, however the post mortem results relating to pregnancy are presented in 
Chapter 6 following artificial insemination (A. I. ), which was carried out as part of the 
Chapter 6 study protocol. 
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4.2.2.5. 1 Carcass characteristics 
The carcass of each heifer was issued with a fat score and conformation grade by an 
independent MLC meat inspector. 
4.2.2.6 Statistical analyses 
Prior to any analysis a general ANOVA was performed .. on the data and the 
distribution of the data was checked on residual plots. This was carried out to 
determine the data distribution status, Le. normal or non-normal distribution. Non-
normally distributed data were log transformed. Where possible, log transformation 
(In) of the data was avoided. 
MUNRO@, a data analysis program (developed by Dr. P. L. Taylor, Edinburgh, 1987), 
was used to identify LH p ~ l s e s s and calculate LH mean and basal concentrations and 
pulse frequency and amplitude (see appendix III for calibration details). The resulting 
statistics were analysed using Genstat 6.1, split-plot analysis of variance with 
repeated measures. Degrees of freedom were adjusted for the Greenhouse-Geisser 
epsilon effect (see 3.2.3 for details). In addition, an orthogonal contrast (independent 
comparison) was carried out on the post-pubertal (follicular and luteal phase) data 
within the LH analysis. This enabled the comparison of both pre- and post-pubertal 
follicular and luteal phase LH output. 
GnRH antibody titres at 1:1,000 dilutions were also analysed using Genstat 6.1 
(ANOVA: Lawes Agricultural Trust, 2001, IACR Rothamsted) split-plot analysis of 
variance with repeated measures. Degrees of freedom were adjusted for the GGE 
effect. 
Follicle counts were analysed in Genstat 6.1 using generalised linear regression 
analysis with Poisson distribution and logarithmic link function. Poisson analysis was 
used because low numbers of large follicles resulted in a skewed distribution of data. 
This analysis program does not provide standard errors of the differences or means. 
Poisson analysis of medium-sized follicles from high (n=3) and low (n=3) GnRH titre 
animals was ~ a r r i e d d out to compare the physiological response following extremes of 
immune response to vaccinations. No medium response data is presented as the 
three remaining animals, which exhibited intermediary GnRH antibody titres were 
judged too variable. in their immune responses, Le., magnitude and longevity of 
elevated GnRH antibody titres. 
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FSH data were log transformed (In) before analysis, to normalise distribution. 
Subsequently, FSH was analysed using split-plot analysis with repeated measures. 
Degrees of freedom were adjusted for the GGE effect. Carcass conformation and fat 
grades were analysed using Chi squared test in Microsoft Excel. All other analysis 
was carried out using Genstat 6.1, ANOVA. 
Where data are transformed to a logarithmic scale to normalise the distribution (FSH) 
of data, the textual description and statistical significance are based on transformed 
data. However, for ease of presentation, especially for presenting standard errors, the 
tables and figures will display the unadjusted data unless otherwise stated. 
4.3 RESULTS 
4.3.1 Live weights and Growth Rates 
Age had a significant effect (P<0.001) upon live weight. The slope of the regression 
for live weight on age (Figure 4.2) indicates an average overall growth rate of 5.66kg 
per week i.e., daily growth of 0.79 kg in control heifers and 0.78 kg in immunised 
heifers (Figure 4.2). These growth rates were not significantly different (P>0.05). The 
mean (± s.e.m.) live weight of both treatment groups of heifers, at 6 ages throughout 
the trial is presented in Table 4.1. 
Figure 4.2. The regreSSion of weight on age in heifers (n=18). The equation of this 
regression line is y = 5.66x + 24.30 (r2 = 0.97). Live weight significantly (P<0.001) 
increased with age. 
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Table 4.1 Live weights (mean ± s.e.m.) of GnRH immunised (n=9) and control (n=9) 
heifers at six ages taken around the time of LH serial bleeds. Immunisation against 
GnRH had no significant (P>0.05) effect on live weight. 
Age Immunised Control ., Overall Mean ± s.e.m. Mean ± s.e.m. Mean ± s.e.m. (weeks) (n=9) (n=9) (n=18) 
4 55.1 (1.9) 56.2 (2.1) 55.6 (1.4) 
16 109.7 (3.4) 115.4 (4.3) 112.6 (2.3) 
29 181.4 (5.6) 192.6 (5.2) 187.0 (4.0) 
48 292.2 (9.0) 294.0 (6.5) 293.1 (5.4) 
63 382.6 (10.7) 395.3 (7.0) 388.9 (6.4) 
65 392.7 (10.2) 405.4 (6.3) 399.1 (5.9) 
4.3.2 Immune response to GnRH vaccine 
4.3.2.1 Injection site response 
The injection site analysis, measured as, the volume of subcutaneous swelling was 
significant (P<0.001), when compared to the response site in control animals where 
there was no response. The response to 2nd booster vaccine was of greater 
magnitude (see Chapter 3; Figure 3.4). 
4.3.2.2 Antibody response 
Antibody titre responses to the primary GnRH vaccination were low and short-lived, 
whereas responses to the 1 st and 2nd booster vaccinations resulted in significant 
(P<0.001) antibody titres (peak: 370/0 ± 4.6 at 1:1,000 dilution) that persisted >15% 
binding for 3.5 weeks. A significant (P=0.002) gender/time difference was seen 
b ~ t w e e n n bulls and heifers. In heifers a further immune response (>.5%) at 23 weeks 
(peak: 20.7% ± 7.8), and lasting 12 weeks, was observed (Figure 4.3). Mean control 
heifer antibody titre was <0.5% binding at 1 in 1,000 dilution. . 
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Figure 4.3 Mean (± s.e.m.) GnRH antibody titre (1:1,000 dilution) profiles over time 
for GnRH immunised (n=9) heifers and GnRH immunised bulls (n=9). Black arrows 
indicate approximate time of vaccination at 2, 6 and 13 weeks of age. Although 
GnRH antibody titres tended to increase (P=0.17) following the primary immunisation, 
significant (P<0.001) increases occurred after the booster injections. A further 
significant (P<0.001) increase in GnRH antibody titres was observed in the heifers at 
-23 weeks of age. This final increase was significantly (P<0.002) different from the 
GnRH antibody titres seen in the bulls at this time. Although declining, small, but 
significant (P<0.05) antibody titres perSisted to the end of the sampling period. 
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4.3.3 Reproductive Hormones 
Results of the analysis of reproductive hormones will be presented in 4 sections. The 
first will describe 4 LH parameters, the second will refer to FSH concentrations and 
the third describes oestradiol concentrations on LH serial bleed days during the 
synchronised follicular phase at 63 weeks and the subsequent luteal phase at 65 
weeks. Finally, an example of progesterone monitoring with a view to determination 
of onset of oes1!0us cyclicity is presented. The decision to measure oestradiol was 
taken when evidence of long-term disruption of LH pulse frequency was discovered 
(for details see section 4.3.4.1.1 and Figure 4.4). 
4.3.3.1 Luteinising hormone 
Four parameters of LH output were investigated and are defined in Chapter 3; 
Table 3.1. 
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4.3.3.1.1 LH pulse frequency 
Mean number of LH pulses at 6 time-points is illustrated in Figure 4.6. LH pulse 
frequency was significantly affected by age (P<0.001). An increase (P<0.001) in LH 
pulse frequency occurred at 11 months in all heifers (about one month prior to 
puberty, as identified by progesterone monitoring). More specifically, following 
puberty (at approximately 12-13 months of age) LH pulse frequency was reduced 
(P<0.001) relative to that observed prior to puberty «12 months). Overall, GnRH 
immunisation did not significantly affect LH pulse frequency (P=0.15). However, post-
puberty, during the follicular phase at 63 weeks of age, immunised heifers showed 
marginally increased pulse frequency (P=O.06), while in the luteal phase, at 65 weeks 
of age, LH pulse frequency tended to be reduced (P=O.06) compared to LH pulse 
frequency in control heifers. 
Figure 4.4 LH pulse frequency in GnRH immunised and control heifers. Standard 
error of the differences (s.e.d.) of means was 0.72, 0.44, and 1.01 for time, status and 
time/treatment, respectively. 
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4.3.3.1.2 LH pulse amplitude 
Mean LH pulse amplitude at six time pOints are illustrated in Figure 4.7. The effect of 
age on LH pulse amplitude was significant (P<0.05), with higher LH pulse amplitude 
at 16, 29 and 48 weeks of age and lower LH pulse amplitude in the neonatal and 
post-pubertal periods. GnRH immunisation did affect (P<0.05) LH pulse amplitude 
over the entire trial. Although there was no significant time/treatment interaction 
(P=0.26), the effects of immunisation are most pronounced at 16 weeks of age. 
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Figure 4.5 Mean LH pulse amplitude in GnRH immunised and control heifers. 
Standard error of the differences (s.e.d.) of means was 0.19,0.13, and 0.27 for time, 
status and time/treatment, respectively. 
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4.3.3.1.3 Basal LH 
Basal LH concentrations were significantly (P<0.005) related to age of the heifers 
(see Figure 4.8.). However, effects of treatment overall were not significant (P=0.13). 
Furthermore, despite an apparent (see Figure 4.6), time/treatment interaction the 
effect of immunisation was not statistically significant (P=O.14). 
Figure 4.6 Basal LH levels in GnRH immunised and control heifers. Standard error of 
the differences of means (s.e.d.) was 0.14, 0.08 and 0.2 for time, status and 
time/treatment, respectively. 
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4.3.3.1.4 Mean LH concentration 
Mean plasma LH concentrations in GnRH immunised and control heifers are 
illustrated in Figure 4.7. Age had a significant (P<O.0001) effect on mean LH 
concentrations. Overall GnRH immunisation did not significantly reduce LH 
concentrations (P=0.1). There was a time/treatment interaction, which approached 
significance (P=0.067) such that LH concentrations appear reduced at 16 weeks of 
age in vaccinated animals, when GnRH antibody levels peaked. 
Figures 4.7 Mean LH concentrations in GnRH immunised and control heifers. 
Standard error of the differences (s.e.d.) of means was 0.13,0.1,0.19 and 0.19 for 
time, status and time/status, respectively. 
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Mean serum FSH concentrations in both groups are presented in Figure 4.8. FSH 
concentrations were significantly affected by age (P<0.005), with relatively high FSH 
concentrations between 4-16 weeks (peak: 8 weeks), lower FSH concentrations 
between 18-28 weeks and low FSH concentrations from 28 weeks of age. However, 
GnRH immunisation had no overall effect (P=0.78) on FSH levels and there was no 
time/treatment interaction (P=0.62). 
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Figure 4.8 Mean (± s.e.m.) serum FSH concentrations in GnRH immunised (n=9) 
and control (n=9) heifers. 
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4.3.3.3 Plasma oestradiol 
Follicular and luteal phase plasma oestradiol concentrations in GnRH immunised and 
control heifers are illustrated in Figure 4.9. Oestradiol concentrations were 
significantly higher (P<O.001) during the follicular phase relative to the luteal phase. 
GnRH immunisation had no significant (P=O.53) effect on either follicular or luteal 
phase circulating oestradiol concentrations. 
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Figure 4.9 Plasma oestradiol concentrations in GnRH immunised (n=9) and control 
heifers (n=9) during a synchronised follicular phase (on the day of LH serial bleed at 
63 weeks of age) and subsequent luteal phase (on the day of serial LH bleed at 65 
weeks of age). 
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Plasma progesterone monitoring was used to determine the onset of oestrous cycles 
and hence, puberty (see Figure 4.10). Age at puberty was not affected by 
immunisation, with control (n=9) and immunised heifers (n=9) attaining puberty at 53 
± 0.6 (mean ± s.e.m.) and 50 ± 2.6 weeks of age, respectively. Age at puberty was 
further confirmed by monitoring oestrous behaviour. Precocious puberty was 
observed in a single immunised heifer (see Figure 4.11). 
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Figure 4.10 Typical example of progesterone profiles indicating the onset of 
oestrous cycles in GnRH immunised (n=2) and control (n=2) heifers. 
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Figure 4.11 Peripheral progesterone concentrations in a heifer exhibiting precocious 
puberty relative to her 17 herd mates. 
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4.3.4 Ovarian follicular development 
4.3.4.1 Medium-size follicle counts 
The number of medium-sized (4-7.9mm) follicles in GnRH immunised and control 
heifers are illustrated in Figure 4.12. Follicle counts varied between individual heifers 
(P<0.001) and with age (P<0.001). Overall, vaccination did not significantly affect 
follicle numbers (P=0.19). However, a time/treatment interaction was seen, with 
GnRH immunised heifers exhibiting significantly fewer (P<0.001) medium-sized 
follicles at 12, 16 and 21 weeks (Figure 4.12.) of age. Thereafter, at 30 weeks, 
immunised heifers had more medium-sized follicles than controls, but by 54 weeks 
(puberty) the follicle counts in both groups both peaked with a similar number. 
Figure 4.12 Mean number of medium-sized (4-7.9mm) follicles, in GnRH 
immunised and control heifers from 12-57 weeks of age. 
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4.3.4.1.1 High and low antibody titre heifers and medium-sized follicles 
Peak GnRH antibody titres (mean ± s.e.m.) at 16 weeks of age in low and high 
antibody titre· groups were 11.2-± 2.30/0 and 70.7 ± 8.1% (binding at 1 in 1, 000 
dilution), respectively. Mean (± s.e.m) number of medium-sized follicles in high (n=3) 
and low (n = 3) antibody titre heifers are shown in Table 4.2. High titre heifers had 
significantly reduced follicle numbers at 12, (P<0.05), 16, and 57 weeks of age 
(P<0.001) relative to Low antibody tite heifers. 
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Table 4.2 The Medium-sized follicle number (mean ± s.e.m) in high (n=3) and low 
(n=3) GnRH antibody titre (AbT) heifers and control (n=9) heifers. 
Age Follicle number Follicle number Follicle number (mean ± s.e.m.) (mean ± s.e.m.) (mean ± s.e.m.) 
weeks High AbT heifers Low AbT heifers Control heifers 
.' 
12 0.7±0.7 2.0±0.6 5.3±1.1 
16 0 3.7±2.0 4.8±1.4 
21 0.3±0.3 0.7±0.7 4.3 ± 1.6 
30 3.0±1.5 5.7±2.3 3.8 ± 1.4 
50 4.3±0.9 4.67 ±2.33 3.8±1.1 
54 5.7±2.2 6.3± 1.2 5.9 ± 1.6 
57 0.3±0.3 8.0±2.9 3.2 ± 1.2 
4.3.4..2 Large follicles 
The number of large follicles (:2:8mm) significantly increased (P<0.01) with 
approaching puberty (see Figure 4.13). However, GnRH immunisation had no affect 
(P=0.3) on the number of large follicles and the number of large follicles did not differ 
(P=0.26) between individuals. 
Figure 4.13 Mean number of large follicles in GnRH immunised and control heifers. 
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4.3.5 Anabolic Response 
4.3.5.1 Carcass conformation 
Table 4.3 Shows carcass conformation and fat grades in control (n=9) and GnRH 
immunised (n=9) heifers, respectively. GnRH immunisation significantly (P<0.05) 
improved carcass c l a s s i f i c a t i o n ~ ~ but not fat grades (P>0.05).-· 
Table 4.3 Carcass and Fat classification in control (n=9) and treated (n=9) heifers. 
Conformation grade Very Good Good Average/Good Average/poor 
Control heifers 0 1 8 0 
Immunised heifers 
-
0 4 5 0 
Fat Grade 3H 4L 4H 5L 
Control heifers 2 2 3 2 
Immunised heifers 0 3 5 1 
4.4 DISCUSSION 
The present study has provided evidence to show that active immunisation against 
GnRH in neonatal heifers (at 2-3 weeks of age) did not permanently impair 
reproductive function. This is in contrast to findings in similar studies in sheep and 
Zebu bulls (Brown et a/., 1994; 1995; Clarke et a/., 1998; O'Occhio, Aspden and 
Trigg, 2001). However, GnRH immunisation in the current study did result in a 
temporary suppression of reproductive function. This is in agreement with a 
concomitant study in neonatal bull calves (Chapter 3) and previous reports in bulls 
(Robertson et a/., 1982; Jeffcoate, Lucas and Crighton, 1982), heifers (Wetteman and 
Castree, 1988; Prendiville et a/., 1995a; Prendiville et a/., 1996) and sheep (Keeling 
and Crighton, 1984). In the current study, transient effects of GnRH immunisation 
were evident through disruption of pituitary gland function (reduction of LH pulse 
amplitude and mean LH concentrations), and a reduction in medium-sized follicles. 
The majority of these changes occurred simultaneous to increased GnRH antibody 
titres, although there was some limited evidence of long-term influence of this 
treatment, i.e., reduced luteal phase LH pulse frequency and improved carcass 
conformation. However, in agreement with other researchers (O'Occhio et a/., 1992; 
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Bell et al., 1997), there was no delay in attainment of puberty, no compromise to 
conception rate and early foetal development (data presented in Chapter 6) following 
fixed-time insemination. 
4.4.1 GnRH Immune Response 
The GnRH vaccine successfully induced significant GnRH antibody titres in all 
vaccinated animals. At a 1: 1,000 dilution, mean peak antibody titre in heifers was 
370/0. This antibody response was similar to those reported by other researchers 
(Johnson et al., 1988; Adams and Adams, 1990) and based on previous reports 
(Fraser, 1980; Robertson et al., 1982; Johnson et al., 1988; Adams and Adams, 
1990; Prendiville et al., 1995a; Adams, Adams and Sakurai, 1996) should be 
sufficient to inhibit reproductive function, i.e. 15-20 % binding (1 in 1, 000; Johnson et 
al., 1988). However, caution should be used when making antibody titre comparisons 
as due to variations between assays, such comparisons are typically inaccurate and 
may be misleading. The time at which GnRH antibody titres reached critical threshold 
levels required for the inhibition of typical reproductive development (14-17 weeks 
and 24 weeks), may have missed the specific window of time during which the 
hypothalamic (median eminence; ME))/pituitary gland are maximally susceptible to 
GnRH antibodies. Sub-threshold antibody titres may indeed be responsible for the 
limited long-term disruption to LH pulse frequency (or negative feedback response of 
the pituitary gland). However, this .disruption was insufficient to suppress reproductive 
function, or significantly compromise fertility. Although heifers appeared to achieve 
higher antibody peak titres, compared with bulls (Chapter 3), mean peak antibody 
titres tended to show reduced longevity and increased variability, wit.h 4 out of 9 
heifer calves showing peak titres <30%. Of these animals, titres peaked after the 2nd 
booster, at 11.5, 15.0, 4.0 and 7.00/0 binding (1:1,000). Similar, "poor responders" 
were reported by Bell et al. (1997) after GnRH immunisation in heifers. The response 
to primary vaccination was small and short-lived, as occurred in the bulls (Robertson, 
Wilson and Fraser, 1979; Robertson et al., 1981; 1982; 1984) and other stUdies in 
heifers (Johnson et al., 1988; Adams and Adams, 1990; Prendiville et al., 1995a; 
• Crowe et al., 2001 b). As with the neonatal bulls, and the majority of other studies in 
heifers (Johnson et al., 1988; Crowe et al., 2001b), the response to subsequent 
GnRH booster injections (1 st and 2nd) was significantly g r e ~ ; l t e r . .
By 30-34 weeks after the primary vaccination antibodies had fallen to low levels in all 
vaccinated cattle (Chapters 3 and 4), but remained detectable and Significantly 
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(P<O.05) elevated, relative to control animals for over one year. Finnerty et al. (1996), 
reported similar findings. There was one exception, which is discussed later. 
The large degree of variation in immune response following GnRH immunisation in 
the newborn calf may have resulted from maternally derived antibodies, which can be 
very wide ranging and titres in calves can persist for several months after birth 
(Literature review). Maternally derived antibodies to bovine herpes virus-1 (BHV1) 
may have blocked or enhanced the immune response to the GnRH-gD subunit BHV1 
conjugate in the current experiment even after 2 booster vaccinations. A recent 
comprehensive study on vaccine development in calves acknowledged that 
designing and implementing a successful calf vaccination program is difficult (Fulton 
et al., 2004). Therefore future active immunisation studies should measure maternal 
antibodies carefully and the affinity of antibodies for the vaccine antigen. However, in 
the cattle studied herein, qualitative and quantitative information on the dams 
immune status, colostrum BHV1 antibody content, calf intake and absorption is 
lacking. As is information on other. variables, which are known to suppress immune 
function such as, calf stress during and after gestation, premature birth and illness 
prior to arrival at the University farm (Eskola and Kyhty, 1998; Tuchscherer et al., 
2002). 
1.4.1.1 GnRH antibody titre rebound or autoimmunity 
In an earlier study of 3-4 year old ewes, previously immunised against GnRH as 
neonatal lambs (Brown et al., 1995) and with undetectable antibody titres, Clarke et 
al. (1998) reported that GnRH antibodies returned following attempts to prime the 
pituitary gland with repeated GnRH injections. Thus exogenous GnRH induced an 
immune response. We believe that the additional significant elevation (P<0.002) in 
GnRH antibody titre at around 23 weeks (Figure 4.3) in this study, in the absence of 
an additional immunisation is a novel observation, possibly caused by a similar 
mechanism. The cause of the additional increase in GnRH titres in the present study 
is unclear, but it may be a response to increasing endogenous GnRH at around 20-
22 weeks of age. However, this speculative suggestion does not explain how 
endogenous GnRH, which due to size is poorly antigenic (Hoskinson et al., 1990; see 
Meloen, 1995), induced such a response. One possible explanation is that the 
cleavage of GnRH from GnRH prO-hormone (Seeburg and Adelman, 1984) is 
disrupted by neonatal immunisation and the subsequent release of the large 
precursor molecule into the hypophyseal portal system may have induced significant 
antibody titre. Damage to the axons of the GnRH neurones following immunisation, 
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as described in boars (Molenaar et al., 1993), may have resulted in leakage of pro-
GnRH into the portal blood. Unfortunately. the occurrence of hypothalamic lesions in 
the current trial was not confirmed, due to restrictions related to SSE. Furthermore, if 
increasing GnRH output at around 23 weeks stimulated an immune response it is not 
clear why a further immune response was not seen at about 48 weeks of age. At this 
time, < 50 days before puberty, in our study, as with previous studies (see Kinder et 
al., 1995), LH pulse frequency peaked, indicating increased GnRH pulse frequency 
(Clarke, 2002). In the previous study in pigs (Molenaar et al., 1993), antibody titres 
were still elevated at slaughter when the hypothalami were examined and lesions 
discovered. It is therefore conceivable that ME damage was caused by the peak 
antibody titres and, through axon leakage and/or infiltration of immune cells (a cellular 
response) into axons, and the GnRH pro-hormone complex induced an additional 
immune response. Five months later, at the time of increased GnRH pulse frequency 
prior to puberty, it is possible that earlier ME damage had been repaired and/or new 
neural networks established in the maturing hypothalamus. Subsequently, the 
increased release of the cleaved GnRH decapeptide was not able to induce a further 
antibody response, which would explain the lack of an "autoimmune response" at 48 
weeks. However, against this argument, in ewes, even after years of undetectable 
titres there was an increase in GnRH antibody titres after GnRH priming. It should be 
noted that an increase in the immune response to increased GnRH pulse frequency 
at around 23 weeks occurred after a period of elevated GnRH antibody titres, but did 
not affect LH pulse frequency. In ewes, however, GnRH release was significantly 
reduced in the long-term relative to controls (Clarke et al., 1998), subsequently 
relatively high levels of exogenous GnRH, which itself stimulates several cytokines 
(Dixit et al., 2003; Tanriverdi et al., 2003), were presented to the i m m ~ n e e system 
(Clarke et al., 1998). In other words, long-term exposure of GnRH to the immune 
system in heifers may have led to a reduced immune response to the hapten over 
time. 
The autoimmune suggestion is however, speculative and there is no direct evidence 
. presented to support the argument. It is possible that there was no autoimmune 
response and the titre rebound was caused by other factors. Although, we are unable 
to explain this phenomenon, an alternative suggestion. is that a proliferation in 
idiotypes and anti-idiotypes, in response to the peak antibody titres, stimulated a 
rebound in titre at about 23 weeks. Idiotypes are often referred to as 'internal images 
of the antigen', (Hay and Thanavala, 1984), which can interact with free antibody and 
lymphocytes to produce anti-idiotypes. Anti-idiotypes are antibodies raised against 
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the antigen binding V-region (idiotype) of an antibody, and some anti-idiotypes have 
a 3-dimensional structure similar to the original immunogen (GnRH-BHV1 in this 
case). Hence, anti-idiotypes are likely to be immunogenic. Idiotype antibodies can be 
formed in the course of a normal immune response and have been shown to have 
both stimulatory and suppressive effects on immune responses (Keeling and Cighton, 
1984; Wigzel, 1987). Furthermore, this suggestion might also explain the absence of 
a further response to increased endogenous GnRH prior to puberty, as titres had not 
recently been elevated at this time. 
Interestingly, this suspected autoimmune response or antibody titre rebound resulted 
in mean (± s.e.m.) antibody titres of 51 ± 2.7% (binding at 1:1,000) in 3/9 immunised 
heifers. A less dramatic response (>50/0 binding 1 to 1,000) occurred in 2 of the 
remaining 6 heifers and -only 1 bull in 9. Differential timing of increased endogenous 
GnRH relative to the 2nd booster vaccination between sexes may influence the 
apparent sex difference in 'titre rebound'. Indeed, LH output in response to increased 
pulsatile GnRH, increased at 16-20 weeks of age in bulls (Rodrigez and Wise, 1989; 
McCarthy, Convey and Hafs, 1979), -16 weeks in ewes (Claypool and Foster, 1990) 
and 12-16 weeks of age in heifers (Swanson and McCarthy, 1978; Schillo et al., 
1982; Dodson et al., 1988). 
Responsiveness of the HPU between sexes to gonadal steroids may also be 
involved. Claypool and Foster (1990) reported age differences between ewes and 
rams in hypothalamic responsiveness to exogenous oestradiol. Thus, differences in 
the magnitude or timing of the GnRH pulse frequency increase may result from 
gender differential stimulation of the immune system. Alternatively, the lack of titre 
rebound, or at least its amplitude, in bulls may reflect gender differences in the 
immune response as occurs in other species (Martin, 2000) following immune 
challenges. These gender differences may be the result of androgen suppression of 
the thymus in males, or sex specific differential steroid, or GnRH, enhancement of 
immune function (Jacobson, 2000) . 
. The individual variation in immune responses in this study may be influenced further 
by individual maturational changes in the immune system. Alternatively, it may 
suggest that the female bovine immune system may be more responsive to the 
GnRH vaccination, and their humoral responses more responsive to changes in 
GnRH levels than males. Indeed, sexual dimorphism of the immune system has been 
reported in rodents and humans, with greater immune responses in females (Martin, 
2000; Tanriverdi et al., 2003). Therefore, it may be that both bulls and heifers 
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produce similar degrees of increased GnRH at 16-22 weeks, but due to a more 
responsive antibody, and possibly also cell mediated, immune system, the greater 
response is observed in heifers. Furthermore, the reduced titre rebound in bulls may 
have resulted because prior to this response antibody titres tended to be higher in 
bulls than in heifer (Figure 4.3). Interestingly, compared to males, females display a 
striking increased incidence of autoimmune reactions (Tanriyerdi et al., 2003). 
As with a previous study by Prendiville et al. (1996) the animals in our trial were 
divided into groups of either low (11.2 ± 2.30/0 binding at 1 :1,000; n = 3) or high GnRH 
antibody titres (70.7 ± 8.1 % binding at 1,1000; n = 3). Because of the small animal 
numbers in these groups, information on effects of antibody titre on gonadotrophin 
secretion is limited. However, some reference to comparisons between the high and 
low antibody titre groups will be made throughout the discussion. 
4.4.2 Gonadotrophic Drive 
4.4.2.1 LH 
Reports of an episodic pattern of LH release developing during the first month of life 
in the heifer (Schams et al., 1981; Dodson et al., 1988), bull (Amann and Walker, 
1983) and lamb (Foster et al., 1975) are. supported by'this study. However, at about 
24 days of age, a large degree of between-animal variation in episode frequency was 
observed with between a and 9 . pulses per 8-hour sampling period. Dodson et al. 
(1988) reported similar findings and suggested that at this age maturational changes 
are under way. 
As previously reported (Day et al., 1987; Bergfeld et aI, 1994 see Kinder et al., 1995), 
LH pulse frequency increased 4-8 weeks prior to puberty, possibly due to reduced 
sensitivity to oestradiol negative feed back on the hypothalamus (see Kinder et al., 
1995). However, t ~ e e increase in mean LH concentrations before puberty (Schillo, 
Dierschke and Hauser, 1982), were less obvious in the current study . 
. As with GnRH immunised bulls, there was no overall effect of treatment on LH pulse 
frequency. 'This finding is in contrast with an earlier study (Prendiville et al., 1996), in 
which LH pulse frequency, but not LH pulse amplitude, was reduced. The exact 
reason for the lack of effect on amplitude in the earlier study is unclear. However, it is 
possible that despite GnRH antibody induced anoestrous status, the heifers were 
subjected to exogenous GnRH agonist, GnRH, and oestradiol treatments. Higher 
oestradiol concentrations are known to increase pituitary sensitivity to GnRH (Kesner 
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et a/., 1981), possibly through enhancing GnRH receptor expression (Schoenemann, 
Convey and Anderson, 1985). Furthermore, with reduced LH pulse frequency, 
pituitary stores would be not so depleted of LH and FSH (Clarke, 2002). 
It is now well established that no LH pulses occur without pulsatile GnRH stimulation 
of the gonadotroph (Clarke and, Cummins, 1984; Clarke, 2 0 ~ 2 ) . . Therefore LH pulses 
may still occur in GnRH immunised animals, if the antibody titres were not sufficient 
to neutralise all the GnRH being released (D'Occhio, Aspden and Trigg, 2001). For 
example, in earlier in vitro studies in sheep (Naor et al., 1980), the gonadotrophs 
were observed to respond with nearly maximal LH release when only 20% of 
available GnRH receptors were bound to GnRH (see McNeilly et al., 2003). Further 
studies in vivo have shown that when 500/0 of GnRH receptors are blocked with a 
GnRH antagonist, ewes· could still respond fully to a GnRH challenge (Wise et al., 
1984). However, LH pulse amplitude was significantly reduced in both the current trial 
and in neonatal bulls (Chapter 3). Earlier work (Clarke and Cummins, 1982) has 
shown that removal of some of the GnRH that reaches the pituitary gland results in a 
reduction in the amplitude of LH pulses. Furthermore, LH pulse amplitude is a direct 
reflection of the releasable pool of LH in the pituitary gonadotrophs (Clarke and 
Cummins, 1985; see Clarke, 2002). Therefore, although GnRH pulses are inducing 
LH release, the amount of GnRH reaching the pituitary gland appears to have been 
reduced by GnRH immunisation and as a result, de novo synthesis of LH and hence 
gonadotroph cell stores of the hormone, may also be reduced (McNeilly et al., 2003). 
A concomitant reduction in GnRH receptor expression, following a decrease in GnRH 
stimulation (Fraser et al., 1982; Popkin and Fraser, 1985) is also likely, however such 
a reduction may not have been sufficient to reduce LH pulse frequency in the current 
study. This is in contrast to findings in anoestrous heifers, in which LH pulse 
frequency and mean LH was reduced, while amplitude and basal LH levels were 
unaffected (Prendiv!lIe et aI, 1996; titres-20% at 1 :640). 
The fact that LH pulse amplitude was reduced over the entire trial despite GnRH 
antibody titres falling and remaining low «5% binding at 1: 1 ,000) by 33 weeks of 
age, indica1es a prolonged suppression of GnRH amplitude following neonatal 
immunisation in heifer calves. Interestingly, although LH pulse amplitude in GnRH 
immunised heifers was not different to that of control heifers at 29, 48 and 63 weeks 
of age, there was an apparent, although non-significant reduction in LH pulse 
amplitude at 65 weeks, during the luteal phase. This may be the result of reduced 
GnRH pulse amplitude, or differential sensitivity of the gonadotrophs to progesterone 
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negative feedback. Steroids are capable of modifying the responsiveness of 
gonadotrophs to GnRH, and hence reducing LH pulse amplitude (Clarke, 2002). 
No affect of GnRH immunisation on LH pulse frequency overall, or during peak 
antibody titres, was observed during this study. After anti-GnRH titres had fallen to 
low levels, however, GnRH immunised animals still tended to exhibit increased LH 
pulse frequency 24 hours prior to oestrus and a marginally significant reduction in 
pulse frequency during the luteal phase (day 12) relative to control heifers. These 
effects are unexpected and difficult to explain, however, the effect during the follicular 
phase may simply reflect variations in the speed of CL regression after PG treatment. 
The more pronounced reduction in LH pulse frequency, seen in GnRH immunised 
heifers during the luteal phase, may indicate increased sensitivity of the 
hypothalamic-pituitary unit to progesterone negative feedback following neonatal 
immunisation. 
Lower LH pulse amplitude post-puberty in all heifers may result from increased 
baseline LH at this time. In the heifers there was a lack of LH pulse amplitude 
inhibition after the primary vaccination, whereas in the bulls, there was a marginally 
significant reduction in amplitude, despite low titres «20/0), in both groups. The 
effects seen at 65 weeks may indicate a long-term effect on LH amplitude, which may 
indicate an increased responsiveness to progesterone negative feedback, or that 
immunisation reduced the ability of the pituitary gland to synthesise LH-J3 subunit in 
response to progesterone. Even when antibody titres are low at 65 weeks of age, 
they may be having some suppressive effect on GnRH drive. Alone, low antibody titre 
effects on LH output may be insignificant. However, the combined affects of low 
antibody titres and progesterone negative feedback, at both the hypothalamic and 
pituitary gland levels, may be sufficient to marginally suppress LH pulse frequency 
and to a lesser extent LH pulse amplitude during the luteal phase. Alternatively 
oestradiol, which Was not different between the two groups, may have reduced 
pituitary LH amplitude. Oestradiol has been shown to increase the sensitivity of the 
hypothalamus to the negative feedback effects of progesterone (Peters, 1985). 
Basal LH concentrations increased (P<0.005) prior to puberty before peaking at 63 
weeks. As with bulls (see Chapter 3) there was a suggestion of reduced basal LH at 
16 and 66 weeks. This finding may reflect the tendency for reduced LH pulse 
amplitude and frequency, which were reduced at this time. Overall GnRH 
immunisation did not significantly reduce mean LH, but mean LH tended to be 
reduced (P=O.067) at 16 weeks, and to a lesser extent at 65 weeks. The suppression 
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of mean LH when GnRH antibody titres are elevated has been previously reported in 
adult heifers (Prendiville et al., 1996), although in other GnRH immunisation (Ref) 
and GnRH .agonist studies basal LH is unaffected by treatment (see D'Occhio and 
Aspden, 1999). 
4.4.2.2 FSH 
In the current study, FSH was elevated (P<O.001) during the first 16 weeks of life in 
the heifers, peaking at around 8 weeks. In support of this observation, FSH 
concentrations in the first 16 weeks of life have recently been reported to be higher 
than in cycling cows (Nakada et al., 2002). The reduction of FSH with increasing age 
may reflect increased numbers of oestrogenic follicles, and elevated peripheral 
inhibin concentrations which have been shown to inhibit FSH concentrations from 60 
days of age onwards (Kaneko et al., 1993; 1995) in heifers. Interestingly, and in 
-
support of our results, the peak of FSH and speed of the FSH rise after a GnRH 
challenge falls with increasing age up to 36 weeks (Nakada et al., 2002). Previous 
reports observed reduced FSH levels following GnRH immunisation (titres -200/0 
1 :640) in post-pubertal heifers (Prendiville et al., 1996). However, it is widely 
accepted that FSH is less responsive to short-term fluctuations in GnRH output 
(Gong et al., 1995; 1996a; Prendiville et al., 1996). Therefore, in the current study 
GnRH antibody titres may have been elevated above a critical threshold for 
insufficient time to suppress FSH concentrations. Alternatively, titres may need to be 
higher in neonatally immunised compared to post-pubertal heifers. 
4.4.3 Gonadal Response 
The medium-sized follicle population in pre-pubertal heifers was maximal at 12 
weeks, at the start of the scanning regime. This is slightly earlier than the 16-26 week 
peak in antral follicle numbers previously reported (Desjardin and Hafs, 1969), 
However, it is in agreement with recent and ongoing studies in young calves 
(Campbell, unpublished). In our study, medium-sized follicle numbers were reduced 
(P<0.001) in GnRH immunised heifers at 12 and 16 weeks when titres >20%, but 
also at 21 weeks, just prior to the detection of the titre rebound. Thus suppression of 
. medium-sized follicles at 21 weeks appears to be due to the immune response to 
endogenous GnRH and/or a prolonged period of low gonadotrophin release following 
clearance of GnRH antibodies from the body. The fact t h ~ t t low antibody titre animals 
exhibited significantly fewer medium-sized follicles at 21 weeks, relative to 16 weeks, 
supports this conclusion (see Table 4.2). Earlier studies on GnRH immunisation in 
post-pubertal heifers reported that growth of follicles (>4-5mm) was either reduced, or 
arrested (Johnson et al., 1988; Adams and Adams, 1990; Prendiville et al., 1995a; 
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1996; Crowe et al., 2001a;b). Evidence of a 'catch-up effect' is seen in Figure 4.12. 
After a prolonged period of suppression medium-sized follicle numbers in treated 
heifers increase, and exceed control values by 30 weeks of age. The explanation for 
this 'rebound' is that, in treated animals a larger pool of follicles developed up to a 
stage where gonadotrophins are required for further development. Following 
adequate gonadotrophin release, a larger number of .responsive follicles are 
recruited. However, there was a lack of correlation between FSH and number of 
medium-sized follicles, which are known to be FSH dependent (Gong et al., 1995; 
1996a). By 54 weeks, medium-sized follicle populations were similar in both treated 
and control groups. Table 4.2 shows further evidence of adequate immune response 
following GnRH immunisation since the high antibody titre animals had total 
cessation of follicle growth at 16 weeks, when antibody titres were maximal. The 
reason for the suppression of medium-sized follicles, despite no detectable reduction 
in FSH concentrations following GnRH immunisation is unexpected. Particularly in 
view of previous GnRH immunisation reports (Crowe et al., 2001a;b), in which both 
medium-sized follicle populations and FSH were reduced. 
The increase (P<0.01) in number of large follicles with approaching puberty seen in 
both control and GnRH immunised heifers in this trial is similar to earlier reports 
(Draincourt, 2001). However, the reason for the increase in large follicle number in 
control heifers at 16 weeks of age is unclear, but may reflect the high number of 
medium-sized follicles and increased LH pulse amplitude at this time. Although 
generally smaller than dominant follicles in adults, pre-pubertal heifers did have some 
follicles >8mm (see Draincourt, 2001). There was no detectable affect on the large 
follicle population following immunisation in this trial. In previous studies in GnRH 
vaccinated pre- and post-pubertal heifers large follicle numbers (Prendiville et al., 
1995a;b; Crowe et al., 2001a;b), the proportion of oestrogenic follicles, and thus 
peripheral o e s t r a d i ~ > 1 1 concentrations, were reduced (Prendiville et al., 1995a), as was 
testosterone in the GnRH immunised bulls (Chapter 3). In the current study, some 
medium-sized follicles were present in the GnRH immunised animals and LH output 
• was not entirely suppressed. It is possible that LH output from the pituitary gland was 
- . 
adequate to enable dominant follicle establishment. The fact that all antral follicles 
have the potential to become dominant (Draincourt e.t al., 2001) supports this 
proposal. 
4.4.4 Attainment of puberty 
In earlier studies in the pre-pubertal heifer (Wetteman and Castree, 1988; 1994; 
D'Occhio et al., 1992; Sejrsen, Enright and Prendiville, 1994; Prendiville et al., 
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1995b), puberty is delayed depending on the protocol and adjuvant used (Prendiville 
et al., 1995b). In the current study, following neonatal immunisation against GnRH, 
puberty was not delayed. This is likely due to the extended time between the fall in 
GnRH antibody titres and typical age at puberty. For example, in other studies pre-
pubertal heifers are immunised against GnRH nearer to the age of puberty 
(Wetteman and Castree, 1994),. either at 6 (D'Occhio et al., 1992), 8 (Sejrsen, Enright 
and Prendiville, 1994; Prendiville et al., 1995b) or 13 months of age (Wetteman and 
Castree, 1988). Therefore titres are elevated at the time of puberty and hence onset 
of cyclicity is delayed until titres fall below a critical threshold level to allow 
resumption of GnRH drive. 
Precocious puberty, i.e., transient increases in progesterone before 300 days of age 
(Kinder et al., 1995) was seen to have occurred in one heifer, by the start of the 
sampling period at 245 days of age (see Figure 4.13). This was an immunised 
animal, which responded well (>70% binding at 1:1,000 after 2nd booster and >500/0 
titre rebound). Interestingly, the heifer's titres, unlike those of all other animals, 
reached a plateau and did not fall below -130/0 binding by week 55. Therefore the 
animal was cycling early with titres of between 13-200/0 binding. Prendiville et al. 
(1996) witnessed a resumption of cyclicity in heifers when titres fell (to -14% at 
1 :640) and Bell et al. (1997) reported similar findings. 
Progesterone levels were seen to rise, but sampling ended before the full cyclic 
pattern of progesterone (two weeks high, one week low) was established. However, 
by 54-56 weeks of age all heifers had exhibited behaviours associated with oestrus. 
By this time the majority of heifers (6/9 controls and 7/9 immunised) had commenced 
luteal activity. However, most heifers did not show the characteristic progesterone 
profiles associated with cyclicity until near the end of the sampling period (-56 weeks 
of age). Based on ultrasound scanning data from a subsequent trial, all but one heifer 
had attained puberty before 78 weeks of age. By 82 weeks of age, intense sampling 
on the subsequent trial showed that all heifers were post-pubertal. There was no 
evidence to suggest that neonatal GnRH immunisation delayed puberty. However, 
the eviderTce from the high and low responding groups and the entire GnRH 
immunisation group indicates that GnRH suppression was at best absolute in only 3/9 
heifers when antibody titres peaked. 
After a 15-week break on pasture, heifers in this trial were re-used in a subsequent 
study (Chapter 6). Following the Chapter 6 study in which heifers were A.I., all 
animals were culled. Post-mortem examination of the reproductive tracts at 96-98 
... . 
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weeks of age revealed that the ovaries, uteri and attendant mid-gestation foetuses, 
were not different (-8 months since the final LH serial bleed in this study) between 
control and immunised heifers (data not shown). This finding agrees with earlier 
reports (D'Occhio et al., 1992; Bell et aI, 1997) in which immunisation commenced at 
24-36 weeks of age, and supports the previous evidence that suppression of 
reproductive function, by active immunisation against G ~ R H , , in the neonate is 
reversible. 
4.4.5 Anabolic Responses 
In the current and previous studies (Prendiville et al., 1995a; Jeffery et al., 1997) no 
significant difference in overall growth rates were observed, although in Bos indicus 
heifers a tendency for reduced overall growth rates following immunisation was 
suggested (Jeffery et al., 1997). In contrast, following GnRH immunisation some 
researchers have reported a reduction in both FCE and overall animal growth rates 
(Adams and Adams, 1990; Adams et al., 1990). Regardless of the overall rate of 
growth, average daily growth in i ~ m u n i s e d d animals was often reported (Adams and 
Adams, 1990; Adams et al., 1990; Prendiville et al., 1995a;b) to be lower than in 
intact heifers during anoestrous in both pre- and post-pubertal animals (Roche and 
Crowe, 2004). There are several possible explanations. First, a reduction in the 
anabolic steroid oestradiol, subsequent to elevated antibody titres in GnRH 
immunised animals, may reduce average daily gains (Moran et al., 1990). However, 
following a fall in GnRH antibody titres and a presumably (no data shown in current 
study) subsequent oestradiol rise (Draincourt et al., 2001) the growth rates overall 
may recover given time (Roche and Crowe, 2004). Second, immunisation per se and 
the resulting immune response may be responsible for reducing average daily gain in 
the short-term after booster immunisations (Crowe, Enright and Roche, 1995; 
Prendiville et al., 1995a;b), possibly by increasing concentrations of various 
cytokines, which can have catabolic effects (Cook and Pariza, 1998). Unfortunately, 
serum oestradiol concentrations and immune cytokines were not measured in the 
current study during the period in which antibody titres were elevated, although 
• testosterone concentrations were reduced at this time in bulls (Chapter 3). It is likely 
that the differences in heifer performance between studies, was due to the duration of 
the suppression of reproductive function (Prendiville et al., 1995a), relative to the 
study length. Furthermore, it has been suggested that a difference in overall growth 
rate following GnRH immunisation was more likely to be seen when average daily 
gains were high (Prendiville et al., 1995a), rather than average as in the current 
study. 
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Our observation that carcass conformation was improved following GnRH 
immunisation in the neonatal heifer is novel. This improved carcass conformation in 
the current trial may have resulted from suppression of oestradiol during elevated 
GnRH antibody titres, followed by increased response of lean tissue to anabolic 
effects of steroids, or a rebound in oestradiol at 26-30 weeks of age, as immunised 
"" 
heifers had an increased number of medium-sized follicles at 30 weeks of age, 
relative to controls. More thorough studies may be required into the effects of 
neonatal GnRH immunisation on body growth should this approach to inhibiting 
reproduction be adopted. 
4.4.6 Conclusions and Future Work 
Active GnRH immunisation in neonatal heifers did not permanently impair 
reproductive function or delay puberty. Further work is needed to investigate the 
effects of exposure of the neonatal hypothalamus to prolonged high GnRH antibody 
titres. A total suppression of pituitary stimulation by GnRH would be optimal. 
However, due to the immaturity of the bovine neonatal immune system, the possible 
blocking effects of maternally derived antibodies, and general poor response to active 
primary vaccinations, a passive immunisation approach may be required. Passive 
immunisation, of the pregnant cow or neonate, or active and passive combination 
protocols, may help to identify. a critical period during which the hypothalamic-
pituitary-unit is maximally susceptible to GnRH antibodies. Subsequently, on the 
basis of this information, the more practical active immunisation regimes may be 
designed. However, the inclusion of diets, which stimulate the maturation and 
response of the immune system, immunomodulation vaccines and carrier proteins to 
which, the dam is unlikely to possess antibodies (e.g., diphtheria toxin as used 
successfully in I m p r o v a C < ~ ~ the commercial GnRH vaccine for pigs), may go some way 
towards reducing th_e variability in antibody response between animals (Reeves et al., 
1989; Bell e{ al., 1997), increaSing the proportion of animals that respond, and 
increasing the magnitude, longevity and 'balance' of the immune response to 
. vaccination early in life. However, due to the phenotypiC variation in immune 
. . 
response and longevity of physiological affects in active immunisation experiments 
(Prendiville et al., 1995b), large groups of animals (>24 a ~ i m a l s s per treatment group) 
may be necessary in future studies. 
Neonatal GnRH immunisation can result in an additional increase in GnRH antibody 
titres, however both the cause and mechanism through which this response occurred 
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is unknown. Therefore future study is required in this area, as a predictable GnRH 
antibody titre increase might be incorporated into an immunisation protocol to act as 
a "self-booster". However, as no previous reports of such an event have been 
published, this phenomenon is likely to be the result of neonatal immunisation. When 
attempting to repeat such a response it should be noted that photoperiod, 
temperature, nutrition, stress and season of birth might influence the timing and 
magnitude of this event. 
There is a lack of understanding in the mechanism of action, through which GnRH 
vaccines elicit their effects. For example, Vaxstrate®, has been withdrawn from the 
market place because prior to suppressing reproductive function animals were 
exhibiting increased fertility. Thus, the recent opinion is that the GnRH-OVA 
conjugate is binding GnRH receptors and acting as a GnRH agonist as well as raising 
GnRH antibodies (Dr. R. Henderson, Pfizer Inc, personal communication). To our 
knowledge there are no publications of this theory. This is unfortunate, as the GnRH 
vaccine/agonist action might help explain the long-term inhibition of fertility in sheep 
(Brown et al., 1994; 1995; Clarke et al., 1998) and bulls (D'Occhio, Aspden and Trigg, 
2001) following immunisation, and gender differences between males and females. 
Furthermore, the mechanism of action may vary between vaccine preparations and 
we strongly suggest that, experiments fnto type of immune response (cellular and 
humoral), the effects of combined GnRH immunisation and GnRH agonist, and the 
mechanism of action through which Vaxstrate® and other vaccines act should be 
conducted. In addition, investigation into whether or not MHC-II molecules are 
expressed on GnRH neuron terminals might contribute to our understanding of the 
apparent gender and species variation in GnRH vaccine response, ,. as we are 
unaware of any research at this level to date. Further understanding of immune 
function and the development of reliable and effective GnRH immunisation methods 
for young animals, is imperative as without this the field cannot develop. 
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CHAPTER FIVE 
EFFECTS OF EXOGENOUS GROWTH HORMONE AND INHIBIN 
IMMUNISATION ON OVARIAN FOLLICLES IN ANOESTROUS EWES 
5.1 INTRODUCTION 
The economic viability of animal production systems such as beef and lamb are 
closely related to rates of reproduction. In domestic ruminants, ovulation rate is the 
major factor limiting the number of offspring. As a result, numerous attempts have 
been made over many years to increase ovulation rates in amounts compatible with 
uterine capacity (Terqui _et al., 1995). 
Increased nutrition prior to mating (flushing) can improve fertility and enhance the 
yield of lambs born by up to 20%, (Smith, Jagusch and Farguhar, 1983). The exact 
mechanisms through which diet· influences reproductive function are still under 
investigation, however, it is thought to be associated with increased sensitivity of the 
follicles to gonadotrophins due to the effects of a number of trophic factors (e.g. GH, 
IGF-I, insulin) (Campbell and Scaramuzzi, 1996; Campbell, 1997; Gutierrez et al., 
1997) and leptin (Keisler, Daniel and Morrison, 1999). Alternatively, exogenous 
hormone administration (e.g. eCG, FSH) and steroid and inhibin immunisation 
(Scaramuzzi, Davidson and Van Look, 1977; Scaramuzzi and Hoskinson, 1984; 
O'Shea et al., 1984; Wrathall et al., 1992; Boland et al., 1994; Hillard et al., 1995) 
have been used to modulate folliculogenesis, increase ovulation rates and ultimately 
birth rates. These techniques have not been commercially successful, due to 
variations in animal responses (Reeves et al., 1989) and practicalities for on-farm 
use. However, through these studies and comparative studies on very ·prolific breeds 
of sheep such as the Booroola Merino, Finnish Landrace and the Romanov (Boulton 
et al., 1995; Draincourt, Hermier and Hanrahan, 1996; Gibbons et al., 1999; Mandiki 
et al., 2000; Dufour et al., 2000), a better understanding has been acquired as to how 
. such breeds of sheep are able to overcome the strong dominant follicle selection 
mechanism which limits cattle and less prolific sheep breeds (e.g.,Galway) to single 
ovulations (Draincourt, 2001). In order to develop ·successful superovulatory 
procedures and to promote their use by the agricultural industry and medical 
profession, a clearer and more detailed understanding of folliculogenesis is essential. 
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Previous research has demonstrated that both the GH/IGF-I (Spicer, Alpizar and 
Echternkamp, 1993; Campbell, Scaramuzzi and Webb, 1996; Lucy et a/., 1999) and 
gonadotrophinlinhibin (Campbell and Scaramuzzi, 1995; Bleach et a/., 1996) axes 
are involved in fOlliculogenesis .. For example, exogenous GH administration in sheep 
and cattle results in an increase in the number of small follicles (Gong, Bramley and 
Webb, 1991; Gong et a/., 1993a;b; 1996b;c). GH administration increases peripheral 
GH, insulin and IGF-I, in addition to increasing IGF-I from ovarian follicles (Gong et 
a/., 1996b). Peripheral IGF-I is synthesised and released from the liver and is 
believed to be primarily responsible for the physiological effects of GH administration. 
IGF-I increases the sensitivity of the follicles to gonadotrophins, stimulating cell 
proliferation and steroidogenesis (Armstrong and Webb, 1997) and enhanCing the 
responsiveness of the granulosa cells to FSH (Spicer, Alpizar and Echternkamp, 
1993; Campbell, Scaramuzzi and Webb, 1996). As a result the number of follicles in 
the 2.1-3.0mm size range increase (Gong et a/., 1996b). 
Studies in prolific breeds of sheep have shown that two possible strategies may be 
used in the production of large litters of lambs (Scaramuzzi et a/., 1993). The first 
strategy is by extending the time that FSH is maintained above a threshold. For 
example, Finnish Landrace and Romanov breeds, despite increased oestrogen levels 
compared to less prolific sheep, appear to have reduced hypothalamic-pituitary gland 
sensitivity to the negative and positive feedback effects of oestradiol. Thus, FSH 
levels decline less rapidly, allowing more time to recruit and maintain more 
preovulatory follicles before FSH levels become sub-threshold. The interval between 
CL regression and the ovulation inducing LH surge is also extended in these breeds 
(Baird and Campbell, 1998). The second strategy is by synchronising and increasing 
.. 
the number of small follicles in the ovaries, which are responsive to the threshold 
level of FSH. Recently, the importance of local factors in follicle development has 
been revealed in t h ~ ~ prolific Booroola Merino, following the identification of a single 
gene mutation named the Fecs gene in the BMP-1 J3 receptor (Montgomery et a/., 
2001; Monget et a/., 2002). Reduced BMP signalling by the BMP-1 J3 receptor leads to 
• physiologic!31 changes such as precocious follicular d e v e l o p m ~ n t , , which results in 
increased ovulation rate (Souza et a/., 2001). In Booroola ewes (which carry the Fecs 
gene) follicular cells are more sensitive to gonadotrophins in vitro (Webb, Campbell 
and Draincourt, 1995), as a result follicles develop and ovulate at a smaller size. Both 
oestradiol and inhibin A concentrations (Campbell et a/., 2003) prior to OVUlation and 
blood progesterone concentrations from subsequent CLs, are similar to those 
reported in less prolific sheep. However, in Fecs gene carriers, 2-4mm follicles 
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express significantly more mRNA for P450arom and inhibin a and P-A subunits (Webb 
et al., 1999b). In addition BMP-2 has been shown to increase oestradiol production 
by ovine granulosa cells in vitro (Souza et al., 2002). Similar studies in cattle 
demonstrated increased oestradiol, inhibin A, activin A and follistatin following 
individual incubation with BMP-4, -6 and -7, although no effects on FSH-induced 
hormone secretion were detected (Glister, Morgan and Knight, 2002). The observed 
precocious follicular development could therefore be due to both hormonal and/or 
local factors (Baird and Campbell, 1998). However, despite administration of identical 
concentrations of gonadotrophins to ewes rendered hypogonadotrophic, following 
GnRH antagonist treatment, Fecs ewes were able to ovulate more follicles than 
controls. Thus, the Fecs gene is thought to act at the ovarian level to enhance 
ovarian responsiveness to gonadotrophic stimulation (Campbell et al., 2003). 
Numerous studies (see sections 1.6.4-1.6.6) have demonstrated that, inhibin 
immunisation results in an increased ovulation rate and increased litter size in both 
sheep and cattle. These effects. are probably elicited through increased super-
threshold FSH levels and yet to be clarified intra-ovarian interactions (Campbell, 
Scaramuzzi and Webb, 1995; Bleach et al., 1996). Intra-ovarian actions of inhibin 
and other factors, such as IGFs and IGFBPs, are complex and inhibins appear to 
have both positive and negative effects on folliculogenesis. For example, inhibin 
promotes LH and FSH stimulated steroid production from theca and granulosa cells, 
respectively (Armstrong and Webb, 1997), but there is recent evidence that free a 
subunit can function as an FSH-binding inhibitor and may also suppress oocyte 
maturation (Knight and Glister, 2001). 
The current study aims to investigate the interaction between the GHIIGF and the 
gonadotrophinlinhibin axes on follicle growth and development. 
5.2 MATERIALS AND METHODS 
5.2.1 Experimental Animals 
Sixteen ewe lambs, North Country mule (Scottish Blackface x Blueface Leicester) x 
Charolais tups (lambing rate 1.88) born on the University Farm between 6th and 26th 
March 1999, were kept on pasture and then group housea in September. All animals 
received a typical University Farm diet of ad-libitum hay and grass nuts. Throughout 
the experiment the live weight of the animals was monitored regularly, usually at the 
153 
Chapter 5: Inhibin and GHIIGF Interactions 
time of blood sampling, and Mr. T Dingle, an experienced Stockman, condition 
scored all animals two days prior to slaughter. 
Despite the small group sizes (n=4), this number of animals was justified by our 
primary intention, to carry out molecular studies on ovarian follicles, to investigate 
mRNA expression for P450 Aromatase (P450AROM) and .LH receptors. However, 
because the magnitude of the GnRH immunisation studies (Chapters 3 and 4), which 
began soon after the current trial ended; the degree of commitment to those studies 
and the time limitations of the Author's Studentship, the completion of ISH analysis 
has not been possible. Molecular investigations into the treatment effects on 
P450AROM and LH receptors, using Immunohistochemical analysis, are under way as 
an alternative to ISH. It is acknowledged that for follicular culture studies such low 
animal numbers are of marginal acceptability. 
Following post mortem examination, the data from one ewe from group D (Ewe 14) 
was removed from the study because the animal presented with under developed 
ovaries. Antiserum from Ewe 14 was used in the subsequent Chapter 6 study and so 
the titration curves display Ewe 14 data. The treatment in this trial is not believed to 
be responsible for the ovarian abnormalities seen in this animal. 
5.2.2 Experimental Protocol 
The experimental period ran from August 1999 to April 2000 during seasonal 
anoestrus. This was because the antibody titre responses were lower than expected 
and the animals required three booster injections. Previous inhibin immunisation 
studies state that during seasonal anoestrous, the FSH rise is either absent (Kusina 
et al., 1994) or reduced in size (Kusina et al., 1995). While it is acknowledged that 
waiting another six months and conducting the experiment during the breeding 
season would have_been ideal, as for example, this would be the time that prolificacy 
treatments would be administered in a commercial system, further booster 
vaccination of these animals was not permitted due to Home Office restrictions. The 
• decision was made to conduct the experiment during anoestrous because our 
- . 
objective was to investigate the interaction between GHIIGF and inhibin. This 
objective was possible, and would add to current knqwledge, regardless of the 
oestrous cycle status, because during seasonal anoestrous fOlliculogenesis 
continues, large antral follicles develop (Campbell, McNeilly and Baird, 1989; Noel, 
Bister and Paraquay, 1993; Kusina et al., 1995) and ovulation rate mechanisms are 
maintained (Webb et al., 1992b). 
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5.2.3 Inhibin vaccine preparation and immunisation 
Inhibin vaccine was prepared just prior to administration. A detailed description of the 
method of vaccine preparation is given in Chapter 2. 
Eight ewe lambs, 21.8 ± 1.2 (mean ± s.e.m.) weeks of age, were actively immunised 
against an inhibin a-C-subunit..fraction, 1-26 tyr-gly conjugated to Imject® keyhole 
limpet haemocyanin (KLH) in Freund's non-ulcerative complete adjuvant (NUFCA; 
Guildhay, Guilford, Surrey). Booster vaccinations containing non-ulcerative Freund's 
adjuvant (NUFA; Guildhay, Guilford, Surrey) were given at 29.5, 36.1 and 54.7 ± 1.2 
weeks of age (mean ± s.e.m.). Vaccines were administered via subcutaneous 
injection (O.4ml) into 4 sites (total 1.6ml) on the back of each animal. Control animals 
received the same KLH and Freund's adjuvant preparations minus the inhibin 
peptide. 
5.2.4 Recombinant Bovine Growth Hormone (rbGH) Administration 
Seven days after the 3rd inhibin booster, animals were sub-divided to give 4 groups, 
of ewes (n=4 per group) to give a 2x2 factorial design. Table 5.1 shows the four 
groups and summarises their respective treatments. 8 animals received a 4ml 
injection (1mg mr1) of rbGH in dorsal neck area (s.c.) at 09:00 for 6 days (days 1- 6). 
The control animals received vehicle only (see section 2.4). 
Table 5.1 Summary of the four treatment groups 
Group Inhibin immunised GH injections 
.• 
A No No 
B Yes No 
C No Yes 
-D Yes Yes 
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5.2.5 Synchronisation of Follicular Waves 
On day 4 of the rBGH treatment regime all animals were given a GnRH agonist (4J.lg; 
1ml volume; Receptal®: Buserelin; i.m. injection in the near side hind leg), i.e., an 
amount considered adequate to induce a surge release of LH and hence synchronise 
the follicle waves (www.intervet.com; Intervet International). 
5.2.6 Blood sampling 
Blood samples were taken every 10-14 days by jugular venepuncture throughout the 
experiment and just prior to each immunisation to monitor inhibin antibody titres. To 
determine circulating FSH concentrations, the frequency of sampling was increased 
to twice-daily samples during the last 9 days of the trial. 
5.2.7 Post-mortem 
S.2.7.1 Inhibin antiserum and tissue collection 
On day 7 ewes were transported to the abattoir, in lairage fresh water was made 
available. Animals were stunned and culled by exsanguination. In order to obtain 
inhibin antiserum, blood was collected from all animals into clean buckets and then 
decanted into 1 litre plastic bottles, which were stored at 4°C, Subsequent to storage, 
for the following S days the clots retracted and the serum was then poured off into 
SOml vials. To further reduce the amount of red blood cell contamination in the 
antiserum, the antiserum was transferred to SOml vials and centrifuged for 30 minutes 
(4,000-x G), and the clear antiserum fraction was pipette into clean bottles and stored 
at -BO°C. 
The left ovaries were fixed in 40/0 Para formaldehyde, and left overnight. Then ovaries 
were cut open and placed in 70% alcohol and stored at RT for in situ hybridisation 
analysis. The right ovaries were placed in a 20ml universal flask containing warm 
(37°C) M199 culture media then immediately taken to the laboratory for follicle 
dissection and culture. 
5.2.7.2 Follicle counts, culture and oestradiol production 
Following dissection, follicles were then counted, measured and using 24 well culture 
plates (Nunclon Life Technologies) and an incubator (37°e; 95% O2 and 50/0 CO2) 
individually cultured in 2ml M 199 culture media for 2h. After culture the follicles were 
stored in vials at -BO°C. The culture media was stored (-BO°C) until oestradiol was 
measured. 
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5.2.8 Radioimmunoassays 
Details of RIA method for measuring reproductive hormones and antibody titres are 
given in Chapter 2 in sections 2.7 and 2.8, respectively. 
5.2.9 Statistical Analyses 
Statistical analyses of data, was carried out using Genstat version 6.1 Anti-inhibin 
titres were analysed using AN OVA. The follicle size data from each of the 4 groups 
was analysed using Poisson regression analysis (logarithmic link function), rather 
than ANOVA, as the data was not normally distributed and the number of follicles in 
the >3.5 group was small. Where data are transformed to a logarithmic scale to 
normalise the distribution of data, the textual description and statistical significance is 
based on transformed_ data. However, for ease of presentation, especially for 
presenting standard errors, the tables and figures display the unadjusted data unless 
otherwise stated. Where Poisson regression analysis is used, no standard errors are 
given. Due to small data sets for oestrogenic follicle numbers, the use of Friedman's 
non-parametric ANOVA was considered, but ruled out because this type of analysis 
is for one-way randomised block data. This data was two-way and completely 
randomised. Therefore, treatment interaction analysis was carried out on individual 
counts. A generalised linear model assuming Poisson errors was used to produce an 
analysis of deviance table for each variable. These values can be interpreted in the 
same way as an ANOVA. The . raw averages and percentages are presented in 
section 5.34 to show which direction the significance effects and trends take. 
5.2 RESULTS 
5.3.1 Live weight and condition scores 
The overall ewe live weights (mean ± s.e.m.) are presented in Figure 5.1. Ewe live 
weights were significantly increased with age (P<O.001). Neither inhibin immunisation 
\ 
(P=0.49) or rbGH treatment (P=O.74) had any influence on live weight. 
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Figure 5.1 Pooled ewe live weights. 
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Table 5.2 Condition scores and live weights (mean ± s.e.m.) prior to culling. Letter 
after a condition score number indicate extremes within a classification grade e.g. L 
and H represent Low and High, respectively. 
Group Condition scores Live weight (kg) 
A 2,3L,3L,3L 50.2 ± 3.3 
B 2, 3L, 3H, 3H 51.3 ± 6.1 
C 2,2, 3L, 3L 51.6±1 .9 
D 2,3L, 3H, 3H 56.8 ± 3.1 
5.3.2 Serum Inhibin antibody titres and pooled serum antibody titres 
Inhibin antibody titres (mean ± s.e.m.) at 1 in 1,000 dilution over time are presented in 
Figure 5.2. Antibody titre responses to primary vaccination were not significantly 
(P>0.05) elevated, whereas responses to 1 st, 2nd and 3rd booster vaccinations 
resulted in significant (P<0.05) antibody titres. Inhibin antibody titres remained 
elevated peaking on the day of slaughter (Figure 5.2). Individual inhibin antibody titre, 
defined as the dilution at which serum antibodies give 40.0/0 binding of 1251-inhibin are 
presented in Figures 5.3 and 5.4. Mean inhibin antibody titres in serum collected at 
slaughter are shown in Chapter 6. 
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Figure 5.2 Comparison of inhibin antibody levels (1 in 1,000 dilution) between 
immunised and control animals. Key: Blue arrows = time of booster vaccination. 
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The 'Bell shaped curves' shown in Figures 5.3 and 5.4 have several phases: an 
increasing phase when antibodies are so highly concentrated that their ability to bind 
to the hapten (inhibin) is impaired. As the antiserum is diluted down the binding 
increases until a plateau phase is reached were binding efficiency peaks. The final 
phase is the 'decline phase' and this phase is used to indicate the antibody titre, as 
the rate of decline with increased dilutions indicates the affinity and number of 
antibodies, which can bind to the hapten. 
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Figure 5.3 Inhibin antibody titration curves in individual ewes: a comparison between 
group B ewes and OE 378 (positive control from a previous experiment; O'Shea and 
Webb, unpublished observations). At 400/0 binding (on the titre decline phase) the 
serum dilution factor range was between 1 in 400 and 1 in 18, 000. 
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Figure 5.4lnhibin antibody titration curves: a comparison between group D ewes and 
OE 378. At 400/0 binding the serum dilution factor range (excluding ewe 15) was 
between 1 in 1, 450 and 1 in 1, 900. Ewe 15 responded poorly to vaccination and 
antibody binding was less than 400/0. The ewe 15 dilution factor at peak binding 
(-280/0) was 1 in 200. 
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5.3.3 F o l l i c l ~ ~ Stimulating Hormone 
Long-term effects of inhibin immunisation on serum FSH concentrations are shown in 
Figure 5.5. Time (P=0.18) and inhibin immunisation (P=0.28) had no significant effect 
on FSH concentrations, despite the apparent increase in FSH concentrations. There 
was also no time/treatment interaction (P=0.21). The apparent increase in FSH after 
the 2nd booster was due to elevated FSH in a single high titre animal (10.01 ng mr1). 
The range of peripheral FSH concentrations was 0.23 - 10.01 ng mr1. During the final 
6 days of the trial, inhibin immunisation (P=0.41) and rBGH injections (P=0.31) had 
no detectable influence on FSH concentrations (see Figure 5.6). 
Figure 5.5 Long-term effects of inhibin immunisation on serum FSH concentrations 
(mean ± s.e.m.). 
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Figure 5.6 Serum FSH concentrations (mean ± s.e.m.), inhibin immunised and 
control ewes, with and without rbGH treatment. Inhibin immunisation (P=0.41) and 
rBGH injections (P=0.31) had no detectable influence on FSH concentrations. Key: 
black arrows = time of rbGH administration. Receptal® GnRH agonist injection was 
given to all ewes to synchronised follicular waves at time 0, i.e. 13 days after the 3rd 
inhibin booster vaccination. 
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5.3.3 Follicle counts 
Administration of rbGH significantly (P<0.001) increased the mean number of follicles 
<3.5mm in diameter (Figure 5.7). The effects of rbGH were significantly (P<0.002) 
reduced when rBGH administration occurred in conjunction with inhibin immunisation. 
Inhibin immunisation had no significant effect on the small follicle population. Inhibin 
immunisation significantly (P<0.006) increased the number of follicles ;?!3.5mm and 
r.BGH had no effect on these large follicles (see Figure 5.8). Key= C + C, IMM + C, C 
+ GH and IMM + GH represent; control (n=4 animals), inhibin immunised without 
rbGH (n=4), control with rbGH (n=4) and inhibin immunised with rbGH (n=3), 
respectively. 
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Figure 5.7 Mean numbers of small follicles «3.5 mm) in the 4 treatment groups. 
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Figure 5.8 Mean follicle number ( ~ 3 . 5 m m m in diameter) in experimental Treatment 
groups. 
4.5 r-----------------------------, 
4 ~ - - - - - - - - - - - - - - - - - - - - - -
c: 
~ ~ 3.5 
ro 
S 3 
0-
8. 2.5 
Q) g 2 
:E 1.5 
~ ~ 1 Q) 
~ ~ 0.5 
o 
C+C 
5.3.3 Oestrogenic follicles 
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. Oestrogeniq follicles were defined as those secreting >100pg/ml/h of oestradiol into 
culture media over a 2h period. This definition was arrived at based on a bimodal plot 
of oestrogen output from all follicles and based on earlier definitions by Webb and 
England, (1982). 
Inhibin immunisation increased the numbers of both oestrogenic (P<O.01) and non-
oestrogenic ~ 3 . 5 m m m follicles (P<O.01). Whereas, Growth hormone increased the 
number of oestrogenic (P<O.005) and non-oestrogenic (P<O.OS) <3.Smm follicles. 
The combination treatments of inhibin immunisation and bGH tended (P=O.07) to 
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increase the number of small «3.5mm) follicles. The raw data is presented in Tables 
5.3 and 5.4 to show the numbers and status of follicles in each group and Figures 5.9 
and 5.10 compare non-oestrogenic and oestrogenic follicle percentages to illustrate 
the direction of significance and trends. The overall mean ± s.e.m diameter of the 
oestrogeneic follicles for the control, immunised, rbGH treated and combination 
treatment groups was 4.4 ± O.2mm, 4.1 ± O.5mm, 2.8 ± O.17mm and 4.1 ± 0.49mm, 
respectively. 
Table 5.3 Numbers and status of <3.5mm follicles in all treatment groups. In the 
combination treatment group n=3 animals, whereas in all other groups n=4. 
Group Total number of follicles Oestrogenic Non-oestrogenic % Oestrogenic 
Control 28 0 28 0 
Immunised 51 1 50 1.9 
GH 78 7 71 8.9 
Immunised + G H 43 5 38 11.6 
Table 5.4 Numbers and status of ~ 3 . 5 m m m follicles in all treatment groups. In the 
combination treatment group n=3 animals, whereas in all other groups n=4. 
Group Total number of follicles Oestrogenic Non-oestrogenic % Oestrogenic 
Control 5 3 2 60 
Immunised 10 4 6 40 
GH 3 1 2 33.3 
Immunised + GH 12 6 6 50 
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Figure 5.9 Percentage of non-oestrogenic and oestrogenic follicles in total <3.5mm 
follicle population. Total follicle number was obtained by pool of all <3.5mm follicles 
from 4 ewes per treatment group, except the combination group (Imm + C; n=3). 
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Figure 5.10 Percentage of non-oestrogenic and oestrogenic follicles in total ~ 3 . 5 m m m
follicle population. Total follicle number was obtained by pool of all ~ 3 . 5 m m m follicles 
from 4 ewes per treatment group, except the combination group (Imm + C; n=3). 
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5.4 DISCUSSION 
The present study has p r ~ v i d e d d evidence to show t ~ a t t GH treatment in sheep 
increases the number of small «3.5mm) follicles, while long-term inhibin 
immunisation increased the number of large (>3.5mm) follicles without a detectable, 
concomitant increase in peripheral FSH. Further limited evidence also suggests that, 
when administered together these two treatments have an additive effect, which 
enhances the number of oestrogenic follicles. 
5.4.1 Immune response 
It has been previously demonstrated that antibodies raised against the porcine a-C 
(1-26 tyr-gly) subunit bind to, and neutralise, the biological activity of the inhibin dimer 
(Boland et al., 1994). As with previous inhibin immunisation studies, (Meyer et al., 
1991; O'Shea et al., 1993; Tannetta et al., 1997; 1998), inhibin antibody titres 
increased significantly after the 1 st booster and with an increased response to 
subsequent boosters. Antibody titres reached only moderate levels (>400/0 binding at 
1: 1,000) even after the 3rd booster, with even the "better responders" in the current 
trial exhibiting much lower inhibin antibody titres relative to very high responding 
animals in previous studies, e.g. the positive control (OE 378) used in the current 
trial. This reduced response is probably due to the age of the ewes at immunisation, 
as in older ewes (age 4-5 years), immunised against bovine a-C (1-26 tyr-gly) 
subunit, similar titres were reported (Boland et al., 1994) after only one booster was 
administered. 
A large variation in immune response was witnessed between individual animals in 
the current study, in agreement with previous reports (Meyer et al., 1991; Boland et 
al., 1994). This was despite using a synthetic peptide fragment of porcine inhibin a-C 
(1-26 tyr-gly) subunit vaccine, which is reported (O'Shea et al., 1994) to reduce the 
• variation C?f immune response compared to earlier crude vaccine preparations using 
bovine follicular fluid (Cummins et al., 1986; AI-Obaidi et al., 1987a;b). This variation 
is largely attributed to individual genetic variation in immune response, rather than 
differences in immunogen dose, breed, or age (Meyer et al., 1991), which can also 
add to variation both within and between studies. 
Reported correlations between inhibin antibody titres and ovulation rates are 
conflicting, with some authors reporting a positive correlation (Boland et al., 1994), 
while others find no correlation (O'Shea et al., 1993). It appears that a positive 
correlation between inhibin antibody titres and ovulation rate can be detected when 
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the immune response and titres are variable (Boland et al., 1994), whereas when 
most animals have a good response no significant correlation was observed (O'Shea 
et a/., 1993). This suggests that there is a threshold level at which inhibin is 
sufficiently neutralised to allow increased follicle recruitment and/or selection, leading 
to increased ovulation rate. Antibody titre levels beyond this threshold may not 
always result in further ovulations. However, the higher, and even superovulatory, 
responses of some animals may be due to individual animal variation in response. 
5.4.2 FSH and follicle growth 
The follicle recruitment window lasts -24 hours (Draincourt, 2001) and has been 
shown to occur <8 hours after the start of the rise in FSH, when FSH concentrations 
reach a follicle specific threshold (Webb, Gould and Draincourt, 1989; Picton and 
McNeilly, 1991; Fry and Draincourt, 1996; Campbell, 1999). The FSH rise would not 
need to be large to stimulate increased recruitment and increased ovulation (Findlay 
et a/., 1989). Wrathall et a/. (1990) suggested that the size of the FSH increment is of 
no consequence, whereas it is the prevention of the preovulatory decline in FSH that 
is important in increasing ovulation rate. A delay in the FSH decline would delay 
selection and allow more time for follicles to differentiate and be selected into the 
ovulatory pool. In contrast, several superovulation studies suggest that the size of the 
FSH rise is important in producing superovulatory responses (see Armstrong, 1993). 
In the current trial a rise in peripheral FSH was seen in the control ewes 
approximately 12h after GnRH administration. Although FSH concentrations tended 
to increase with time in control animals (P=0.09), variation between animals was 
evident as previously reported (AI-Obaidi et a/., 1987a;b) and the expected FSH rise 
in the treated groups was not apparent. This indicates that there was a lack of 
\ 
synchronisation of follicle waves following GnRH administration, which would have 
induced ovulation or atresia in large antral follicles, and hence would provide the 
.. conditions for an increase in FSH and for the recruitment of the next wave of follicles. 
Passive inhibin immunisation consistently results in an abrupt elevation in circulating 
FSH concentrations (Mann et al., 1989; 1993; Wrathalr et al., 1990; Campbell and 
Scaramuzzi, 1995; Campbell, Scaramuzzi and Webb, 1995). However, it was noted 
that, FSH levels soon declined (Mann et a/., 1989; 1993; Wrathall et a/., 1990; 
Campbell and Scaramuzzi, 1995) by day 6 (Campbell, Scaramuzzi and Webb, 1995), 
despite the presence of high antibody titres (Mann et a/., 1989; 1993; Campbell and 
Scaramuzzi, 1995; Campbell, Scaramuzzi and Webb, 1995). In contrast, previous 
publications on the effects of active immunisation against inhibin (as in the current 
study) on peripheral FSH levels are conflicting. For example, subsequent to active 
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inhibin immunisation, FSH concentrations were either increased (AI-Obadi et al., 
1987a;b; Findlay et al., 1989; O'Shea et al., 1989c; Mizumachi et al., 1990; Wrathall 
et al., 1990; 1992; Tannetta et al., 1997) or remained unaltered (Henderson et al., 
1984; Schanbacher, 1988a; "Meyer et al., 1991; Schanb'acher, Schemm and Rhind, 
1991; Fray, Wrathall and Knight, 1994; Tannetta et al., 1998). Findlay et al. (1989) 
suggested several explanations for these inconsistencies in FSH response; such as 
day of blood sampling relative to follicle recruitment and dominance, frequency of 
sampling, radioimmunoassays used and group sizes. Indeed, Wrathall et al. (1990) 
reported a 22% increase in FSH with random sampling, yet after frequent sampling· 
(the sampling regime_ used in the current study), no change in peripheral FSH was 
observed in either the follicular or luteal phases. Furthermore, following long-term 
active inhibin immunisation (>6 months) FSH concentrations were no different to 
control ewes, despite increases in numbers of large oestrogenic follicles (Tannetta et 
al., 1998) and/or ovulation rate (Wrathall et al., 1990; Knight et al., 1991; Fray, 
Wrathall and Knight, 1994). These findings are similar to those in our current trial, 
however, in the above trials during the initial active immunisation regime, the same 
ewes exhibited elevated FSH concentrations (Wrathall et al., 1990; 1992), and the 
return of FSH to control levels may have resulted from homeostatic adjustment of the 
pituitary gland responsiveness to inhibin and steroid negative feedback with time. 
Our failure to detect differences in FSH concentrations may be due to small group 
numbers, as was the case in the study by Henderson et al. (1984), although this is 
unlikely as comparisons between inhibin immunised and controls (n=8 per group) 
also showed no difference (P=0.33) in FSH concentrations. Alternatively, an 
inadequate sampling frequency may be responsible for our inability to detect 
differences in FSH. Bister and Paquay (1983) reported that although the mean FSH 
" 
concentrations in cyclic and anoestrous ewes were similar, peripheral FSH was more 
variable in anoestrous ewes. A further explanation may be that the contribution of 
• inhibin to ..negative feedback regulation of FSH may be reduced in an·oestrous ewes 
relative to cycling animals (Kusina et al., 1994; 1995), while oestradiol's feedback role 
may be increased (Legan and Karsch, 1980). For exampie, the magnitude of the FSH 
rise following inhibin passive immunisation was 500/0 less during seasonal anoestrous 
than during the breeding season (Kusina et al., 1995). Moreover, active inhibin a-
subunit immunisation increased peripheral FSH concentrations in cycling ewes, but 
not anoestrous ewes (Kusina et al., 1994). 
... . 
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It is well established that FSH is inhibited by testicular and ovarian inhibin, and by 
oestradiol negative feedback (sections 1.1.3.4 and 1.1.4.4). The lack of elevated FSH 
in this and previous trials is likely the result of negative feedback from increased 
oestrogenic follicle n u m b e r s ~ ' ' as has been reported previo'usly (Campbell et al., 1995). 
Also difficulty in detecting FSH may be due to the fact that, increased FSH is 
transient, and only detected during the recruitment phase i.e., prior to negative 
feedback. Meyer et al. (1991) speculated that elevated oestradiol concentrations, 
arising from increased follicular mass following inhibin immunisation, may explain 
depressed LH concentrations, and absence of an increase in FSH concentrations in 
some studies. Indeeq, higher oestradiol in inhibin immunised lambs, would also be 
consistent with their lower preovulatory LH surge values (Goodman and Karsch, 
1980). The effects of this are increased ovulation rate and lambing rate despite no 
detectable increase in FSH. This may also have occurred in the present trial. More 
large oestrogenic or precocious (smaller oestrogenic) follicles in respective, inhibin 
immunised and rbGH treated animals may result in increased negative feedback on 
FSH and LH. This agrees with results from bovine follicular fluid treated ewes in 
which inhibin reduced the level of oestradiol negative feedback (Campbell and 
Scaramuzzi, 1996). However, rbGH treatment has previously been reported 
(Tannetta et al., 1997) to reduce the inhibin antibody induced rise on FSH, probably 
due to more small follicles and hence more inhibin negative feedback on FSH. 
5.4.5 Inhibin immunisation: mechanism of action 
In the present study long-term inhibin immunisation alone resulted in increased 
numbers of large (>3.5mm) follicles 72h after follicle wave synchronisation (Figure 
5.8). This is in agreement with previous work (O'Shea et al., 1984; AI-Obaidi et al., 
1987a;b; Forage et al., 1987a; Mizumachi et al., 1990; Wrathall et al., 1990; 1992; 
Campbell, Scaramuzzi and Webb, 1995; Tannetta et al., 1997). It is unclear how 
inhibin immunisation in this and previous trials (Henderson et al., 1984; Schanbacher, 
1988; Meyer et al., 1991; Schanbacher, Schemm and Rhind,' 1991; Fray, Wrathall 
and Knight, 1994; Tannetta et al., 1998) increased .follicular development and 
ovulation rate, since alterations in FSH concentrations were not detected. These 
findings suggest that inhibin antibodies may act at the ovarian level. Alternatively, this 
may suggest that the increase in FSH due to immunisation were only transient and 
difficult to detect in animals with asynchronous follicular waves. Following 
immunisation,., the hapten. hormone concentrations have been known to be either 
reduced by antibody neutralisation or increase following a "rebound" effect, as 
described following steroid immunisation {Scaramuzzi et al., 1980; Scaramuzzi, 
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Martinez and Van Look, 1980). Recently, Tannetta et aI, (1998) reported that inhibin 
A and activin A were significantly increased following long-term active immunisation, 
without a concomitant significant increase in follistatin. Unfortunately, the effects of a-
C-subunit inhibin antibodies in the current trial on in"hibin, activin and follistatin 
concentrations, and more importantly, the bioavailability of these hormones is 
unknown. 
Inhibin and the inhibin a-subunit are known to affect folliculogenesis at the level of the 
ovaries. For example, in addition to inhibiting pituitary FSH release (Baird et a/.,· 
1989), inhibin may increase steroidogenesis, by enhancing LH induced androgen 
-production by thecal cells, as demonstrated by in vitro studies in sheep (Campbell 
and Webb, 1995; see Webb et al., 1999a) and several other species (rat; Hsueh et 
al., 1987; human; Hillier, 1991; cow; Wrathall and Knight, 1993). Conversely, in vivo 
infusion of the ovine ovary via' the ovarian artery with recombinant human inhibin 
reduced ovarian oestradiol and androstenedione secretion (Campbell, Scaramuzzi 
and Webb, 1995a), although FSH may have mediated these effects. Inhibin also 
competes with activin for, and may elicit its effects through, activin receptors (Knight 
and Glister, 2001), whereas the free a-subunit competes with FSH-R and with inhibin 
for the type " activin receptor (Robertson, Hertan and Farnworth, 2000; Knight and 
Glister, 2001; 2003). It may also reduce oocyte competence and the ability of the 
subsequent ovum to form blastocysts after fertilisation (Silva, Groome and Knight, 
1999). Furthermore, given that activin A is increased following inhibin immunisation 
(Tanneta et a/., 1998), and activin A has been shown to up-regulate FSH-R and 
aromatase activity in rat granulosa cells, it may have a role in oocyte maturation 
(Knight and Glister, 2001). The increase in activin A, in the absence of a significant 
rise in its binding protein, follistatin, could explain how long-term inhibin immunisation 
\ 
enhances follicular development and ovulation rate, without necessarily promoting a 
sustained increase in peripheral FSH (Tannetta et a/., 1998). Recent findings support 
. this suggestion as activin A and activin B may have roles in bovine oocyte maturation 
and fertilisation (Silva, Groome and Knight, 2003). Furthermore, it has recently been 
demonstrated in prolific sheep breeds that the oocYte plays a greater role in 
modulating folliculogenesis and ovulation rate than was previously anticipated 
(Montgomery et al., 2001; Wilson et a/., 2001; Fabre et a/., 2003). Oocyte secreted 
BMPs have a role in modulating follicular development and ovulation rate (see 
section 1.1.51. Moreover,_ follistatin binds BMPs (Otsuka et al., 2001a) and the 
evidence to date indicates that follistatin adversely affects prolificacy (Christensen, 
Redmond and Laarveld, 2000). By reducing the ratio of follistatin to activin (Tannetta 
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et al., 1998) the amount of follistatin available to bind BMPs may be reduced, thus 
promoting prolificacy. The exact mechanism through which a-C subunit immunisation 
induces increased inhibin A and activin A and the subsequent effects require further 
.. .' 
investigation. Current evidence suggests that inhibin and inhibin subunits appear to 
have both adverse and beneficial effects on follicular development, however further 
investigation is required. For example, the effects of immunisation against inhibin on 
TGF-p super family proteins and the relative importance of the intra-follicular actions 
of inhibins, activins and follistatin throughout antral follicular development requires 
clarification. 
5.4.4 Effects of rbGH on follicles and interactions with inhibin 
The increase in small follicle numbers in the current trial is in agreement with earlier 
findings following rbGH administration in ewes (Gong et al., 1996b) and heifers 
(Gong, Bramley and Webb, 1991; Gong et al., 1993; 1996; 1997). GH administration 
is thought to cause increased small follicle numbers by increasing liver and 
pancreatic production and release of IGF-I (Pell, 1990; Cohick, 1998; Armstrong et 
al., 2000) and insulin (Gong et al., 1996b; as described in 1.1.5.1). Indeed, rbGH 
administration has been observed to increase plasma IGF-I concentrations 2-3 fold 
(Davis, Smith and Gluckman, 1990; Gong, Bramley and Webb, 1991; Eckery et al., 
1994; Tannetta et al., 1997), without affecting peripheral FSH, oestradiol or 
progesterone concentrations (Tannetta et al., 1997) or ovulation rate in sheep (Davis, 
Smith and Gluckman, 1990; Eckery et al., 1994; Gong et al., 1996b) and cattle 
(Gong, Bramley and Webb, 1991; Gong et al., 1993a). IGF-I increases proliferation 
and steroidogenesis (see Armstrong and Webb, 1997) and enhances the 
responsiveness of bovine and ovine granulosa cells to FSH (Monniaux and Pisselet, 
1992; Spicer, Alpizar and Echternkamp, 1993; Campbell, Scaramuzzi and Webb, 
\ 
1996). It does this by increasing gonadotrophin receptor expression and by 
stimulating the andenylate cyclase second messenger system (Webb et al., 1999a; 
Lucy et a/., 1999). As a result, the number of gonadotrophic sensitive follicles 
responding to gonadotrophic drive, i.e., being recruited, differentiating and attaining 
oestrogenic status following GH and FSH treatment has recently been shown to 
increase in ewes (Gong et al., 1993a). On the basis of rGH dose response study 
(Gong et al., 1997) and the absence of GH receptors in bovine follicles (Lucy et al., 
1993), the direct actions of GH are considered to be less important than the ovarian 
actions of e n ~ o c r i n e e IGF-! (see Webb et al., 1999a; Lucy et al., 1999; Webb et al., 
2003a;b). 
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In conclusion, this work has confirmed and extended previous work showing that 
rbGH administration results in an increase in the number of small antral follicles in 
sheep and that active inhibin immunisation results in an increase in the number of 
.' .' 
large antral follicles. Preliminary evidence also suggests that the combination of 
these treatments results in earlier maturation of small antral follicles, based on literary 
evidence we can speculate that these effects are possibly due to an increase in FSH 
receptors, which are reported to be inhibited by inhibin a-subunit (Knight and Glister, 
2003) and increased by IGF-I (Lucy et al., 1999). However, it is unclear as to whether 
these treatments are additive or whether the effects are the result of a direct 
interaction of the two systems. The eagerly awaited immunohistochemical results 
may e n a ~ l e e us to draw a stronger conclusion as to whether these two systems 
interact. Finally, the fact that these effects occurred independently of detectable 
changes in peripheral FSH concentrations suggests that they are mediated via intra-
follicular control mechanisms. 
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CHAPTER SIX 
THE EFFECT OF PASSIVE INHIBIN IMMUNISATION IN CATTLE ON 
OVARIAN FOLLICLE DEVELOPMENT 
6.1 INTRODUCTION 
One of the most effective ways of improving beef production efficiency is to increase 
twinning rate in suckler beef cattle (Echternkamp and Gregory, 1999a). Computer 
simulation and embryo transfer studies suggest that input costs per unit of beef 
output could be reduced and profit margins increased by 20-300/0 (Guerra-Martinez et 
al., 1990), in herds with a 400/0 twinning rate (Diskin et al., 1987). Twinning rate in 
cattle is a product of ovulation rate, conception rate and embryo (Van Vleck and 
Gregory, 1996) and foetal survival (Rutledge, 1975), and ovulation rate and twinning 
rate are positively correlated ( ~ = O . .75-9.0; Van Vleck, Gregory and Echternkamp, 
1991; Gregory et al., 1997). However, due to low incidence (0.5-4.5%; Pfau et al., 
1947) and heritability of twinning (0.04; Syrstad, 1984), the development of the 
Nebraskan Meat Animal Research Centre (MARC) ~ 3 5 0 / 0 0 twin bearing suckler herd, 
through natural selection, has taken almost two decades (Echternkamp and Gregory, 
1999b). 
FSH is the primary hormone controlling follicle development (section 1.1.4.2) and 
immunoneutralisation of one of the major feedback hormones controlling FSH, 
namely inhibin, often leads to an increase in peripheral FSH concentrations 
(Glencross et al., 1994; Campbell et al., 1995; Terqui et al., 1995; Akagi et al., 1997; 
2002; Takedomi et al., 1997). As a consequence ovarian follicle growth is stimulated 
and the number of recruited follicles can be increased (Campbell, Scaramuzzi and 
Webb, 1995; Campbell and Scaramuzzi, 1995; Takedomi et al., 1997). Furthermore, 
following a longer period of FSH elevation (Kaneko et al., 1993b; 1995; Glencross et 
~ a l . , , 1994), cohort follicles have more time available to grow, differentiate and attain 
ovulatory status, thus increasing the chance of multiple ovulation. Further evidence 
(Campbell et al., 1995; Bleach et al., 1996) suggests that inhibin antibodies act at the 
ovarian level to enhance follicular development independently of peripheral FSH 
concentrations, but the exact mechanisms involved have not been fully elucidated. 
Several alternatives to natural selection have been investigated with a view to 
developing faster, more practical approaches to increase twinning rates in ruminants. 
These approaches have included exogenous hormone treatment (Armstrong, 1993) 
and immunisation against reproductive hormones (Hillard et al., 1995), however 
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extreme variation in animal response, both between animals and within a single 
animal across successive oestrous cycles (Webb and Morris, 1988), to exogenous 
gonadotrophins and active immunisation regimes, against both gonadal steroids 
(Price et a/., 1987a) and inhibin (Bindon et a/., 1988; Scanlon et a/., 1993), have 
resulted in a failure to consistently induce twin ovulations in cattle. In contrast, inhibin 
immunisation has proved relatively successful in sheep (O'Shea et a/., 1994). The 
possible reason for this difference between sheep and cattle are many. However, we 
hypothesised that the main cause was the overriding influence of the dominant 
follicle in cattle, i.e., the drive to produce a single egg. Thus, it was reasoned that the 
variation in response to vaccination was possibly due to immunising animals at an 
inappropriate stage of the follicular wave, which would lead either to a low response, 
if a dominant follicle was present (Straigmiller and England, 1982; Guilbault et a/., 
1991; H u h ~ i n e n n et a/., 1992), or an over stimulation if the immunisation boost 
coincides with follicular recruitmen.t. This problem, allied with a more general difficulty 
in obtaining repeatable titres following immunisation in cattle, means that active 
inhibin immunisation is unlikely to succeed as a means of inducing twin ovulations in 
cattle. 
Passive inhibin immunisation has received less research attention, due to the 
transient nature of the response to passive immunisation and the large quantities of 
antibody required in cattle (Hillard et a/., 1995). However,' using a passive 
immunisation protocol in sheep, which involved an acute bolus injection of inhibin 
antiserum followed by supplementary smaller daily injections, FSH concentrations 
were increased, multiple follicles developed and multiple ovulation's occurred 
(Campbell, Scaramuzzi and Webb, 1995; Campbell and Scaramuzzi, 1995). Thus, 
the acute and controllable nature of passive immunisation enables treatment of 
animals to occur . ~ t t an optimum stage of the follicular wave, with long-term elevation 
in inhibin titre, as occurs with active immunisation. In a similar inhibin passive 
immunisation study, using polyclonal sheep antiserum, in Holstein-Angus cross 
~ ~ heifers, a highly effective and repeatable induction of twin ovulations was obtained 
(Campbell, Gong and Webb, unpublished observations). Twin ovulations were 
observed in 4/6 heifers and one of the other two remaining animals had two dominant 
follicles, but only a single ovulation. 
The objective of the current study was to investigate the affects of passive inhibin 
immunisation on circulating FSH, folliculogenesis, ovulation, corpora lutea (CLs) and 
progesterone concentrations in a larger group of heifers using antiserum raised in 
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ewes (Chapter 5). Also, as the antiserum in the current trial was of lower titre, we aim 
to compare the antibody titres between groups and the physiological responses 
exhibited. 
6.2 MATERIALS AND METHODS 
6.2.1 Experimental Animals 
A total of 18 beef cross heifers aged 18 months and weighing 510.6 ± 17.2 kg were 
involved in the current experiment. The heifers had previously been used in the 
GnRH immunisation study (Chapter 4). There were several reasons, which justify the 
re-use of these animals. Firstly, the current study took place 15 weeks after the 
Chapter 4 study endea (>15 months since the last GnRH booster) and GnRH 
antibody titres were not detectable. Secondly, gonadotrophin and ovarian steroid 
concentrations, reproductive anatomy, follicle development, ovarian cycles and 
oestrus behaviour was similar (P>0.05) in both treatment groups. Thirdly, the heifers 
had been acclimatised to handling and ovarian scanning procedures to reduce 
stress. Finally, the UK was suffering from FMD outbreak and keeping the heifers for 
an additional trial was considered preferable to buying in new animals from outside 
sources. Animals were randomly selected for treatment by an independent 
adjudicator. The results of this random selection are shown in Figure 6.1. Animals 
were group housed on straw and fed twice daily with concentrate and ad libitum hay. 
Figure 6.1 A schematic illustration of the results of random heifer selection. Treated 
(n=3) and control (n=6) heifers from the earlier study described in Chapter 4 were 
immunised against inhibin in the current study, while GnRH immunised animals (n=6) 
and Chapter 4 control animals (n=3) served as control heifers in the current study. 
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Figure 6.2 Experimental protocol 
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6.2.2 Passive immunisation 
The dose of inhibin antiserum used in the previous cattle study (Campbell, Gong and 
Webb, unpublished) was calculated on a weight for weight basis, given cattle are on 
average 10 times heavier than sheep. In an earlier investig.ation this antiserum dose 
was shown to be capable of stimulating a sustained increase in circulating FSH 
concentrations in sheep (Campbell et a/., 1995). Figure 6.3 shows the titration curve 
for the antiserum used in this study. 
Figure 6.3 Inhibin antibody titres in polyclonal antiserum: a comparison between DE 
378, which provided the antiserum in the previous trial (Campbell, Gong and Webb, 
unpublished), ewe 5 and the pool of antiserum used in the current study. The 
antiserum pool was made up of ewe 5 antiserum (-560/0) and a small amount of DE 
378, the. remainder of the antiserum was derived from other inhibin immunised ewes. 
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In the current study it was calculated that only a fraction (-1/4) of the dose of 
"antiserum used in the earlier study (Campbell, Gong and Webb, unpublished) was 
available for use. However only a 400/0 twinning rate was required to meet economic 
targets and the earlier study achieved >400/0 twin ovulation rate. Furthermore, at the 
time, there was no information available on the minimum antiserum titre, required to 
induce twin selection and ovulation in cattle. The inhibin antiserum was injected 
directly into the jugular veins of 9 heifers. For control animals the antiserum was 
substituted for normal ewe serum. The initial dose of 108ml was given 96 hours after 
the 2nd prostaglandin injection. Five subsequent injections of 14ml were administered 
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at 24 hourly intervals. For details on vaccine preparation and production of antiserum 
see Chapters 2 and S, respectively. 
6.2.2.1 Oestrous synchron,isation and artificial insemination 
The animals were synchronised by giving 2 injections of PGF2a 12 days apart. 
Following ovulation, a 3rd PGF2a injection was given to induce luteolysis and allow the 
dominant follicle(s) of the first follicular wave after oestrus to ovulate. All heifers were 
artificially inseminated (A.I.) at fixed times, 72 and 96 hours, relative to the 3rd PGF2a 
injection. If the corpus luteum (Cl), which formed after 2nd PGF2a was not able to 
respond to the 3rd PGF2a injection on Day 7 (Figure 6.2), a further PGF2a injection was 
given on Day 8 to induce CL regression, and timing of A.\, was adjusted accordingly. 
6.2.2.2 Blood sampling 
Blood samples were collected by jugular venepuncture (section 2.S.1) every 8 hours 
from 24 hours after the 2nd PGF2a injection until the 2nd artificial insemination, to 
measure peripheral inhibin antibody titres and FSH concentrations. Thereafter, to 
determine circulating progesterone concentrations, blood collection was carried out 
at 3-4 day intervals. 
6.2.2.3 Real-time ultrasound scanning 
Ultrasound scanning of the ovaries was performed trans-rectally using a real-time B-
mode, linear array ultrasound scanner fitted with a 7.5MHz rectal transducer (Aloka 
550500; Aloka, Tokyo, Japan). Scanning was performed by one of two skilled 
technicians, both of whom were highly experienced in scanning of 'the bovine 
reproductive tract for experimental purposes. Following faecal evacuation of the 
rectum, the ovaries and uterus were located by rectal palpation prior to the 
introduction of a scanning probe. 
The presence of all antral follicles on each ovary was recorded. The diameters of 
.small «4mm) and medium-sized (4-7.9mm) follicles were estimated against the 
centimetre scale on the monitor. larger follicles ( ~ 8 m m ) ) and Cls were measured 
using the electronic calliper feature on the machine along the longest and shortest 
axis of the follicle/Cl, the mean of these two measurements being the recorded size. 
Scanning was initiated 24 hours after the 2nd PGF2a injection and was performed 
every 12 hours until 48 hours prior to the 1st A.\, To ascertain the number and size of 
the Cl(s), which formed subsequent to 3rd PGF2a injection, additional scans were 
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performed on Days, 5, 10, 16 and 31, relative to oestrus (Day 0) after 3rd PGF2a 
injection. 
6.2.2.4 Oestrus 
Oestrus was determined using KAMARTM heat mount detectors and observations of 
behaviour as described previously (sections 1.3.4.1 and 2.9.1). 
6.2.2.5 Post-mortem 
Heifers were slaughtered 14-16 weeks after A.1. 
6.2.2.5. 1 Foetus and ~ e p r o d u c t i v e e tract assessment 
Following slaughter the foetus, ovaries, uterus and ovaries of each animal were 
weighed and measured, prior to examination. The results of carcass assessments, 
which were also conducted, are presented with results of the previous GnRH 
immunisation trial in Chapter 4. 
6.2.3 Statistical Analyses 
Prior to any statistical analysis a general. AN OVA was performed on the data and the 
distribution of the data was checked on residual plots. Where necessary the data was 
log transformed (In). FSH data was log transformed and analysed using Genstat 6.1 
(Lawes Agricultural Trust, 2001, IACR Rothamsted), using split-plot analysis with 
repeated measures and degrees of freedom adjusted for the GGE effect. Ovarian 
follicle counts of medium-sized (4-7.9mm) and large ( ~ 8 m m ) ) were analysed in 
Genstat 6.1, using generalised linear regression analysis, with Poisson 'distribution 
and logarithmic (In) link function. This analysis was selected due to the small mean 
numbers of large (>8mm) follicles. Poisson analysis gives no standard errors of 
difference (s.e.d) or standard errors of means (s.e.m.). Anti-inhibin titres were 
analysed using Genstat 6.1, ANOVA. Where data are transformed to a logarithmic 
scale to normalise the distribution of data, the textual description and statistical 
~ ~ significance_ is based on transformed data. However, for ease of presentation, 
especially for presenting standard errors, the tables and figures display the 
unadjusted data unless otherwise stated. 
6.3 RESULTS 
With permission, some unpublished results from a previous trial (B.K. Campbell, J. G. 
Gong and R. Webb) are presented in a comparative way with the results of the 
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present trial. Antibody titres from the current study and the earlier study are 
comparable as samples from both studies were assayed together. 
6.3.1 Antibody titres 
Mean antibody titres, 8 hours after inhibin antiserum injection, are compared with 
those of the previous (Campbell, Gong and Webb, unpublished) and shown in Figure 
6.4. Heifers in the Campbell, Gong and Webb trial had significantly (P<0.001) higher 
anti-inhibin titres than those of the present trial, (Figure 6.4). Mean control heifer titre 
was <2.00/0 binding at each dilution. Mean inhibin antibody titres (1 in 20 dilution) 
over time are illustrated in Figure 6.5. Inhibin antibody titres remained constant for 
6.5 days after the antiserum bolus injection. 
Figure 6.4 A comparison of mean (± s.e.m.) inhibin antibody titres, in peripheral 
serum 8 hours after a bolus injection of antiserum, between the current experiment 
(referred to as Williams) and the previous experiment (Campbell, Gong and Webb, 
unpublished observations) referred to as Campbell. Heifers in the Campbell trail had 
significantly (P<0.001) higher inhibin antibody titres than heifers in the current study. 
80 
70 I-------------------l-e-Campbell (n=5) 
60 
Williams (n=9) 
CD 50 
c 
U 
c 40 CD 
~ ~0 30 
20 
10 
0 
0 20 40 60 80 100 
Serial dilution of serum 
180 
Figure 6.5 Mean (± s.e.m.) inhibin antibody titres in the peripheral serum of 9 heifers 
(1 :20 dilution) over time. Key: blue arrows represent booster antiserum injections, 
relative to bolus administration (time 0). 24h after the bolus antiserum was 
administered the mean anti-inhibin titres stabilised between 35-400/0 binding. 
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6.3.2 Reproductive hormones 
Due to observations made during ultrasound scanning of the ovaries, 3 heifers were 
withdrawn from the trial. Heifer 7: because we were unable to identify time of 
ovulation or observe a Cl, however this animal was exhibiting oestrous cycles. 
Failure to identify time of ovulation was also the reason for withdrawing heifer 23, 
although this animal was cycling and a Cl was present. Heifer 24 had three follicular 
cysts on her left ovary and was acyclic at the time of this study. Examination of the 
ovaries and reproductive tract of this animal confirmed that the uterus was relatively 
immature and the right ovary was adhered to the bladder wall. The experiments 
reported in this thesis are not considered to be responsible for the abnormalities in 
. heifer 24. 
6.3.2.1 Follicle stimulating hormone 
Mean serum FSH in both treatment groups is presented in Figure 6.6. FSH 
concentrations did not change significantly throughout the sampling period (P=0.12). 
Furthermore, treatment had no Significant effect on serum FSH concentrations 
(P=0.27), and there was no time! treatment interaction (P=O.36). 
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Figure 6.6 Mean FSH concentrations in inhibin immunised and control heifers with 
time (P=0.12). Standard error of the differences of means were; 0.26, 0.12, 0.41 and 
0.39 for time, treatment and time / treatment interactions, respectively. 
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6.3.2.2 Progesterone 
Examples of typical pregnant and non-pregnant progesterone profiles and growth of 
associated CL are presented in Figures 6.7 and 6.8, respectively. Figure 6.9 shows 
the one and only immunised heifer, which exhibited a twin ovulation and associate 
CL. In all three Figures, A.1. occurred 24 and 48h after Oestrus (Heat). 
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Figure 6.7 Progesterone concentration in plasma and associated growth of CL 
diameter relative to oestrous cycle synchronisation treatments and ovulation in a 
non-pregnant heifer (2475). Key: PG3 = 3rd PGF2a injection. H = approximate time of 
heat. A.1. occurred at Heat +24 and +48h. 
30 
E 27 
E 
::; 24 
o 
"'0 21 
c: 
~ ~ 18 
~ ~ 15 
c: 
~ ~ 12 
c: 
e 9 Q) 
..... 
~ ~ 6 
C) 
e 3 a. 
o 
..... 
.... 
-4 o 4 
...... CL1A j 
-+-CL2A 
...... ~ ~ . 
-+-CL3A 
I 
" 
-7 Progesterone 
"" 
/ 
- ~ ~ CL regression .... 
--
PG3 .. .. 
- H 
--
. 
8 12 16 20 24 28 32 36 40 44 48 
Time (days) relative to 1 st ovulation 
Figure 6.8 Progesterone concentration in plasma and associated growth of CL 
diameter relative to oestrous cycle synchronisation treatments and ovulation in a 
pregnant heifer (39). Key: PG3 = 3rd PGF2a injection. H = approximate time of heat. 
A.1. occurred at Heat +24 and +48h. 
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Figure 6.9 Progesterone concentration in plasma and associated growth of CL 
relative to oestrous cycle synchronisation treatments and ovulation in a pregnant 
heifer (73). Note the presence of an additional CL (CL 38) indicative of a double 
ovulation. The life span of the additional CL was short (5 days). Key: PG3 = 3rd 
PGF2a injection. H = approximate time of heat. A.1. occurred at Heat +24 and +48h. 
CL number indicates the PG injection that the CL referred to is following, and A or 8 
indicates from which ovulatory follicle the CL is derived, e.g., an additional CL 
following ovulation after 3rd PGF2a injection is referred to as CL 38. 
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6.3.3 Ovarian follicle development 
Populations of small «4mm) antral follicles in control and immunised heifers are 
presented in Figure 6.10. During the sampling period the number of small follicles did 
not differ between individuals, or between ultrasound scans (P>O.05). Furthermore, 
treatment had no overall influence on the number of small follicles overall (P>O.05). 
However, there was a significant time/treatment interaction (P<O.001; 36-72h) during 
which, small follicle numbers were reduced in the immunised heifers. 
The mean number of medium-sized (4-7.9mm) follicles in the inhibin immunised and 
control heifers are illustrated in Figure 6.11. The number of medium-sized follicles in 
the ovaries varied between individual heifers (P<O.001) and with stage of the 
oestrous cycle (P<O.001). Passive inhibin immunisation caused a significant increase 
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in the number of medium-sized follicles (P<O.001) overall and there was a significant 
time/treatment interaction (P<O.001; 0-48h). 
, 
Numbers of large follicles ( ~ 8 m m ) ) in treated and control groups are presented in 
Figure 6.13 the follicle numbers varied between individuals (P<O.01) and with day 
relative to ovulation (P<O.001). Treatment had no affect on numbers of large follicles 
(P=O.68) and there was no time/treatment interaction (P=O.94). 
Figure 6.10 Mean numbers of small antral follicles in control and immunised heifers. 
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Figure 6.11 Mean number of medium-sized follicles in control and inhibin immunised 
heifers. 
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Figure 6.12 Mean number of large follicles in control and inhibin immunised heifers. 
3 
C/) 
..... Control (n=7) 
a> 2.5 
....... Immunised (n=8) 
.2 
.E 
a> 2 
~ ~
a:s 
-0 1.5 
L-
a> 
..c 
E 
:l 
c 
1 
c 
a:s 
a> 0.5 ~ ~
0 
-72 -48 -24 0 24 48 72 96 120 144 168 
Time relative to ovulation (hours) 
6.3.3 Twinning rate, conception rate and reproductive assessment 
Inhibin immunisation had no significant effect on ovulation rate or CL number. The 
treatment status in this trial of 8 heifers, which conceived to fixed time artificial 
insemination following the 3rd injection of PGF2a, is presented in Table 6.1. In 
addition, the pregnancy status, CL diameter, day of gestation, foetal weights are also 
shown. The weight of ovaries was not comparable between heifers due to 
asynchrony of fOlliculogenesis at the time of slaughter, i.e., at time of slaughter 
heifers were at different stages of follicular waves, and the number and size of antral 
follicles and CLs affects ovarian weight. Foetuses with a crown-rump length of 16 cm 
were approximately 98 days old, other foetuses were -112 days of age. Due to the 
small numbers of pregnant animals and practical considerations at slaughter, foetal 
weight analysiS was not possible. 
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Table 6.1 Post-mortem results and immunisation status from eight pregnant heifers 
age approximately 22.5 months. GnRH status indicates the treatment the animal 
received in the previous trial (Chapter 4), i.e., control (con) or GnRH immunised 
(Imm). Inhibin status i n d i c a t e ~ ~ the treatment received in the current trial. 
Heifer 1.0. GnRH Inhibin CL Pregnant Foetal Foetal Foetal 
Status Status ~ i a m e t e r r Uterine Weight Crown-Rump Gender 
(mm) Horn (Grams) Length 
(em) 
14 Con Con 25 Right 245.8 16 Female 
1445 Con Imm 12 Right 260.8 16 Female 
1447 ' Imm Imm 11 Right 324.5 16 Female 
7020 Con Imm 14 Right 273.5 16 Female 
51 Con Con 21 Left 695.1 20 Male 
73 Imm Imm 21 Left 686.7 20 Female 
39 Imm Con 12 Left 700.8 20.5 Male 
338 Imm Con 23 Right 777.2 21 Male 
6.4 DISCUSSION 
The current study on the effects of passive immunisation against inhibin in heifers 
has provided some evidence that inhibin antibodies act at the ovarian level to 
enhance the recruitment of follicles, without a detectable increase in pituitary FSH 
release. Furthermore, the evidence suggests that while lower levels of inhibin 
antibodies are adequate to enhance recruitment and/or reduce the rate of atresia in 
medium-sized follicles. Higher inhibin antibody titres may be necessary to over-ride 
the strong dominant follicle selection mechanism in heifers. In addition, the results of 
this and a previous trial (Campbell, Gong and Webb, unpublished), demonstrate that 
. a threshold inhibin antibody titre range is required to obtain a reproducible increase in 
ovulation rate on which future passive inhibin immunisation studies may be based. 
Finally, this approach of a bolus followed by subsequent small antiserum injections 
has successfully been shown to give a steady and consistent concentration of 
circulating inhibin antibody titres. 
6.4.1 Follicle stimulating hormone response 
In the current,. study there was no detectable increase in peripheral FSH 
c o n c e n t r a t i o n ~ ~ following immunisation. Earlier studies report variations in the FSH 
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response to active inhibin immunisation. For example, some authors observed an 
elevation in peripheral FSH concentrations (Glencross, 1992; Glencross et al., 1994; 
Scanlon et al., 1993; Akagi et al., 2002), while others reported no significant change 
in FSH (Schanbacher, 1 9 8 ~ ; ; Glencross et al., 1992; Morris and Grealy, 1993; 
Scanlon et al., 1993), or intermittent FSH increases (Morris, Grealy and Screenan, 
1995a;b). Previous experiments involving passive inhibin immunisation of cattle have 
also reported an increase in peripheral FSH concentrations (Kaneko et al., 1993; 
1995; Takedomi et al., 1997; Akagi et al., 1997). Considerable variation in plasma 
FSH concentrations, both within and between animals, coupled with inadequate 
blood sampling regimes, has previously been blamed for the lack of detectable 
changes in FSH concentrations (Glencross et al., 1994), however, we believe our 
sampling regime to have been adequate. Therefore variation is likely to be linked to 
follicle waves and the transient nature of the FSH rise in relation to the stage of 
folliculogenesis. 
The peak FSH concentrations prior to ovulation (Akbar et al., 1974; Schams and 
Schallenberger, 1976), the secondary FSH peak, which typically occurs 24 hours 
after an LH surge (Dobson, 1978; Webb et al., 1980; see Peters, 1985), preceding 
follicle wave emergence (Adams et al., 1992; Sunderland et al., 1994), and the 
decrease in FSH around the time of selection (Sunderland et aI., 1994) were 
undetectable because of the large variation in FSH concentrations between 
individuals. This large variation in FSH is probably due to asynchrony of follicle 
waves between animals. After ovulation follicle recruitment follows, however the time 
of ovulation relative to the 2nd PGF2a injection, and hence recruitment varied between 
individuals by 2.5 days. We acknowledge that presenting FSH waves relative to an 
LH peak may have enabled us to detect any FSH differences that might have 
occurred, however, we did not measure LH in this study. 
6.4.2 Follicle Response 
. Asynchrony ~ o f f follicular waves in the current study led to a large variation in the time 
of antiserum administration relative to ovulation (range: -24 to +36 hours) and the 
emergence of the subsequent follicular wave. However, treatment effects included; a 
reduction in small follicles (36-72h), increased medium-sized follicles (0-48h), but no 
effect on large follicles or ovulation rates. These data may indicate that initially inhibin 
antibodies reduced the rate of atresia in medium-sized follicles and subsequently 
increased the number of r e c ~ u i t e d d follicles. Treatment appears to have increased the 
,., 
numbers of small follicles, which made the transition into the medium-size category. 
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Interestingly, although the number of small follicles was similar in individual heifers, 
there were significant individual differences in the numbers of both recruited and 
dominant follicles (Figures 6.11 and 6.12). As inhibin antibody titres were similar in all 
animals, unlike previous actiye inhibin immunisation trials (Sunderland et a/., 1991; 
Scanlon et a/.,1993; Morris and Grealy, 1993; Mantovani et a/., 1997), this suggests 
that, individual animals (and/or follicles) respond differently to passive immunisation 
with anti-inhibin serum. However, the asynchrony between heifers, with respect to 
time of ovulation relative to the PGF2a injection may be responsible for some of this 
variation. In contrast to earlier active inhibin immunisation studies (Price et a/., 
1987b; Morris, McDermot and Screenan, 1991; Morris et a/., 1993; Morris, Grealy 
and Screenan, 1995; Sunderland et a/., 1991; Glencross, 1992; Glencross et a/., 
1992; 1994; Scanlon et a/., 1993; Akagi et a/., 2002), no increase in ovulation rate 
was observed in the current study. However, one heifer exhibited a small and short-
lived accessory CL (Figure 6.9). 
6.4.3 Ovulation rate 
Previous passive inhibin immunisation experiments (Takedomi et a/., 1997; Akagi et 
a/., 1997) report extreme variability and superovulatory responses when excessively 
high doses (7Sml; Takedomi et a/., 1997; 37.S and SOml; Akagi et a/., 1997) of high 
antibody titre antiserum are administered (SO% binding at 1: 96,000; Kaneko et a/., 
1993) and large increases in peripheral FSH concentrations observed (Kaneko et a/., 
1993; 1995; Takedomi et a/., 1997; Akagi et a/., 1997). The lack of an increased 
ovulation rate in the current study and the high incidence of twin ovulat,ions in the 
previous (Campbell, Gong and Webb, unpublished) study, confirm that antiserum 
dose is critical to the physiological response. 
Despite no affect of treatment on ovulation rate, evidence in the current and previous 
, studies (Glencross et a/., 1992; Kaneko et a/., 1993; Bleach et a/., 1996) suggests 
that the stimulatory effects of in hi bin antibodies on small and medium-sized follicles 
act at the ovarian level. Inhibin antibodies may enhance the responsiveness of small 
and medium-sized follicles to gonadotrophic drive (as discussed in Chapter S) thus 
promoting development and reducing atresia, without a detectable increase in FSH. 
However, to over-ride the selection mechanism and reduce atresia in selected 
follicles, higher inhibin antibody titre (Akagi et al., 1997) may be necessary and a 
small increase in FSH required. Indeed, earlier work (Kaneko et al., 1993) supports 
the current findings that small and medium-sized follicles are more responsive to 
'" 
inhibin antibodies than large or dominant follicles. This may be because medium-
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sized follicles are gonadotrophin dependent, but due to the lack of LH receptors they 
are totally FSH dependent. For example, after passive inhibin immunisation, when 
titres had returned to pre-treatment levels dominant follicle numbers, which had been 
increased (4.7 ± 0.9), returned .. to control levels within 24 h<?urs. In contrast, small and 
medium-sized follicles continued to be increased relative to control heifers for several 
days (Kaneko et a/., 1993). 
6.4.4 Inhibin Antiserum Dose and Inhibin Antibody Titres 
The current passive immunisation protocol demonstrates that, inhibin antibody titres 
can be maintained at elevated levels, as reported in ewes (Campbell and 
Scaramuzzi, 1995). T h ~ ~ small variations in antibody titres may be further reduced by 
the use of a herd of more uniform weight, or by varying the dose of antiserum 
according to weight of the animal, although this is unlikely to be practical. A problem 
with earlier studies (Kaneko et a/., 1993; 1995; Akagi et a/., 1997; Takedomi et a/., 
1997) is that animal numbers are small (3-5 animals per treatment group), which 
makes comparisons between trial and groups within trials more difficult. However, 
when comparing the findings between studies (Akagi et a/., 1997, Campbell, Gong 
and Webb, unpublished and the current trial), it is clear that inhibin antibody titres in 
the current trial may have been too low. For example, at 1 :30 plasma dilution, on Day 
1-2 of the oestrous cycle, anti-inhibin titres were in the previous (Campbell, Gong and 
Webb, unpublished) and current studies about 620/0 and 290/0 binding, respectively 
(Figure 6.3). Antibody titres in the earlier trials (Kaneko et al., 1993; 1995; Takedomi 
et a/., 1997; Akagi et a/., 1997) are not directly comparable to our study because of 
.. 
different assays used. Differences in persistence of titres around 3 days after 
oestrus, the breed of cattle used, and the protocol used might also be partly 
responsible for differences in ovulation rates and FSH responses to vaccination 
between trials. In the previous (Campbell, Gong and Webb, unpublished) and current 
studies, the bolus injection was given on the day of ovulation and daily boosters 
thereafter for 5 days, until a PG injection, to which all animals responded. This longer 
~ ~exposure to a steady level of inhibin a-subunit antibodies resulted in increased 
follicular growth. Furthermore changes, for example, in the activin: follistatin ratio 
(Tannetta et al., 1998) or the expression of a and (3-subunits, or inhibin dimer 
concentrations relative to a-subunits may have occurred during the more prolonged 
period of inhibin antibody in the current trial, relative to the earlier study (Akagi et al., 
1997). The more abrupt introduction of inhibin antibodies in the Akagi et al. (1997) 
trial may not have allowed the time for the aforementioned suggested changes to 
occur. The m . ~ s t t obvious difference between the previous studies i.e., Akagi et al., 
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(1997) and Campbell, Gong and Webb (unpublished) is the immunogen used (32kDa 
inhibin vs. a-C inhibin subunit). The choice of immunogen has been shown to affect 
the physiological response dramatically (Knight et a/., 19a9; Scanlon et a/., 1993; see 
O'Shea et al., 1994; Terqui ,et al., 1995). Indeed, d e c r ~ a s e d d variability and high 
proportion of twin ovulators in the UK study relative to the Japanese studies (Akagi et 
a/., 1997, Takedomi et a/., 1997) was observed. Furthermore, the current study 
provides further evidence to support the evidence (Scanlon et a/., 1993; Bleach et a/., 
1996) that the effects of a-C subunit antibodies· act at the ovarian level, although the 
exact mode(s) of action have yet to be elucidated. 
The data indicates that inhibin a-subunit antibodies might act at the ovarian level to 
enhance follicle recruitment and/or reduce atresia. However, an inhibin immunisation 
effect mediated through FSH cannot be ruled out. An increase in twin ovulation rate 
may be achieved following this passive inhibin immunisation protocol if antibody titres 
in heifers are >30 and <650/0 binding at 1 in 30 dilution, and this treatment can be 
applied accurately at the correct stage of follicular recruitment. 
6.4.5 Future work 
To attain consistent double ovulations, an improvement in follicular wave 
synchronisation is required. This may be achieved by using a controlled intra-vaginal 
progesterone releasing device (CIDR) treatment regime or PG injections coupled 
with GnRH treatment. In addition, larger animal numbers are required and higher titre 
antiserum. A suggested alternative protocol may be a two-tier anti-inhibin titre 
protocol. A lower antiserum volume as in the current trial to increase recruited follicle 
number, without over stimulating the ovaries, followed by a higher titre antiserum 
(Campbell, Gong and Webb, unpublished), to overcome the mono-ovulatory drive 
and prevent atresia by increaSing the number of follicles which are able to 'switch' 
their dependency from FSH to LH when FSH concentrations decline . 
. Future investigations into inhibin antibody modes of action at the ovarian level and 
the subsequent effects on prolificacy should adopt the use of in vivo physiological 
models. For example, using long-term GnRH agonists ·to inhibit pituitary gland 
gonadotrophin release, followed by exogenous FSH and LH injections to mimic the 
typical patterns of gonadotrophic release, and passive inhibin immunisation, the intra-
ovarian role of inhibin antibodies may be elucidated. However, care must be taken to 
avoid over-stimulation of the ovaries with exogenous FSH. For a dose response 
study, see Murphy, Boland and Roche, (199a). 
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CHAPTER SEVEN 
GENERAL SUMMARY AND DISCUSSION 
The main finding of this thesis is that, neonatal active GnRH immunisation of calves 
did not permanently impair reproductive function, and with the exception of limited 
improvements to carcass classification, all inhibited characteristics were similar to 
control animals by 17 months (bulls; Chapter 3) and 22.5 months (heifers; Chapter 4). 
As discussed, these findings are in contrast to earlier GnRH immunisation trials on 
reproductive function i n ~ s h e e p p (Brown and Mattner, 1992; Brown et al., 1994; 1995; 
Clarke et al., 1998) and pre- and post-pubertal zebu bulls (O'Occhio, Aspden and 
Trigg, 2001) were neonatal and early active immunisation protocols resulted in a 
permanent suppression of reproductive function in a gender specific proportion of 
animals. The timing, in relation to hypothalamic maturation, and magnitude of the 
elevation in numbers of unbound high affinity GnRH antibodies in the circulation 
(GnRH antibody titre) may be responsible for the lack of long-term physiological 
responses in the studies herein, compared with earlier trials. For example, antibody 
titres were greater in studies by Brown et al. (1994; ewes; 50% binding at 1:1,500-
1: 18,300) and Brown et al. (1995; rams; 50% binding at 1 :2000-1 :50,000) than those 
reported in Chapters 3 and 4. Future neonatal immunisation studies should adopt 
new approaches to ensure satisfactory immune responses and elevation in titres. 
In chapter 4, we report on an "autoimmune response/titre rebound" to the early 
immunisation regime. The incorporation of a significant and predictable "self-booster" 
response into an immunisation protocol might be extremely useful when designing an 
i m m u n i s a ~ i o n n protocol, which for practical reasons, must keep the number of booster 
vaccinations to a minimum. The cause of the observed elevation in titres, in the 
absence of a booster vaccination is unclear, and although we have discussed and 
speculated on the possible causes in Chapter 4, there is no direct evidence to 
indicate that there was an autoimmune response. 
In addition, these two chapters (3 and 4) describe one of the most comprehensive 
studies on the acquisition of sexual maturity in bull and heifer calves and make a 
significant contribution to knowledge in this field. 
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The Chapter 5 study has confirmed and extended previous work showing that rbGH 
administration results in an increase in the number of <3.5mm antral follicles in sheep 
and that active inhibin immunisation results in an increase in the number of ~ 3 . 5 m m m
antral follicles. Preliminary eyidence also suggests that the combination of these 
treatments results in earlier maturation of small antral follicles, it is unclear as to 
whether these treatments are independent and simply additive, or whether the effects 
are the result of a direct interaction of the two systems. On going 
immunohistochemical results may enable us to draw a stronger conclusion as to 
whether these two systems interact. Finally, the fact that these effects occurred 
independently of detectable changes in peripheral FSH concentrations suggests that 
they might be mediated, to some extent at least, via intra-follicular control 
mechanisms. 
As with Chapter 5, passive inhibin immunisation in heifers (Chapter 6) did not result 
in a detectable increase in circulating FSH concentrations. Thus, this study has also 
provided some evidence that inhibin antibodies act at the ovarian level to enhance 
follicle recruitment. However, the key finding of this study comes from the comparison 
between it, and a previous trial (Campbell, Gong and Webb, unpublished). Evidence 
suggests that while lower levels of inhibin antibodies are adequate to enhance 
recruitment and/or reduce the rate of atresia in medium-sized follicles. Higher inhibin 
antibody titres may be necessary to over-ride the strong dominant follicle selection 
mechanism in heifers. Moreover,' the results of this and a previous trial (Campbell, 
Gong and Webb, unpublished), demonstrate that a threshold inhibin a n ~ i b o d y y titre 
range is required to obtain a reproducible increase in ovulation rate, on which future 
passive inhibin immunisation studies may be based. Finally, this approach of a larger 
bolus antiserum injection followed by subsequent small antiserum injections has 
successfully been shown to give a steady and consistent concentration of circulating 
inhibin antibody titres. 
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APPENDIX I 
Assay Calculations 
Composite standard curve: 
Use % binding (B/Bo) throughout. 
Calculate mean and standard error of the means (s.e.m.) for each point of the 
standard curve across all assays. Plot these as a standard curve. This is a composite 
standard curve for the set of assays. 
Minimum detectable dose (lower sensitivity): 
Calculate TB/mean TB (within assay) x 100 for each TB. Calculate the standard 
deviation of all TB across all assays. 
Then: 100-(SOx2)=O/o binding. This percentage binding is then read from the 
composite standard curve to give a minimum detectable dose in ng tube-1• If the 
standards are per tube, the calculation must be corrected for amount assayed, by 
multiplying by 1000/assayed J.ll. 
If the assay is extracted, the data must be adjusted for the extraction efficiency. 
Inter-assay variation: 
Calculate the standard deviation of the QCs across all the assays, and average 
them. Mean the values of all QCs also. 
Coefficient of variation = 
100 x SO where X = mean of QC values 
X SO = mean of SO of QCs 
Intra-assay variation: 
S = square root of (sum of d2) 
2n 
where d = difference in QC/sample pairs 
n= number of pairs used. 
For the intra assay variation one can also just mean all the sample .coefficients of 
. variation (covs) for each assay. 
Algorithm: 
Smoothing window: 
Nadir window: 
Minimum pulse interval: 
Rise threshold: 
Baxter parameters: 
APPENDIX II. 
MUNRO Settings 
MUNRO 
60 mins 
35 mins 
30 mins 
2 standard deviations (s.d.) 
B1: 0.02920 
B2: 
B3: 
G parameters (s.d. units): G1: 
0.02970 
0.00089 
3.979 
2.399 
1.679 
1.239 
0.930 
G2: 
G3: 
G4: 
G5: 
APPENDIX III 
Examples of LH pulse profiles from GnRH immunised and control bulls during a 
serial bleed at 16 weeks of age. Black arrows indicate the Authors estimation of an 
LH pulse occurrence. 
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APPENDIX IV 
Examples of LH pulse profiles from GnRH immunised and control bulls during a 
serial bleed at 16 weeks of age. Black arrows indicate the Authors estimation of an 
LH pulse occurrence. 
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APPENDIX V 
Examples of LH pulse profiles from GnRH immunised and control bulls during a 
serial bleed at 16 weeks of age. Black arrows indicate the Authors estimation of an 
LH pulse occurrence. 
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